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1. Schizophrenia 
 
Schizophrenia is a severe psychiatric disease, characterized by a range of 
dysfunctions in perception, thinking, language, behavior, affect, volition, drive 
and cognition. No single symptom is pathognomonic for the disease. Psychotic 
episodes with delusions, hallucinations and often bizarre behavior, combined 
with disorganized speech and thinking are often alternated with periods in 
which negative symptoms, such as loss of initiative, flattening of affect and 
psychomotor poverty are prominent. These signs and symptoms are associated 
with marked social or occupational dysfunction. The prevalence is 
approximately 0.5 percent of the total population. The incidence is about 0.2 per 
thousand inhabitants in the age category of fifteen to forty-five. The worldwide 
incidence of schizophrenia is remarkably stable and apparently hardly 
influenced by differences in cultural background (Eaton et al., 1995). The mean 
age at onset for the first psychotic episode is in the early or mid-twenties for 
men and in the late-twenties for women. The onset can be acute or insidious and 
most individuals have some sort of prodromal signs and symptoms such as self-
negligence, social withdrawal and flattening of affect. About a quarter of the 
patients fully recovers after one or two psychotic episodes, half of the patients 
shows partial recovery with remittent episodes, while the remaining quarter 
shows a chronic course (Hegarty et al., 1994; Ram et al., 1992). Mortality is 
high, with a suicide rate of 10 percent. The illness usually reaches a stable level 
after the first two to five years (Belitsky and McGlashan, 1993). The course of 
illness in the early phase of the disease is a good predictor for the long-term 
course (Harrison et al., 1996). Other known factors associated with a good 
prognosis are good premorbid adjustment, acute onset, later age at onset, being 
female, precipitating events, associated mood disturbance and no family history 
of schizophrenia. 
 
 
2. Cognition and schizophrenia: history and theoretical models 
 
Nowadays it is widely accepted that schizophrenia is caused by a cerebral 
dysfunction and cognitive deficits are among the common symptoms of 
schizophrenia. This does not diverge much from the first studies describing the   Introduction 
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schizophrenia concept in the beginning of the last century. Especially, Bleuler 
who introduced the name “schizophrenia” in 1911 saw cognitive deficits as the 
fundamental phenomena in schizophrenia. After this publication however the 
neurocognitive research on schizophrenia felt into oblivion due to a lack of 
impressive results, to re-emerge in the last decades of the twentieth century. At 
present the most dominant heuristic model states that schizophrenia is caused by 
a neurobiological deficit, probably caused by genetic factors and detrimental 
events during early development. This causes psychopathology later in life 
because the affected brain areas mature later in life. In this model cognition is 
often viewed as an intermediate between neurobiological functioning and higher 
levels of functioning such as social functioning and self-awareness. Recent 
etiological theories, which incorporate neurobiological and cognitive 
functioning in schizophrenia, can be divided into three broad categories. The 
first category consists of those theories that view cognitive deficits as the core 
of the disease. Goldman-Rakic (1994) for example proposed that the 
fundamental impairment in schizophrenia is a defect in working memory, which 
is viewed as the ability to guide behavior by representational knowledge of the 
outside world. This is supposed to be caused by a dysfunction in the cortical 
processing networks by which the prefrontal cortex accesses and holds “on line” 
this representational knowledge through its connections with parietal and limbic 
areas. Hemsley (1994) proposes that the core deficit in schizophrenia is a 
weakening of the influence of stored memories on current input, caused by a 
disruption in the normal input tot the basal ganglia from the limbic system 
(Gray et al., 1991).  
The second category of theories assumes that cognitive deficits and symptoms 
are both symptoms of the disease and are caused by the same neurobiological 
dysfunctions. Andreasen (1997) for example proposed that schizophrenia is 
caused by a deficit in the circuitry connecting the thalamus, frontal cortex and 
cerebellum, resulting in “cognitive dysmetria”, which is characterized by an 
impairment in coordinating perception, encoding, retrieval and prioritization of 
experience and information, hence resulting in cognitive deficits and 
psychopathology.  
Cornblatt (1999) suggests that a combination of several genes can cause 
neurobiological deficits, which eventually lead to schizophrenia. These   Introduction 
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neurobiological deficits cause attention deficits on the one side and clinical 
symptoms on the other side. Both can cause social deficits. 
The third category of theories views the syndrome as the results of different 
disease processes, causing cognitive deficits and symptoms independently. 
Murray (1987, 1992) for example proposed that two different processes can 
play a role, a distinct neurodevelopmental process, which has its origins in 
genetic deficits and early risk factors can cause premorbid symptoms, cognitive 
deficits and negative symptoms, while a high affective reactivity can induce 
positive symptoms in combination with stress-full circumstances. 
 
 
3. Cognitive deficits in schizophrenia 
 
Cognitive deficits are often found in schizophrenia. This paragraph gives an 
overview of the most important findings in several domains of cognitive 
functioning. The division in cognitive functions is only for clarity because this 
division is artificial and most tasks appeal to several functions at once. It is also 
important to realize that there is a distinction between the performance on a task 
and the underlying cognitive function it is supposed to measure. The former is 
called an indicator and the latter a construct. 
 
Attention 
It is very difficult to give a conclusive definition of attention. Globally speaking 
it is the mental power, which enables us to direct our mental capacity during 
some time, so we can perform well on a task. In the neuropsychological 
literature attention is often divided into four constructs. The first is sustained 
attention, the ability to maintain an information- processing task during a certain 
amount of time. The second, focused attention, aims at the ability to focus one 
attention on a particular stimulus, while other stimuli are ignored. The third, 
divided attention aims at the ability to divide ones attention between two or 
more different stimuli. The fourth is flexibility of attention, the ability to switch 
ones attention from one kind of stimulus to another.  
More recent neurobiological research on the nature of attention shows that 
globally attention can be divided into two constructs, intensity and selectivity 
(Eling and van Zomeren, 1997). Intensity is the level of arousal or activity,   Introduction 
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which enables a person to use its mental capacity for a task. By selectivity the 
attentional control functions are meant. Unfortunately, there are no proper 
indicators or tasks to measure these constructs selectively. This holds especially 
for intensity. Mostly correct signal detection or speed are taken as a global 
measure of intensity.  
On signal-detection tasks performance there is no indication of impairment in 
sustained attention in schizophrenia. This would imply a time-on-task effect, 
which is not found. Vigilance, a state of readiness to detect and respond to 
certain small changes occurring at random time intervals in the environment 
(Nuechterlein et al., 1994) is most often assessed with the continuous 
performance paradigm, which involves tachistoscopic presentations of a quasi-
random series of stimuli at a rapid fixed rate over 5-15 minutes with instructions 
to respond to a predestinated stimulus or sequence of stimuli (Nuechterlein et 
al., 1994). Variations with degraded visual images or in which one has to 
respond only if the designated target is preceded by a fixed target, exist. 
Schizophrenic patients as a group typically show impaired signal/noise 
discrimination on continuous performance tasks (Nuechterlein et al., 1991). 
Slowness in performing cognitive tests is a characteristic feature of 
schizophrenia, which has been well documented over the years (Nelson et al., 
1990). Often used tasks are cancellation tasks, the Digit Symbol task from the 
WAIS, Trail Making Test part A and reaction time tasks. In a large meta-
analysis of reaction time data from 40 studies (Schatz, 1997) a generalized 
slowing appears to be a significant aspect of information processing in 
schizophrenia.  
The evidence for deficits in selectivity of attention in schizophrenia is less 
consistent. Often used indicators are the Stroop interference score and the Trail 
Making Test interference score and more complex reaction time tasks. In the 
most well known version of the Stroop paradigm, interference occurs when 
naming the print color of a word when the word itself has the name of another 
color. This is measured by the increased amount of time required to complete 
the task. According to Cohen and Serban-Schreiber (1992) schizophrenic 
patients show a clear interference effect. A number of studies did not replicate 
these findings (e.g. Taylor et al., 1996; Chen et al., 2001).  
In a study with the Stroop and five other experimental inhibition tasks no 
differences were found between a group of first episode schizophrenic patients   Introduction 
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and healthy controls (Broerse, 2002). The Trail Making Test is usually part of a 
larger test battery. The interference occurs when the subject must connect 
alternating letters and numbers. This is measured by the extra amount of time it 
takes to alternate instead of connecting only the numbers. In a large meta-
analysis of cognitive functioning in schizophrenia (Heinrichs and Zakzanis, 
1998), a large effect size is found on Trail Making Test interference, and only 2 
out of 15 studies reviewed, did not find a significant effect. In a large meta-
analysis on reaction time data (Schatz, 1997), there was an additional effect for 
problems with inhibition tasks next to a general slowing of information 
processing. 
 
Memory 
Memory is no unitary concept and can be divided in several systems and 
subsystems or processes (Schacter and Tulving, 1994). As for explicit memory, 
information first comes into primary memory or working memory (Baddeley 
and Hitch, 1974). This can be divided into three subsystems. Two short-term 
memory stores, the articulary loop and the visuospatial sketchpad, which hold 
information for maximum thirty seconds without interference, and the central 
executive, a more general cognitive function, which controls these systems. 
Information goes from short-term memory to long-term episodic memory by 
means of rehearsal or elaborate processing. Episodic memory enables people to 
encode and retrieve personal information, which is encoded in relation to spatial 
and temporal context. Three processes can be distinguished in manipulating 
episodic information: encoding, consolidation and explicit retrieval of 
information. The other long-term memory system is semantic memory, an 
organized amount of context-free knowledge, together with rules to manipulate 
this knowledge. Explicit retrieval processes can also play a role in the retrieval 
from semantic memory. In contrast to explicit memory, there is an implicit 
memory system, which deals with the uncontrolled or automatic use of several 
cognitive and motor processes, which are difficult to put into words. 
The results of memory research in schizophrenia will be extensively described 
in chapter four. In sum, it may be stated that the memory deficits found in 
schizophrenia are explicit, verbal as well as visual and mostly concern active 
memory processes, such as encoding and retrieval processes in long-term 
memory systems.    Introduction 
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Executive functions 
Executive functions play a role in effortful cognitive processes. On a short time 
scale these functions are supposed to direct other cognitive functions, such as 
the allocation of attention, inhibition of automatic responses or switching of 
attention to different sources. On a larger time-scale they enable us to behave 
properly in novel situations in order to reach a certain goal. Goal formulating, 
planning, initiation and evaluation of performance then play an important role. 
The term executive functioning is often mixed up with “frontal functioning”, 
because people with frontal lobe lesions often show deficits in executive 
functioning. Although the frontal lobes obviously play a role in executive 
functioning, this is not inclusive. Therefore the term executive function is 
preferred. The executive processes on a short time scale seem to resemble 
selective attention processes, and are measured with the same tasks such as 
Trailmaking Test interference and Stroop interference. Another often-used test 
for executive functioning is the Wisconsin Card Sorting Test (WCST; Heaton, 
1993). In this test cards are used with figures of varying forms, colors and 
numbers. The subject has to sort the cards according to some unknown criterion 
(form, color or number) after each sort feedback is given whether the sort was 
correct or not. After a specified number of correct sorts, the sorting criterion is 
changed without notifying the subject. In most studies schizophrenic patients 
perform consistently worse than controls on this test (Heinrichs and Zakzanis, 
1998, Johnson-Selfridge and Zalewski, 2001). The problem with this task is that 
it is rather difficult and calls upon many different functions such as memory, 
attention, learning, abstraction and of course executive functions; therefore it is 
difficult to say what causes problems in test performance. 
It is rather difficult to test the executive processes on a larger time-scale because 
the highly structured and predictable nature of the test situation is the opposite 
of novel and unknown situations in which one has to call upon executive 
functions. 
 
Intelligence 
In general there are two theories defining intelligence. The multiple component 
theory states that intelligence is composed of several correlated functions. The 
other theory states that intelligence is one single factor called “g”, for general   Introduction 
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intelligence. The way in which both concepts of intelligence are assessed gives 
more insight into these constructs.  
For both types of tests holds that the validity is reflected in their predictability 
for educational and occupational achievement. Almost all intelligence tests 
result in an IQ score with a mean of 100 and a standard deviation of 15. 
The multiple component theory is operationalized in battery-like tests, which 
are made up out of several subtests.  The idea behind it is that by computing the 
total results of all subtests, the specificity of each subtest disappears into the 
background. The intelligence score can be interpreted as the average efficiency 
of the total set of components. The most well known of these tests is the 
Wechsler Adult Intelligence Scale (WAIS; Wechsler, 1981).  
One of the most often used tests to measure “g” is the Raven’s Progressive 
Matrices (Raven et al., 1983). In this task one has to complete a visual pattern 
with one of several response alternatives, so that it becomes a coherent whole. 
Recent neuro-imaging research suggests that “g” derives from a specific frontal 
system, important for diverse forms of behavior by directing other cognitive 
processes (Duncan et al., 2000). 
Another test often used in intelligence research is the National Adult Reading 
Task (NART; Nelson et al., 1991). This test is supposed to measure premorbid 
intelligence. The subject has to read out loud a list with different words with an 
irregular spelling; the ability to pronounce these words in the right way is 
supposed to be a robust indicator for premorbid functioning and has a high 
correlation with WAIS IQ in healthy individuals. 
Schizophrenia patients as a group score lower on intelligence tests than would 
be predicted from family and environmental variables (Aylward et al., 1984). 
This is thought to result from two sources. Some studies have found evidence 
for a decline from premorbid performance after illness onset (Aylward et al., 
1984; Gold, 1998). Some studies also found that schizophrenia patients had 
lower premorbid IQ as a child, than children who were unaffected (David et al., 
1997; Kremen et al., 1998). However, Isohanni et al., (1999) found that 
schizophrenia could also be linked to very high intelligence. 
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4. Cognitive deficits in schizophrenia: is there a pattern? 
 
The previous paragraph showed that a wide range of cognitive deficits is found 
in schizophrenia. A persistent question in the schizophrenia literature is whether 
this reflects a generalized or a specific cognitive deficit. The idea behind this 
question was that a specific deficit could point to the involvement of certain 
brain areas, which are supposed to play a role in the etiology of schizophrenia, 
whereas a more general deficit could point to more diffuse brain damage or 
even to non-specific factors, such as a lack of motivation or energy, or the 
interference of psychotic symptoms (Keefe, 1995). There is some support for a 
generalized deficit in the literature. Blanchard and Neale (1994) found a pattern 
of generalized dysfunction regardless of the method of analysis used to assess 
performance. But most recent studies support a specific cognitive deficit against 
a background of more general dysfunctioning (Censits et al., 1997; Saykin et al., 
1991, 1994). In a large meta-analysis on 204 studies on cognitive differences 
between schizophrenia patients and controls, a general cognitive impairment 
was found with varying degrees of cognitive deficits for several domains. The 
largest impairment was documented for compound measures of global verbal 
memory, bilateral motor skills and performance IQ (Heinrichs and Zakzanis, 
1998).  
The problem with this kind of data is that it involves group comparisons while 
there are large inter-individual differences between patients. Not all patients, for 
example show cognitive deficits according to clinical norms (Palmer et al., 
1997; Kremen et al., 2000). Large differences are also found between patients 
with cognitive deficits. Some patients only show a deficit in one domain of 
functioning, such as memory or executive deficits, while others show a range of 
cognitive deficits comprising all domains of functioning.  
The question is how to cope with these inter-individual differences in cognitive 
research. In large group comparisons of schizophrenia patients versus controls a 
lot of information is lost due to the cognitive heterogeneity of the patients. 
Another way around is to search for different cognitive subgroups. 
Unfortunately this has not been very fruitful. Some researchers found small 
differences in psychopathology between cognitive subgroups (Heinrichs and 
Awad, 1993; McDermid and Heinrichs, 2002).    Introduction 
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Studies on monozygotic twins discordant for schizophrenia, in which the ill 
twin almost always performed worse than the unaffected co-twin, however 
supported the idea that all patients have cognitive impairments instead of the 
existence of different subgroups.  A dimensional approach, like in 
psychopathology research, may be the best way to analyze cognitive 
functioning in schizophrenia. Regarding etiology, one could suggest that one or 
more continuous neurobiological processes, which cause of variety of cognitive 
deficits, are affected to different degrees in schizophrenia. 
 
 
5. Cognition and psychopathology 
 
From the beginning of this century, attempts have been made to group patients 
into different subtypes of schizophrenia according to psychopathology (e.g. type 
I en II, Crow, 1980; positive and negative syndromes, Andreasen and Olson, 
1982). In the last decade however a more dimensional approach to the study of 
schizophrenia has emerged. In this approach one tries to divide symptoms 
instead of patients into groups or dimensions. These dimensions are considered 
to be continuous and symptoms of several dimensions can co-occur in 
individuals (Andreasen et al., 1993). Factor analytic techniques were used to 
identify these dimensions in schizophrenia. Although there is some variability 
in these studies, consistencies emerge. In almost all studies a positive, a 
negative and a disorganization or cognitive component are found (Andreasen et 
al., 1994). Some studies also found an excitement and a depression-anxiety 
dimension (Kay and Sevy, 1990; Bell et al., 1992; Lindemayer et al., 1994, 
1995). It has been suggested that these dimensions represent different 
underlying pathologies and therefore attempts have been made to find the 
different cognitive correlates of these psychopathology dimensions. This is 
described in chapter five. In sum, some correlations are found, but the results 
are not very consistent and the correlations, although statistically significant, are 
rather weak. 
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6. Cognition and functional outcome 
 
Functional outcome in schizophrenia appears to be multidimensional, consisting 
of relatively independent domains such as interpersonal functioning, 
occupational functioning, independent functioning in community settings, 
performance on basic daily activities. A decline of functioning in one or more of 
these areas as compared with premorbid functioning is one of the diagnostic 
criteria for schizophrenia according to DSM-IV (APA, 1994). Social 
withdrawal or a problem to function properly in interpersonal contacts is often 
seen in schizophrenia. The majority of the patients show disabilities in social 
role performance fifteen years after illness onset (Wiersma et al., 2000). The 
onset of schizophrenia is also associated with a pronounced decline in 
employment (Mueser et al., 2001). Rates of competitive employment in 
schizophrenia tend to be low, with most estimates in the 10-20 percent range 
(Mueser et al., 2001). Although only a certain percentage of patients ends up 
staying in a psychiatric hospital or living in sheltered accommodation (14% in a 
large European study, Wiersma et al., 2000), a large percentage of the patients 
living in the community experience problems with independent functioning, 
performance of basic daily activities or leisure activities and therefore rely on 
community services. Quite a few studies have investigated the association 
between cognitive functioning and functional outcome, mostly with correlations 
or regression analyses (Green et al., 2000). Most studies use a wide range of 
cognitive variables and outcome measures, some studies even use laboratory 
assessment of social skills as outcome measures. These studies in general find 
highly significant correlations, but this could also be caused by the similarities 
between neuropsychological test conditions and laboratory social skill 
assessment. For clarity, only the results of studies assessing daily life 
functioning are reported.  
Most cross-sectional studies find some significant correlations, but the 
explained variance is very low and due to the large number of measures there is 
always the possibility that the significant correlations are due to chance.  
Fewer studies have investigated the predictive value of cognition on outcome, 
and only one study has used a first episode group to investigate the predictive 
value of cognitive measures at illness onset. The results of these studies are 
rather inconsistent and as yet no first episode study has been conducted in   Introduction 
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which the predictive power of a broad range of cognitive variables has been 
investigated. 
 
 
7. The multicenter study on schizophrenia 
 
The studies described in chapter two, four and six of this thesis were based on 
data gathered with the multicenter study on neurobiological and 
neuropsychological predictors of functional status in first-onset schizophrenia: 
social disabilities, burden on the family, need for care and quality of life 
(ZonMw 940-33-015). This study was a collaboration of the university hospitals 
of Groningen, Amsterdam and Utrecht and focused on the predictive value of 
neuropsychological and neurobiological factors for functional outcome at two 
year follow-up in all first or second episode patients who were referred to the 
departments of psychiatry for treatment over a period of 1.5 years (1997 – 
1998). 
Diagnosis was based on structured interviews (SCAN; Wing et al., 1990; 
CASH; Andreasen et al., 1992). Exclusion criteria were severe mental 
retardation and a known systemic or neurological illness. A diagnosis of drugs 
or alcohol abuse or dependence was not an exclusion criterion, because this 
would exclude a substantial part of the first episode patients and leave a less 
representative cohort of this population.  
Baseline measures at illness onset used for prediction were neurocognitive 
measures of attention, memory, executive functioning and intelligence and 
MRI-measurements. Data concerning obstetric complications, psychopathology, 
drugs or alcohol abuse or dependence, social functioning and burden of care 
were also gathered. Two years after inclusion follow-up data were collected 
concerning course of illness, psychopathology, social functioning, need for care 
and quality of life. 
Initially one hundred and thirty eight patients were included. One hundred and 
eighteen completed the neurocognitive assessment and from this group one 
hundred and three also completed follow-up assessment. 
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8. Outline of this thesis 
 
Chapter two presents a study on the characteristics of schizophrenia patients 
without clinically relevant cognitive deficits. These patients were studied in 
order to examine whether they represent an etiologically different subgroup, a 
general effect of disease severity or whether their cognitive deficits do not reach 
a clinical threshold due to a greater cognitive compensation capacity.  
In  chapter three the assumption that frontal impairment is a core deficit in 
schizophrenia is examined by means of both neuropsychological assessment 
and saccadic eye movements tasks in twenty-four recent onset patients. In 
addition, the relationship between saccadic and neuropsychological measures 
was studied.  
In chapter four the question whether the memory impairments in schizophrenia 
should be understood as pure memory deficits or as the result of another 
underlying cognitive deficit is studied. One hundred eighteen recent onset 
patients from the multicenter study were compared with 45 controls on several 
memory tasks. The role of processing speed and central executive functions on 
memory performance was examined with regression analysis for all subjects 
and for patients separately.  
Chapter five describes a study on the cognitive correlates of five symptom 
dimensions in a group of 50 recent onset psychotic patients. We were especially 
interested in the depression dimension, since it has not been studied extensively 
thus far. Both objective and subjective cognitive measured were used.  
Chapter six presents a study on the predictive value of cognitive measures on 
course of illness and functional outcome in recent onset schizophrenia. One 
hundred and three first episode patients from the multicenter study participated 
in the follow-up assessment two years after inclusion. Differences in outcome 
between CI and CN patients were also analyzed.  
In  Chapter seven the results of all studies presented in this thesis are 
summarized, followed by some general conclusions concerning the nature and 
outcome of cognitive deficits in schizophrenia. 
 
 
   Introduction 
  14   
References 
 
American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 
4
thed. . American Psychiatric Association, Washington DC. 
 
Andreasen, N.C., 1997. The role of the thalamus in schizophrenia. Can. J. Psychiatry 42, 27-33. 
 
Andreasen, N.C., Carpenter, W.T.Jr., 1993. Diagnosis and classification of schizophrenia. 
schizophr. Bull. 19, 199-214.  
 
Andreasen, N.C., Flaum, M., Arndt, S., 1992. The Comprehensive Assessment of Symptoms and 
History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 
49, 615-623. 
 
Andreasen, N.C., Nopoulos, P., Schultz, S., Miller, D., Gupta, S., Swayze, V.,  Flaum, M., 1994. 
Positive and negative symptoms of schizophrenia: past, present, and future. Acta Psych. Scan. 
Suppl. 384, 51-59.  
 
Andreasen, N.C., Olsen, S., 1982. Negative versus positive schizophrenia: definition and validation. 
Arch. Gen. Psychiatry 39, 789-794. 
 
Aylward, E., Walker, E., Bettes, B., 1984. Intelligence in schizophrenia: a meta-analysis of the 
research. Schiz. Bull. 10, 430-459. 
 
Baddeley, A.D. and Hitch, G., 1974. Working memory. In I.G.A. Bower (Ed.) The psychology of 
learning and motivation. Academic Press, New York, pp 47 – 90. 
 
Belitsky, R, McGlashan, T.H., 1993. The manifestations of schizophrenia in late life: a dearth of 
data. Schiz. Bull. 19, 683-685. 
 
Bell, M., Milstein, R., Beam Goulet, J., Lysaker, P., Cicchetti, D., 1992.The Positive and Negative 
Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive 
validity. J. Nerv. Ment. Dis. 180, 723-728. 
 
Blanchard, J.J. and Neale, J.M., 1994. The neuropsychology of schizophrenia: generalized or 
differential deficit. Am. J. Psychiatry 151, 40-48. 
 
Bleuler, E., 1911. Dementia Praecox oder Gruppe der Schizophrenien. In G. Aschaffenburg (Ed.) 
Handbuch der Psychiatrie. Deuticke, Leipzig /Wien. 
 
Broerse, A., den Boer, J.A., submitted. Inhibition deficits in schizophrenia? A cognitive study.  
 
Censits, D. M., Ragland, J. D., Gur, R. C., Gur, R. E., 1997. Neuropsychological evidence  
supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr.  
Res. 24, 289-298. 
 
Chen, E.Y.H., Wong, A.W.S., Chen, R.Y.L., Austin, G., 2001. Stroop interference and facilitation 
effects in first episode schizophrenic patients. Schizophr. Res. 48, 29-44. 
 
Cohen, J.D.,  Servan-Schreiber, D., 1992. Context, cortex and dopamine: a connectionist approach 
to behavior and biology in schizophrenia. Psychol. Rev. 99, 45-77. 
 
Cornblatt, B., Obuchowski, M., Roberts, S., Pollack, S., Erlenmeyer-Kimling, L., 1999. Cognitive and 
behavioral precursors of schizophrenia. Dev. Psychopatholol. 11, 487-508. 
 
Crow, T.J., 1980. Positive and Negative schizophrenic symptoms and the role of Dopamine. Br. J. 
Psychiatry 137, 383-386.   Introduction 
  15   
 
David, A.S., Malmberg, A., Brandt, L., Allebeck, P., Lewis, G., 1997. IQ and risk for schizophrenia: a 
population-based cohort study. Psychol. Med. 27, 1311-1323. 
 
Duncan, J., Seitz, R.J., Kolodny, J., Bor, D., Herzog, H., Ahmed, A., Newell, F.N., Emslie, H., 2000. 
A neural basis for general intelligence. Science 289, 457-460. 
 
Eaton, W.W., Tien, A.Y. and Poeschla, B.D. 1995. Epidemiology of schizophrenia. In J.A. den Boer, 
H.G.M. Westenberg and H.M. van Praag (Eds.). Advances in the neurobiology of schizophrenia. 
John Wiley and sons, New York, pp 27-57. 
 
Eling, P.A.T.M., van Zomeren, A.H. 1997. Aandacht. In B.G. Deelman, P.A.T.M. Eling, E.H.F. Haan, 
A. Jennekens-Schinkel, A.H. van Zomeren (Eds.). Klinische neuropsychologie. Boom, Amsterdam, 
pp 125-144. 
 
Gold, J.M., 1998. Schizophrenia and intellectual decline. Am. J. Psychiatry 155, 1633-1634. 
 
Goldman-Rakic, P. S., 1994. Working memory dysfunction in schizophrenia. J. Neuropsychiatry 
Clin. Neurosci. 6, 348-357. 
 
Gray, J.A., Feldon, J., Rawlins, J.N., Hemsley, D.R., Smith, A.D., 1991. The neuropsychology of 
schizophrenia. Behav. Brain Sci., 14, 1-84. 
 
Green, M. F., Kern, R. S., Braff, D. L., and Mintz, J., 2000. Neurocognitive deficits and functional 
outcome in schizophrenia: are we measuring the "right stuff"? Schiz. Bull. 26, 119-136. 
 
Harrison, G., Croudace, T., Mason, P., Galzebrook, C., Medley, I., 1996. Prediction the long-term 
outcome of schizophrenia. Psychol. Med. 26, 697-705. 
 
Heaton, R.K, Chelune, G.J., Kay, K.K. Curtiss, G.,1993. Wisconsin Card Sorting Test manual: 
revised and expanded. Western Psychological Services, Los Angeles. 
 
Hegarty, J.D., Baldessarini, R.J., Tohen, M., Waternaux, C. and  Oepen, G., 1994. One hundred 
years of schizophrenia: a meta-analysis of the outcome literature. Am. J. Psychiatry 151, 1409 
1416. 
 
Hemsley, D.R., 1994. A cognitive model for schizophrenia and its possible neural basis. Acta. 
Psychiatr. Scand. Suppl. 384, 80-86. 
 
Heinrichs, R.W., Awad, A.G., 1993., Neurocognitive subtypes of chronic schizophrenia. Schizophr. 
Res. 9, 49-58. 
 
Heinrichs, R.W. & Zakzanis, K.K., 1998. Neurocognitive deficit in schizophrenia: a quantitative 
review of the evidence. Neuropsychology 12, 426-445. 
 
Isohanni, I., Jarvelin, M.R., Jones, P., Jokelainen, J., Isohanni, M., 1999. Can excellent school 
performance be a precursor of schizophrenia? A 28-years follow-up in the Northern Finland 1966 
birth cohort. Acta Psychiatr. Scand. 100, 17-26. 
 
Johnson-Selfridge, M., Zalewski, C., 2001. Moderator variables of executive functioning I 
schizophrenia: meta-analytic findings. Schizophr. Bull. 27, 305-316. 
 
Keefe, R. S., Roitman, S.E., Harvey, P.D., Blum, C.S., DuPre, R.L., Prieto, D.M., Davidson, M., 
Davis, K.L., 1995. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: 
spatial working memory in patients with schizophrenia. Schizophr. Res. 17, 25-33. 
 
 
   Introduction 
  16   
Kremen, W.S., Buka, S.L., Seidman, L.J., Goldstein, J.M., Koren, D., Tsuang, M.T., 1998. IQ 
decline during childhood and adult psychotic symptoms in a community sample: a 19-year 
longitudinal study. Am. J. Psychiatry 155, 672-677.  
 
Kremen, W.S., Seidman, L.J., Faraone, S.V., Toomey, R., Tsuang, M.T., 2000. The paradox of 
normal neuropsychological function in schizophrenia. J. Abnorm.  Psychol. 109, 743-752. 
 
Kay, S.R., Sevy, S., 1990. Pyramidical model of schizophrenia. Schizophr. Bull. 16,537-545. 
 
Lindenmayer, J.P., Bernstein Hyman, R., Grochowski, S. A., 1994. A new five factor model of 
schizophrenia. Psychiatr. Q. 65, 299-322.  
 
Lindenmayer, J.P., Grochowski, S., Hyman, R.B., 1995. Five factor model of schizophrenia: 
replication across samples. Schizophr. Res. 14, 229-234.  
 
McDermid, S.A., Heinrichs, R.W., 2002. Schizophrenia and memory impairment: Murray, R.M., 
Lewis, S.W., 1987. Is schizophrenia a neurodevelopmental disorder? Br. J. Psychiatry 295, 681-
682. 
 
Mueser K.T., Salyers M.P., Mueser P.R., 2001. A prospective analysis of work in schizophrenia. 
Schizophr. Bull. 27, 281-296. 
 
Murray, R.M., Jones, P., O’Callaghan, E., Takei, N., Sham, P., 1992. Genes, viruses and 
neurodevelopmental schizophrenia. J. Psychiatry Res. 26, 225-235. 
 
Nelson, H.E., Pantelis, C., Carruthers, K., Speller, J., Baxendale, S. and Barnes, T.R., 1990. 
Cognitive functioning and symptomatology in chronic schizophrenia. Psychol.  Med. 20, 357-365. 
 
Nelson, H.E. and Willison, J.R., 1991. National Adult Reading Test (NART) Test manual. NFER 
Nelson Publishing Company, Windsor England. 
 
Nuechterlein, K.H., 1991. Vigilance in schizophrenia and related disorders. In S.R. Steinhauer, J.H. 
Gruzelier and J. Zubin (Eds.), Handbook of schizophrenia. Vol. 5: Neuropsychology, 
psychophysiology and information processing. Elsevier, Amsterdam.  
 
Nuechterlein, K.H., Buschbaum, M.S., Dawson, M.E., 1994. Neuropsychological vulnerability to 
schizophrenia. In A.S. David and J.C. Cutting (Eds.), The neuropsychology of schizophrenia. 
Lawrence Erlbaum Associates Ltd., Hove U.K. 
 
Palmer, B.W., Heaton, R.K., Paulsen, J.S., Kuck, J., Braff, D., Harris, M.J., Zisook, S., Jeste, D.V., 
1997. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 11, 437-
446.  
 
Ram, R., Bromet, E.J., Eaton, W.W., Pato, C., Schwartz, J.E., 1992. The natural course of 
schizophrenia: a review of first admission studies. Schizophr. Bull. 10, 185-207. 
 
Raven, J.C., Court, J.H. and Raven, J., 1983. Manual for Raven’s Progressive Matrices and 
Vocabulary Scales. Section 1-7. Raven Ltd., Londen. 
 
Saykin, A.J., Gur, R.C., Gur, R.E., Mozley, P.D., Mozley, L.H., Resnick, S.M., Kester, D.B. and 
Stafiniak, P., 1991. Neuropsychological function in schizophrenia. Selective impairment in memory 
and learning. Arch. Gen. Psychiatry 48, 618-624. 
 
Saykin, A.J., Shtasel, D.L., Gur, R.E., Kester, D.B., Mozley, L.H., Stafiniak, P., Gur, R.C., 1994. 
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. 
Gen. Psychiatry, 51, 124-131. 
   Introduction 
  17   
Schacter, D.I. and  Tulving, E., 1994. What are the memory systems of 1994. In D.I. Schacter and 
E. Tulving (Eds.). Memory systems 1994. MIT Press, Cambridge, pp. 1-38. 
 
Schatz, J., 1998. Cognitive processing efficiency in schizophrenia: generalized vs domain specific 
deficits. Schizophr. Res. 30, 41-49. 
 
Wechsler, D., 1981. Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, 
New York. 
 
Wiersma,  D., Wanderling, J., Dragomirecka, E., Ganev, K, Harrison, G., van der Heiden, W., 
Nienhuis, F.J., Walsh, D., 2000. Social disability in schizophrenia: its development and prediction 
over 15 years in incidence cohorts in six European centers. Psychol. Med. 30, 1155-1167. 
 
Wing, J.K., Babor, T.F., Brugha, T.S., Burke, J., Cooper, J.E., Giel, R., Jablensky, A., Regier, D.A., 
Sartorius, N., 1990. SCAN Schedules for Clinical Assessment in Neuropsychiatry. Arch.Gen. 
Psychiatry 47, 589-593 
    
   
Chapter 2 
 
 
 
Schizophrenic patients without neuropsychological 
deficits: subgroup, disease severity or cognitive 
compensation? 
 
 
 
 
 
Published 
Holthausen, E.A.E., Wiersma, D., Sitskoorn, M.M., Hijman, R., Dingemans, 
P.M., Schene, A.H., van den Bosch, R.J., 2001. Psychiatry Research 112, 1-11. 
 Patients without neuropsychological deficits 
 
 
20   
Abstract 
 
Some schizophrenic patients do not show clinically relevant cognitive deficits. 
The question remains whether this represents the existence of an etiologically 
different subgroup, a general effect of disease severity or whether their 
cognitive deficits do not reach a clinical threshold due to a greater cognitive 
compensation (“brain reserve”) capacity. A group of 23 out of 118 first onset 
patients was identified as cognitively normal. The cognitive profile of these 
patients was compared with that of 45 healthy controls. Next these patients were 
compared with the cognitively impaired patients on obstetric complications, 
premorbid adjustment, age at onset, PANSS ratings, social functioning and 
substance abuse. In addition both groups were compared on intelligence and 
educational level as indirect indicators of cognitive compensation capacity. 
There were no differences in obstetric complications, premorbid adjustment, 
age at onset, psychopathology or substance abuse between both patient groups. 
There was a significant difference in social functioning, which is a consequence 
rather than a cause of cognitive deficits. However, the cognitively normal 
patients scored significantly higher on measures of intelligence and educational 
level than the cognitively impaired patients. This suggests that a difference in 
cognitive compensation capacity could explain the existence of a cognitively 
normal patient group.  
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1. Introduction 
 
It is generally accepted that cognitive deficits are a major characteristic of 
schizophrenia. They are often supposed to be the fundamental impairment, 
which causes psychopathology and social dysfunctioning (Andreasen, 1997; 
Goldman-Rakic, 1994; Hemsley, 1994). However, not all schizophrenic patients 
show cognitive deficits according to standard clinical norms. Several studies 
have identified a group of schizophrenic patients with cognitive functioning 
within normal limits (Bryson et al., 1993; Palmer et al., 1997; Silverstein and 
Zerwic, 1985; Kremen et al., 2000). Estimates of the proportion of patients 
without neuropsychological impairments vary from 23 % (Kremen et al., 2000) 
to 73 % (Bryson et al., 1993). 
There are several possible explanations for this phenomenon. The “cognitively 
normal” (CN) patients might represent a subgroup within the schizophrenic 
population. An etiological theory, which could explain the existence of 
cognitively normal and cognitively impaired (CI) subgroups, comes from 
Murray et al. (1987; 1992). He proposes that in a subgroup of patients, the CI 
patients, the disease has a distinct neurodevelopmental cause, which has its 
origins in genetic defects and early risk factors such as obstetric complications. 
These patients are characterized by premorbid symptoms, such as motor and 
behavioral problems, cognitive deficits, poor social adjustment, an early onset 
and more negative symptoms. The CN group also has a vulnerability to 
decompensate into psychotic symptoms, but they show less evidence of a 
developmental disease and are less likely to show premorbid symptoms or 
cognitive deficits. Another explanation for the existence of CN patients would 
be a general effect of disease severity. The difference between cognitively 
normal and cognitively impaired patients could be an artificial distinction on a 
severity continuum. This would imply that CN patients are less severely 
affected but still show signs of cognitive decline at a subclinical level. It is also 
to be expected that the more severe the disease, the more severe are all its 
manifestations from early age on, with the CN group showing better premorbid 
functioning, less psychopathology, and better social functioning. 
The few studies that examined the characteristics of CN patients all used 
chronic patient groups in which the effects of hospitalization, recurrent episodes 
and long-term medication can bias the results. Most studies looked at Patients without neuropsychological deficits 
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differences in psychopathology. None of these studies analyzed differences in 
obstetric complications and premorbid functioning, other than premorbid IQ 
estimates (Kremen et al., 2000). Silverstein and Zerwic (1985) found that CN 
patients had more paranoid symptoms than patients with cognitive deficits. 
Kremen et al. (2000) also found a significantly higher proportion of the 
paranoid subtype in the CN group, although there was no significant difference 
in symptom ratings. Both Palmer et al. (1997) and Torrey et al. (1994) showed 
that CN patients had less negative symptoms than CI patients. These data are 
not entirely consistent, but they suggest that the two groups show predominantly 
positive and negative symptoms respectively. This would be in accordance with 
the first explanation, which suggests that the neurodevelopmental, cognitively 
impaired group shows more negative symptoms. However a study of Kremen et 
al. (2000) showed that a schizophrenic subgroup with neuropsychological test 
scores within normal limits actually performed significantly worse and had a 
different profile shape than normal controls, which would be more in 
accordance with a general effect of disease severity. Indirect evidence for 
subclinical cognitive decline in the CN group also comes from studies with 
discordant monozygotic twins, in which in almost all cases the schizophrenic 
twin was cognitively impaired compared to his or her co-twin, who represented 
the optimal level of cognitive achievement (Goldberg et al., 1990; 1995; Torrey 
et al., 1994 ).  
According to the literature both explanations could be true, still there could be 
another explanation as well. It is also possible that all patients have some sort of 
underlying neuropathology, which causes cognitive deficits in CI patients, but 
does not cause the same deficits in CN patients because they have more 
capacity to compensate for brain dysfunction. This would be in accordance with 
the “ brain reserve capacity” theory (BRC; Satz, 1993) used in dementia 
research. This theory argues that, because of environmental enrichment, genetic 
predisposition or both, some individuals develop a cognitive reserve that may 
increase the threshold for cognitive symptoms after acquired brain pathology. 
Because psychosocial studies have shown the protective as well as the risk 
effects of intelligence and education on adaptive behavior, aging and health 
(Gurland, 1981; Mortimer, 1988), a number of studies have used intelligence 
and educational level as indirect measures of BRC (Mortimer, 1997; Mortimer 
and Graves, 1993; Schmand et al., 1997; Schofield, 1999; Stern et al., 1996). Of Patients without neuropsychological deficits 
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course one could argue that it is self-evident that individuals with greater 
intelligence and better education simply perform better on neuropsychological 
tests. However, several longitudinal studies have shown a link between higher 
educational attainment and resistance to cognitive change (Evans et al., 1993; 
Farmer et al, 1995). Joyce et al. (2002) found a dissociation between cognition  
and IQ in a group of schizophrenic patients who had premorbid and current IQ 
levels in the normal range but displayed working memory deficits. Weickert et 
al. (2000) found a separate IQ component in a principal component analysis of 
neuropsychological and intellectual test data in a group of schizophrenia 
patients. Although the BRC model comes from dementia research, in which it is 
applied to an acquired neurological disorder, it could be applicable to 
schizophrenia as well. Schizophrenia is believed to be a neurodevelopmental 
disorder, but there is evidence that the most remarkable decline in cognitive 
functioning takes place just before or during illness onset (Kelly et al., 2000; 
Rabinowitz et al., 2000). 
Our main objective was to separate a group of first onset schizophrenia patients 
with cognitive functioning within normal limits from cognitively impaired 
patients, to study whether this distinction reflects a difference in disease 
severity, two different subgroups or a difference in cognitive compensation 
capacity. If the CN group shows no evidence of cognitive deficits, less obstetric 
complications, less negative symptoms but no difference in positive symptoms 
as compared to the CI group, and premorbid adjustment comparable to controls, 
then this could indicate an etiologically different subgroup. Cognitive decline at 
subclinical levels, less severe psychopathology and better premorbid adjustment 
in the CN group as compared to the CI group, could indicate a difference in 
disease severity. If the difference between cognitively normal and cognitively 
impaired patients is caused by a difference in compensation capacity, the most 
important difference between the groups would be in intelligence and education, 
as indirect measures of compensation. Both groups were also compared on 
measures of social functioning and substance abuse to study the association 
between these variables and cognitive functioning.  
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2. Method 
 
2.1. Subjects 
 
The study included 118 patients who had recently experienced a first or a 
second psychotic episode according to DSM-IV (American Psychiatric 
Association, 1994) and were diagnosed within the schizophrenia spectrum 
(schizophrenia, schizoaffective disorder, schizophreniform disorder). All 
patients participated in a Dutch multicenter study of the university hospitals of 
Groningen, Utrecht and Amsterdam. Diagnosis was based on a structured 
interview (SCAN; Wing et al., 1990 or CASH; Andreasen et al., 1992). 
Exclusion criteria were severe mental retardation and a known systemic or 
neurological illness. Eighty-seven males and thirty-one females were included. 
Mean age was 23 years (sd 5.3). Forty-five healthy controls, thirty-eight males 
and seven females, were included in order to establish standard scores on 
cognitive tests. Exclusion criteria for controls were a history of mental illness, 
mental retardation and a known systemic or neurological illness. Mean age was 
24 years (sd 6.4). The healthy control group was recruited through 
announcements in the local newspapers. There were no significant differences 
between patients and controls for sex (χ²  = 2.10, n.s.) or age (F(1,161) = 0.29, 
n.s.). Twenty-five patients used typical antipsychotics, seventy-five patients 
used atypical antipsychotics, eighteen patients did not use antipsychotic 
medication. Ten patients also used anticholinergic medication.  
 
 
2.2. Procedures and instruments 
 
Cognitive measures 
All patients completed an extensive neuropsychological battery after being 
stabilized for at least six weeks on medication. Most cognitive measures in our 
study were chosen because of their widespread use in clinical practice. In 
addition, there should be evidence for their discriminatory power in studies of 
schizophrenic patients and normal controls on these measures (e.g. Keefe et al., 
1995; Saykin et al., 1994; Van den Bosch et al, 1996).  The cognitive measures 
were grouped into nine ability areas as presented in Table 1. Tests included a  Patients without neuropsychological deficits 
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double stimulus Continuous Performance Task (CPT; van den Bosch et al., 
1996); a computerized STROOP task; form A, B and C of a new version of the 
Trail Making Test (Vink and Jolles, 1985); a Finger tapping test; the Dutch 
translation of the California Verbal Learning Test (Delis et al., 1987); the Rey 
Complex Figure Test (Rey, 
1964); Verbal Fluency tasks 
(category and letter);  
a computerized Spatial Working 
Memory Task (Keefe, 1995). 
When variables resembled the 
normal distribution, patients’ test 
scores were transformed into z-
scores using means and standard 
deviations of the normal control 
group. Otherwise normalized 
standard scores were used to 
establish cut-off points. In this 
procedure, the percentage of 
persons in the standardization 
sample falling at or above a raw 
score point is calculated. This 
percentage is transformed into a z 
score by reference to a normal 
distribution frequency table 
(Walsh and Betz, 1985). A patient 
was considered cognitively 
impaired if he had at least one z score of 2 or more below normal in one ability 
area. The z-scores and normalized standard scores were also used to compute 
the mean z-scores per domain for all three groups.  
 
Obstetric complications, premorbid adjustment, age at onset 
Information concerning obstetric complications (OCs) was obtained with a self-
report questionnaire for the mother. Because the frequency of individual OCs is 
not very high, two sum scores representing the different reproductive periods 
(pregnancy and birth) were computed and used as dichotomous items in the 
Table 1. Cognitive battery with tests grouped by 
ability area 
Perceptual sensitivity  
   CPT d’ 
 Attention-selectivity 
   STROOP interference score 
   Trail Making Test interference score 
Perceptual and psychomotor speed 
   CPT RT (ms) 
   Trail Making A and B (s)  
   STROOP names (s) 
   STROOP colors (s) 
   Finger tapping   
Memory-verbal-encoding 
   CVLT trial 1 to 5  
Memory-verbal-consolidation 
   CVLT long term free recall  minus trial 5 
Memory-verbal-retrieval 
   CVLT short term free recall minus short term cued recall 
   CVLT long term free recall minus long term cued recall 
   CVLT difference between recognition and long term recall 
Memory-visual 
   Rey Complex Figure Test  percentage immediate recall 
   Rey Complex Figure Test percentage delayed recall 
   Spatial Working Memory Task immediate recall 
   Spatial Working Memory Task delayed recall 
Verbal Fluency 
   Verbal Fluency Categories 
   Verbal Fluency Letters 
Visuoconstruction 
    Rey Complex Figure Test copy Patients without neuropsychological deficits 
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analyses. Because hypoxia is mentioned as an important factor in explaining the 
relation between OCs and schizophrenia in recent reviews (McNeil et al., 2000; 
Geddes et al., 1999), a special sum score for OCs related to hypoxia was also 
computed. OCs during pregnancy were: vaginal bleeding; early contractions; 
high blood pressure; rhesus incompatibility; pre-eclampsia; rubella; syphilis; 
substance abuse from the mother. OCs during birth were: gestational age less 
than 37 weeks; caesarian; labor longer then 36 hours; breech delivery; forceps 
delivery; vacuum extraction; epileptic seizures; incubator more then 4 weeks; 
birth weight lower then 2000 grams; placental anomalies; cord prolapse; 
cyanosis; slow heart rate; asphyxia; oxygen treatment. The latter five were also 
used to compute a hypoxia sum score. Premorbid adjustment was inferred from 
employment status and history of intimate relationships before inclusion. Data 
concerning premorbid adjustment and age at onset were gathered in a Case 
Record Form using all possible sources of information.  
 
Psychopathology, substance abuse and social functioning 
Symptoms were rated on the Positive and Negative Syndrome Scale (PANSS; 
Kay et al., 1987) within the same week as the neuropsychological assessment. 
These ratings were used to obtain dimensional scores by calculating the sum 
scores loading high on the positive, negative, disorganization, depression and 
excitement dimensions as described in Lindenmayer et al. (1995). The total 
PANSS score minus the disorganization dimension was used as a general 
measure of psychopathology. The disorganization dimension was left out of the 
computation because of a large overlap with cognitive measurements (Bryson et 
al.1999). Depressive symptoms were also rated with the Montgomery Åsberg 
Depression Rating Scale (MADRS; Montgomery and Åsberg, 1979). Not all 
variables resembled the normal distribution. If possible log and square root 
transformations were performed. Social functioning during the month preceding 
inclusion was assessed with the Groningen Social Disabilities Schedule (GSDS; 
Wiersma et al., 1988), a semi-structured interview that measures social role 
functioning on seven roles. Substance abuse or dependence was rated with the 
relevant section of the Composite International Diagnostic Interview (CIDI; 
WHO, 1990). Substance abuse or dependence was divided into four substance 
categories for analyses 
 Patients without neuropsychological deficits 
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Indirect measures of cognitive reserve capacity: education and 
intelligence 
Level of education and performance on intelligence tasks were taken as indirect 
measures of compensation. All subjects were asked about their highest 
educational attainment, and whether they still received education at illness 
onset. The Dutch educational system differentiates already after primary school; 
therefore we have chosen a coding system other than years of education. This 
goes from 1: primary school up to 8: university or graduate school. Thirty seven 
percent of the patients still received education; for these patients we took the 
level they were aiming at minus half a point (e.g., a Law school student 
received a code of 7.5 instead of 8).  A log transformation was performed on 
educational level in order to fit the normal distribution. Four subtests of the 
Dutch translation of the Wechsler Adult Intelligence Scale, (WAIS; Stinissen et 
al., 1970): comprehension, vocabulary, block design and picture arrangement, 
were administered to the patients. The mean subtest C-score of these four 
subtests was taken as a measure of intelligence. These C-scores go from 0 tot 10 
with a mean of 5 and a standard deviation of 2. Because the Dutch translation of 
the WAIS is from 1970, we also give corrected mean C-scores in which we take 
account for an estimated IQ gain of 0.25 IQ points a year from 1971 to 1996 
(Flynn, 1998). The corrected average C-score is 5.8 with a standard deviation  
of 2. 
 
 
3. Results 
 
A group of 23 patients (19%) without clinically relevant cognitive deficits was 
identified. The other 95 patients had deficits in at least one ability area (range 1-
8). 34 of the 45 controls (76 %) had no cognitive deficits according to our 
criteria. If we use our criteria to predict group membership (schizophrenia 
versus healthy controls) 79 % of the subjects is correctly classified, the 
sensitivity is 81% and the specificity is 76 %.  The CN group consisted of 15 
men and 8 women; mean age was 24.8 years (sd 5.5), average parental 
education was at High School level. Four patients used typical antipsychotics, 
fourteen used atypical antipsychotics, five patients did not use antipsychotic 
medication. One patient also used anticholinergic medication. The CI group Patients without neuropsychological deficits 
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consisted of 72 men and 23 women; mean age was 22.9 years (sd 5.2), average 
parental education was at High School level. Twenty-one patients used typical 
antipsychotics, sixty-one used atypical antipsychotics, eight patients did not use 
antipsychotic medication. Nine patients also used anticholinergic medication. 
There were no significant differences between CN and CI patients for sex (χ² = 
1.07, ns.), age (F(1,116) =  2.43, ns.), parental education (F (1,98) =  1.85, ns.), 
type of medication (χ² = 3.05, ns.) or the use of anticholinergic medication (χ² = 
0.63, ns.).  
The question whether the CN group was really cognitively normal or showed 
cognitive deficits at subclinical levels was examined by independent-sample t-
tests between CN patients and controls and visual inspection of cognitive 
profiles (Table 2 ; see also Figure 1). 
 
Table 2. Cognitive ability area scores for CN and CI patients and effect sizes for the comparison 
between CN and CI patients and CI patients and controls 
 
  Cognitively normal 
n= 32 
mean        sd 
Cognitively 
impaired, n = 95 
mean          sd 
Effect size  
CN vs. CI 
patients
1 
Effect size  
CN vs. 
controls
2 
            
1.Perceptual- sensitivity  -0.25 0.88  -1.68 1.37  1.04  -0.25 
2. Attention-selectivity   0.04  0.83   -0.65  1.43  0.48   0.04 
3. Speed  -0.60 0.45  -1.75 1.12  1.03  -0.60 
4. Verbal encoding  -0.57 0.72  -1.42 1.09  0.78  -0.57 
5. Verbal consolidation   0.46  1.46  -0.50  1.47  0.65   0.46 
6. Verbal retrieval   0.06  0.78  -0.33  0.82  0.48   0.06 
7. Visual memory  -0.00 0.63  -1.28 1.39  0.92    0.00 
8. Verbal Fluency  -0.32 0.80  -1.00 0.68  1.00  -0.32 
9. Visuoconstruction  -0.08 1.11  -1.08 2.06  0.49  -0.08 
            
1 Cohen’s d based on the standard deviation of the CI group 
2 Cohen’s d based on the standard deviation of the control group 
 
The CN patients performed significantly worse than controls on perceptual and  
psychomotor speed (t (66) = 3.85, p < .000) and verbal encoding (t (66) = 2.44, 
p = .017), with medium effect sizes. The cognitive profile shape of the CN 
patients deviates from that of normal controls and follows that of CI patients, 
who performed worse than both controls and CN patients on all domains. 
Although the profiles suggest that CN patients performed better than controls on 
verbal consolidation, this difference is not significant. Differences between CN 
and CI patients were also tested by independent sample t tests.  Patients without neuropsychological deficits 
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All differences were significant, with 5 effect sizes in the larger range; all other 
effect sizes were medium. 
 
Figure 1. cognitive profiles 
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Differences between CN and CI patients on obstetric complications, premorbid 
adjustment and substance abuse were tested with chi-squared tests (table 3). 
Data concerning the employment status of normal controls were also available 
(17.8 % regular employment, 71.1 % study and 11.1 % unemployed). There was 
no significant difference between controls and CN patients, but there was a 
significant difference between controls and CI patients in employment status (χ² 
= 13.99, p = .001). Differences on age at onset, psychopathology, social 
functioning and indirect measures of compensation were tested with ANOVA or 
Mann-Whitney U tests. Differences in the percentage of subjects showing 
disabilities on individual social roles were tested with chi-squared tests (table 
4). There were no significant differences in obstetric complications, 
employment situation before inclusion, history of intimate relationships or age 
at onset. 
There was no significant difference on general psychopathology minus 
disorganization. Also no evidence for different symptom profiles was found. 
The CI patients only had a significantly higher score on the disorganization 
dimension (F(1,116) = 4.93, p < .05). No significant differences in substance 
abuse or dependence were found.  Patients without neuropsychological deficits 
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Table 3. Differences between patients with and without cognitive deficits on obstetric complications, 
premorbid adjustment and substance abuse. 
 
 
 
Both patient groups differed significantly in general social functioning, in favor 
of the CN group. This was significant for the self-care role (χ² = 4.46, p < .05) 
and the work role  (χ² = 8.09, p < .01). CN Patients scored significantly higher 
on intelligence (F (1,116) = 7.19, p < .01) and level of education (F (1,116) = 
7.30, p < .01) than CI patients. Mean level of education for the controls was 5.9 
with a standard deviation of 1.5. The difference between CN patients and 
controls was not significant, the difference between CI patients and controls was 
significant (t (138) = 6.39, p < .000) 
 
 
 
  Cognitively normal  
n = 23 
% patients 
Cognitively impaired  
n = 95 
%patients 
Significance 
(Chi-squared, 
 two-tailed) 
     
Obstetric complications     
Pregnancy 35.3  48.7  ns. 
Birth 43.8  31.5  ns. 
Hypoxia-related 31.3  20.5  ns. 
      
Premorbid adjustment     
Employment status     
Regular 39.4  26.4   
Study 37.2  47.8  ns. 
Sickness benefit, sheltered  
employment, unemployed 
23.4 26.1  
History of intimate relationship     
Never 50.0  39.1   
< 6 months  27.7  21.7  ns. 
> 6 months  22.3  39.1   
      
Substance abuse     
Alcohol 24.5  21.7  ns. 
Cannabis 54.1  47.4  ns. 
Sedatives 4.2  0  ns. 
Miscellaneous 9.5  13.0  ns. 
      Patients without neuropsychological deficits 
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Table 4. Differences between patients with and without cognitive deficits on age at onset, 
psychopathology, social functioning, and indirect measures of cognitive compensation. 
 
  Cognitively  “normal” 
patients n = 23 
mean              sd 
Cognitively  impaired 
patients, n = 95 
mean              sd 
Significance 
(two-tailed) 
          
Age at onset  23.7 5.6  21.8  4.9    ns. 
          
Psychopathology          
Positive *  2.0  1.1  2.3  1.0   ns. 
Negative 2.0  0.7  2.4  1.0    ns. 
Disorganization 1.6  0.3  1.9  0.7  .028 
Depression 2.1  0.9  2.4  1.0    ns. 
Excitement 1.4  0.6  1.7  0.8    ns. 
PANSS total minus 
disorganization  
47.4 12.9  53.8  16.2    ns. 
MADRS total score  12.3  9.4  14.6  10.4   ns. 
          
Social functioning          
Total score**  1.0  0.7  1.3  0.6  .035 
Self care***  26.1   50.5   .029 
Family role  69.6   78.9    ns. 
Kinship role  52.2   67.4    ns. 
Partner role  56.5   69.5    ns. 
Citizen role  73.9   81.1    ns. 
Social role  56.5   65.3    ns. 
Work role  69.6   91.6   .010 
     
Compensation          
level of education  
(1-8) 
5.3 2.3  3.9  2.1  .011 
mean WAIS C-score 
(1-10) 
6.8 1.0  5.9  1.5  .008 
Mean corrected WAIS C-
score 
6.1 1.0  5.4  1.5  .008 
          
* Standardized PANSS ratings ranging from 1:absent to 7: extreme 
**  Standardized GSDS ratings ranging from 0: no disability to 3: extreme disability 
** * Percentage of subjects showing disability 
 
 
4. Discussion 
 
In this study 19 % of the patients were found to have no cognitive deficits, 
which is lower than the percentage found in some other studies (63 % in 
Zilverstein and Zerwic, 1985; 42% and 73% in Bryson et al., 1993). We 
preferred a conservative approach, however. Patients with only one deficit were 
already classified as cognitively impaired, whereas the other studies used the Patients without neuropsychological deficits 
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Luria-Nebraska or the Halstead-Reitan impairment scores, so patients had to 
perform weakly on several items to be classified as cognitively abnormal. There 
is a negligibly small difference with the studies of Palmer et al. (27%; 1997) 
and Kremen et al. (23%, 2000) who also used a composite neuropsychological 
battery and more stringent criteria. If the criteria for cognitive impairment were 
used to predict group membership, than all three studies would classify a fair 
amount of subjects correctly (respectively, 76 %, 85% and 79% in 
chronological order). Our study would be the most sensitive and the least 
specific. This means that our criteria for cognitive normality were most strict. 
Our results suggest that the CN patients still show signs of cognitive decline at a 
subclinical level, because their cognitive profile deviates from that of normal 
controls and follows more or less the same direction as that of the CI patients. 
The CN patients performed significantly below the level of normal controls on 
perceptual and psychomotor speed and verbal encoding.  They performed better, 
although not significantly, than controls on the verbal consolidation measure. 
This might be an artifact because consolidation is computed by subtracting the 
number of words on delayed recall from the number of words on immediate 
recall (verbal encoding). Since the CN patients already showed a weak 
performance on verbal encoding, they could not loose many words from 
memory. The subclinical deficits in the CN group and their almost similar 
profile shape suggest that the two patients groups do not represent etiologically 
different subgroups. It rather suggests that all patients experience cognitive 
dysfunctions at a certain level even if they are still within normal limits. The 
fact that no differences between both groups in obstetric complications, age at 
onset or premorbid adjustment were found, makes it even less likely that the CN 
patients represent an etiologically different subgroup.  
However, no significant difference in the total level of psychopathology (minus 
disorganization because of conceptual redundancy) and age at onset was found. 
The only significant difference in psychopathology was found on the 
disorganization dimension. These findings reject a general effect of disease 
severity.  
The only measures on which the CN group scored higher, apart from social 
functioning, were education and intelligence. The CN group had a score slightly 
above average on intelligence tests. Mean educational attainment was also 
reasonably high in this group, a level comparable with College. This is in Patients without neuropsychological deficits 
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accordance with the brain reserve capacity theory (BRC; Satz, 1993), which 
states that people with greater BRC, measured indirectly by education and 
intelligence, are better able to compensate for the negative effects of brain 
pathology on cognition.  There is evidence that not all domains of cognitive 
functioning are equally affected in schizophrenia. Several studies mention a 
generalized deficit with more pronounced impairment in verbal learning, 
attention-vigilance and speeded visual-motor processing (Censits et al., 1997; 
Saykin et al., 1991; 1994). Therefore it is possible that compensation in these 
more severely affected areas is not always conclusive, which could explain the 
significant differences on verbal learning and perceptual and psychomotor 
speed between CN patients and controls.  
Cognitive deficits are associated with social dysfunctioning in schizophrenia 
(Dickerson et al., 1996; Green, 1996). Therefore it is to be expected that the CI 
group has more problems in social functioning. Indeed, both patient groups 
differed significantly in general social functioning in favor of the CN patients. 
Close inspection of the various social roles, however, revealed that this was 
mostly due to significant differences in self-care and work roles. These roles 
depend less on interpersonal interactions and more on the acquisition and 
execution of skills than the other roles. It is possible to function marginally in 
interpersonal contacts and still perform within normal limits on a job with less 
interpersonal demands. No significant differences in rates of substance abuse or 
dependence between the two patient groups were found. This suggests that the 
effect of chronic substance use on cognition is not very strong.  
Because not much time had passed between onset of the current episode and 
time of testing it is possible that state-like effects have had their impact on 
cognitive performance. It seems unlikely that this will have significant effects 
on the results of this study because there is no reason to assume that both patient 
groups are differentially affected. Also, the BRC theory is applicable for both 
state and trait like effects of brain dysfunction on cognition. One could also 
argue that the differences in cognition between CN and CI patients are caused 
by the same amount of cognitive decline from different levels of cognitive 
functioning as is paralleled in differences in IQ and education. However, IQ and 
cognition are not identical as was shown by Joyce et al. (2002) and Weickert et 
al. (2000). And a decline from higher levels would  implicate that premorbidly Patients without neuropsychological deficits 
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CN patients would have performed above the level of normal controls on five of 
the nine domains, on which they now equal controls, which is highly unlikely.  
The use of the BRC theory, normally used in research on progressive dementia, 
for a neurodevelopmental disorder as schizophrenia also raises some questions. 
In dementia the BRC predicts later onset of cognitive deficits for those with 
greater cerebral reserve. Because schizophrenia is not a progressive 
deteriorating brain disease, we suggest that cerebral reserve will be protective 
against the cognitive effects of neuropathology at any age. It could be argued 
that it is not justified to use education as an indirect measure of compensation 
capacity in schizophrenia because of premorbid attenuated educational 
attainment. It is not clear however at what developmental stage educational 
attainment is affected. In the NIMH discordant twin study for example school 
grades were strikingly similar between affected and well twins (Torrey et al., 
1994). So it seems more likely that educational attainment is not severely 
affected during early development. The Dutch educational system, and hence 
our scoring system, is rather robust for this, because the Dutch system already 
differentiates after primary school into four levels. 
Overall this study suggests that cognitive compensation could explain the 
existence of cognitive “normality” in schizophrenia. The evidence is rather 
indirect, because we cannot proof directly that CN patients truly resist the 
cognitive effects of brain pathology due to a larger compensation capacity. We 
did not have premorbid cognitive data or an estimate of premorbid intelligence. 
There were, however, no differences in other indicators of premorbid 
functioning (employment status or intimate relationships), which suggests that 
there were no large differences in general functioning other than intelligence 
and educational level between both groups before illness onset. This would 
make it less likely that CI patients already showed the severe cognitive deficits 
found in this study before illness onset. We think that compensatory 
mechanisms should be included in comprehensive models of cognitive 
dysfunction in schizophrenia.  
This study also seems to challenge models of schizophrenia in which 
cognition is seen as the core deficit, and the cause of clinical symptoms 
(Goldman-Rakic, 1994; Hemsley, 1994), because CN patients performed 
significantly better than CI patients on all cognitive domains, while no 
significant differences in psychopathology were found.  Patients without neuropsychological deficits 
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Abstract 
 
Many observations have supported the general idea of impaired frontal function 
in schizophrenia. In particular neuropsychological studies have shown severe 
frontal deficits. However, other studies found normal cognitive function in a 
proportion of patients. Since saccadic tasks also provide an index of frontal 
function, we examined the presence of frontal deficits in patients by means of 
both neuropsychological and saccadic tasks, and compared the sensitivity of 
both approaches for frontal impairment. In addition, we examined the 
relationship between saccadic and neuropsychological measures. Twenty-four 
schizophrenic patients and twenty healthy controls completed an extensive 
neuropsychological battery and three saccadic tasks. Based on the 
neuropsychological battery alone, 42% of the patients showed frontal deficits, 
whereas combined use of neuropsychological and saccadic tasks resulted in 
79% with frontal deficits. The antisaccade task appeared able to detect frontal 
deficits in patients who were without frontal impairment on the 
neuropsychological battery. Saccadic deficits were, however, not necessarily 
accompanied by deficits on frontal neuropsychological measures. This suggests 
that the saccadic and neuropsychological tasks used in the present study 
targeted different frontal functions. This view was supported by the lack of 
correlations between saccadic and frontal neuropsychological measures.  
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1. Introduction 
 
Many observations have supported the general idea of impaired frontal function 
in schizophrenia. In particular, studies addressing frontal functions by means of 
neuropsychological (NP) tests have demonstrated severe cognitive deficits. It 
has, therefore, been proposed that frontal cognitive deficits are among the core 
deficits of schizophrenia (Goldman-Rakic 1994; Hemsley 1994). However, this 
assumption is not in accordance with studies that found a substantial proportion 
of patients with normal NP performance, including performance on frontal tasks 
(Silverstein & Zerwic 1985; Bryson et al. 1993; Palmer et al. 1997; Holthausen 
et al. 2002). Estimates of this proportion vary from 19% (Holthausen et al. 
2002) to 73% (Bryson et al. 1993).   
In order to determine if frontal impairment is a core deficit of schizophrenia, it 
seems worth the effort to evaluate frontal functions by means of an alternative 
method, namely the recording of saccadic eye movements. Saccades are fast eye 
movements, which are made to fixate objects on the fovea. These eye 
movements can be easily implemented in various cognitive tasks. An advantage 
of such tasks is that the neural systems subserving these tasks are well known 
from primate studies (Bruce & Goldberg 1985; Hikosaka & Wurtz 1991; 
Everling et al. 1999) and performance is not dependent on manual and verbal 
capacities. In addition, a smaller number of cognitive subprocesses are 
involved, since the visual stimuli are very simple and do not require complex 
integrative processing (in contrast to pictures, words, etc), and the eye 
movement response does not require cross-modal integration. Due to these 
characteristics, we presume that saccadic tasks target frontal functions rather 
specifically.  
Saccadic tasks have proven to be a valuable tool in estimating functional 
impairment in certain psychiatric patient groups (Everling & Fischer 1998). In 
particular, in schizophrenic patients saccadic abnormalities were found (Thaker 
et al. 1989; Crawford et al. 1995; Hutton et al. 1998). With respect to these 
abnormalities, it is useful to make a distinction between visually guided (or 
externally driven) saccades and voluntary saccades, which are usually generated 
in (simple) cognitive paradigms (Tusa et al. 1986). Visually guided saccades 
require mainly spatial attention and the generation of a precise motor program, 
whereas voluntary saccades require intact higher order, executive functions. A Frontal normality in schizophrenia 
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large number of studies have shown that schizophrenic patients perform 
accurately on visually guided saccades (Crawford et al. 1995; Hutton et al. 
1998; Karoumi et al. 1998), whereas they have severe problems with voluntary 
saccades, as measured in, for example, the antisaccade and memory saccade 
task. On these tasks, patients show typical failures in suppressing response 
tendencies towards suddenly appearing stimuli (Crawford et al. 1995; 
McDowell & Clementz 1997).  
Saccadic tasks and NP tasks have both been used to assess frontal functions. It 
is, therefore, not surprising that several studies have looked at the relationship 
between these tasks in psychiatric patient groups (Rosse et al. 1993; Crawford 
et al. 1995; Schreiber et al. 1995; Tien et al. 1996; Radant et al. 1997; Karoumi 
et al. 1998; Snitz et al. 1999; Nieman et al. 2000; Gooding & Tallent 2001). The 
majority of these studies, however, used only few NP tests. Moreover, the 
results were inconsistent, except for a positive association between antisaccade 
inhibition failures and performance on the Wisconsin Card Sorting Test 
(WCST; perseveration errors) (Rosse et al. 1993; Crawford et al. 1995; Tien et 
al. 1996; Radant et al. 1997; Karoumi et al. 1998) and a spatial working 
memory task (Gooding & Tallent 2001). These positive associations have been 
attributed to a common dependency on the (dorsolateral) prefrontal cortex 
(DLPFC), which has been reported to be crucially involved in each of these 
tasks (Berman et al. 1986; Goldman-Rakic 1994; O'Driscoll et al. 1995; 
Sweeney et al. 1996; Doricchi et al. 1997). Since neuroimaging studies have 
shown that various other NP tasks, like the Continuous Performance Task 
(Hager et al. 1998), the Stroop Task (Peterson et al. 1999), the Trail Making 
Test (Lesnik et al. 1998), and Verbal Fluency (Hugdahl et al. 1999), are also 
dependent on the (pre)frontal cortex, it remains to be elucidated why previous 
studies failed to find consistent associations between these tasks and saccadic 
tasks. The extent of DLPFC involvement in these NP tasks might determine 
whether significant relations are obtained.  
The main goal of the present study was to evaluate the assumption that frontal 
impairment is a core deficit of schizophrenia, an assumption which implies that 
all patients show frontal deficits. Since the traditional use of NP tests has 
revealed inconsistent results, frontal function was examined by means of NP 
tasks as well as saccadic tasks, which were presumed to target frontal function 
more specifically. We examined whether adding saccadic tasks to a NP test Frontal normality in schizophrenia 
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battery would increase the sensitivity to detect frontal impairment, and whether 
specific saccadic measures were more sensitive to frontal deficits than NP tasks. 
Therefore, we first established the number of patients with frontal deficits based 
on the NP tasks alone, and compared this with the number of patients obtained 
when NP tasks were combined with saccadic tasks. Second, we compared the 
performance on specific saccadic measures in patients with and without frontal 
impairment on the NP test battery. We also examined the number of patients 
showing deficits in two other, non-frontal domains, namely psychomotor speed 
and memory. Finally, we were interested in the relationship between saccadic 
measures, which were presumed to target frontal function, and frontal NP 
measures, since the literature provides inconsistent results on these correlations.  
 
 
2.  Methods  
 
2.1 Subjects 
 
The study included 24 patients (18 males and 6 females) who had recently 
experienced a first or a second psychotic episode according to DSM-IV 
(American Psychiatric Association 1994) and received a diagnosis within the 
schizophrenia spectrum (schizophrenia, n=12; schizophreniform disorder, n=11; 
schizoaffective disorder, n=1). The diagnosis was based on a structured 
interview (SCAN; Wing et al. 1990). Exclusion criteria were severe mental 
retardation, systemic or neurologic illness, severely impaired vision, medication 
other than antipsychotics, and severe tardive dyskinesia. The mean age was 
26.54 (SD 8.47) years and average education was at high school level. Eighteen 
patients used atypical antipsychotic medication (olanzapine and risperidone), 
five patients used classic antipsychotic medication, and one patient was drug-
free. 
A control group of 20 healthy volunteers (15 males and 5 females), recruited 
from the local community, was included to evaluate the saccadic performance 
of patients. The mean age was 20.95 (SD 2.80) years and average education was 
at high school level.  
The patient and control groups were matched for gender and level of education, 
whereas there was a difference for age (p= .007). The factor age is known to Frontal normality in schizophrenia 
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have an influence on both cognitive (Elias et al. 1990) and saccadic 
performance (Fischer et al. 1997), however, the age difference between our 
groups was too small (5.6 years) to have a significant influence on performance.     
 
 
2.2 Neuropsychological measures 
 
An extensive NP test battery was completed. Tests included a double stimulus 
Continuous Performance Task (CPT; Van den Bosch et al. 1996), a 
computerized Stroop task (Stroop 1935), the Trail Making Test (TMT; Vink & 
Jolles 1985), a Finger Tapping test, the Dutch translation of the California 
Verbal Learning Test (CVLT; Delis et al. 1987), the Rey Complex Figure 
(RCF; Rey 1964), and Verbal Fluency (VF). Table 2 shows the 15 measures 
obtained by each of these tests. The following four measures were considered to 
reflect frontal functioning: CPT d’, Stroop interference, TMT interference, and 
VF items in category. The raw test scores were converted into z scores, and 
patients showing a z score below –2 on one of the four frontal measures were 
characterized as ‘frontally impaired’ (FI), whereas the other patients were 
characterized as ‘frontally normal’ (FN). This criterion for group assignment 
was chosen, because of its frequent use in clinical settings. A similar procedure 
was used to determine the presence of deficits in two non-frontal domains, 
psychomotor speed and memory. The following five measures were considered 
to reflect psychomotor speed: CPT reaction time, Stroop word reading and color 
naming, TMT trail A, and Finger Tapping, whereas memory function was 
presumed to be reflected in: CVLT encoding, consolidation, retrieval, total 
intrusions, and RCF percentage recall.  
In order to examine the relationship between saccadic measures and NP 
performance in the frontal, psychomotor speed, and memory domains, we 
calculated three composite scores for each of these domains. These were based 
on the mean z scores of the NP measures described above.  
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2.3 Saccadic eye movement recording 
 
Subjects were comfortably seated 90 cm in front of a color monitor in a 
darkened room. Eye movements were recorded using an infrared limbus 
reflection device (Iris Skalar, Skalar Medical, B.V.), and head movements were 
restrained by an adjustable headrest. Visual stimuli, small green squares of 
approximately 3 mm, were presented against the darkened color monitor. 
Before presentation of the tasks, subjects were presented with calibration 
stimuli and a series of 20 practice trials. Saccades were identified using 
interactive software (developed at the University Maastricht, The Netherlands) 
which enabled the rejection of artifacts due to, for example, eye blinks.  
Saccade detection was based on a velocity criterion of 30°/s in addition to an 
acceleration across three consecutive samples. Since the minimum latency of a 
visually guided saccade is approximately 100 ms (Fischer & Ramsperger 1984), 
the first saccade of at least 3° made 100 ms after target onset was scored as the 
response.  
 
 
2.4 Saccadic measures 
 
Three saccadic tasks were completed: a visually guided saccade task, an 
antisaccade task and a memory saccade task (Figure 1).  
Visually guided saccade task After central fixation (800 ms), a stimulus was 
randomly presented 7.5° or 15° to the left or right for 1000 ms. Subjects were 
expected to respond with a rapid and accurate eye movement. Intertrial interval 
was 1000 ms, and 48 trials were completed. This task required the integration of 
spatial attention, visual perception, and a precisely targeted motor program, but 
placed few demands on higher order, executive functions. The performance was 
evaluated for latency of saccadic onset and the number of too early anticipations 
on stimulus behavior.  
Antisaccade task After central fixation (800 ms), a stimulus was randomly 
presented 7.5° or 15° to the left or right for 2000 ms. Subjects were required to 
direct a saccade towards the spatial position in the visual field opposite to that 
of the stimulus. There was no intertrial interval, and 48 trials were completed. 
The task required both the suppression of the reflexive saccade that would Frontal normality in schizophrenia 
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normally be generated in response to a novel visual target and the generation of 
a volitional saccade to the opposite hemifield. The performance was evaluated   
for the number of inhibition errors (reflecting a failure in the ability to suppress 
a response tendency), the latency of appropriate saccades, and the latency of the 
inhibition errors.  
Memory saccade task After central fixation (800 ms), a stimulus was 
randomly presented 7.5° or 15° to the left or right for 200 ms. Subjects were 
required to suppress the reflexive saccade to the stimulus and delay the saccade 
for 700 ms (until fixation point offset). There was no information on the 
location of the previously presented stimulus at the moment of saccade 
initiation. Intertrial interval was 3000 ms, and 48 trials were accomplished. This 
task examined the ability to generate an internal representation of space as well 
as the programming of a volitional motor action and the ability to delay (inhibit) 
the saccadic motor program during the memorization period. The task also 
examined the inhibition of an immediate saccadic reflex to the stimulus. 
However, this inhibition was relatively easy when compared to the antisaccade 
task, since the fixation point remained on during stimulus presentation, which 
facilitates the engagement of attention.   
 
 
 
  
 
  
 
 
 
  
 
1A. Visually guided saccades 
 1B. Antisaccades 
1C. Memory saccades 
Figure 1. Saccadic paradigms 
1A: A visual stimulus is presented in 
a random sequence to the left or right 
of a central fixation point and subjects 
are instructed to respond with a rapid 
and accurate eye movement 
1B:  Antisaccades are directed 
towards a spatial position in the 
opposite visual filed tot that of the 
stimulus. The paradigm requires 
suppression of the refexive saccade 
that would normally be generated in 
response to a novel visual target, and 
the generation of a volitional saccade 
to the opposite hemifield. 
1C:  Subjects are instructed to 
suppress the normal reflexive eye-
movement in response to a novel 
stimulus, and to delay the saccade 
until the offset of the central light. 
There is no visual information on the 
location of the previously presented 
target at the moment of saccadic 
initiationFrontal normality in schizophrenia 
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Performance on this task was evaluated for two parameters. First, the number of 
immediate inhibition errors (reflecting a failure in the ability to suppress a 
response tendency), which occur in the early phase of the delay period (0 to 250 
ms), and second, the number of delay errors (reflecting a defect or weakness in 
inhibition mechanisms which normally prevent an already prepared saccadic 
motor program from being directly initiated), which occur in the late phase of 
the delay period (250 to 700 ms). 
Based on animal studies (Funahashi et al. 1993; Everling & Munoz 2000) and 
studies in patients with brain lesions (Pierrot-Deseilligny et al. 1991a,b), the 
following measures from the antisaccade and memory saccade task were 
considered to reflect frontal function: antisaccade inhibition errors, memory 
saccade inhibition errors, and memory saccade delay errors. The raw test scores 
on these measures were converted into z scores, and patients showing a z score 
below –2 on at least one of these measures were regarded as showing frontal 
saccadic impairment. 
 
  
2.5 Statistical analyses 
 
Differences between the FI and FN group on major demographic variables (age, 
gender, and level of education) were examined by means of t tests or chi-square 
analyses. Differences between the FI, FN and control groups on saccadic and 
NP measures were examined by one-way analysis of variance (ANOVA) 
followed by post hoc testing (Fishers’ protected T tests, alpha .05). When 
variables did not resemble the normal distribution, non-parametric Kruskal-
Wallis tests followed by Mann-Whitney U tests were performed. The 
relationships between saccadic and NP performance were examined in the total 
sample with Pearson correlation coefficients. 
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3.  Results 
 
3.1 Presence of frontal, psychomotor speed, and memory deficits in 
patients 
 
Table 1 shows how deficits in the frontal, psychomotor speed, and memory 
domains were distributed within the patient sample when the NP test battery 
was considered alone and when the NP tasks were combined with the three 
putatively frontal saccadic measures. Based on the NP tasks alone, 10 patients 
(42%) showed frontal impairment, whereas combined use of NP and saccadic 
tasks revealed 19 patients (79%) with frontal deficits. Combined use of NP and 
saccadic tasks also revealed that none of our patients were without cognitive 
deficits.  
 
Table 1. Cognitive deficits in the frontal, psychomotor speed, and memory domain in patients. 
 
Defective cognitive domain  Number of patients 
  NP tasks alone  NP + saccadic tasks 
None 1  0 
Frontal 
a 1  2 
Speed 
a b 5  2 
Memory 
a 5  2 
Frontal + Speed  1  4 
Frontal + Memory  1  4 
Speed + Memory  3  1 
Frontal + Speed + Memory  7  9 
Overall frontal (either with or without deficits in other domains)  10  19 
Overall speed (either with or without deficits in other domains)  16  16 
Overall memory (either with or without deficits in other domains)  16  16 
            a no deficits in the other two domains. 
            b speed=psychomotor speed. 
 
 
3.2 NP test performance of the FI, FN, and control groups 
 
Based on the NP test battery, 10 patients were characterized as ‘frontally 
impaired’ (FI group), while 14 patients were characterized as ‘frontally normal’ 
(FN group). No significant differences were found in age, gender, or level of Frontal normality in schizophrenia 
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education between the FI, FN, and control groups. Table 2 shows the 
performance of these groups on all NP measures included in the test battery.  
 
Table 2. Neuropsychological performance in the FI, FN, and control group.  
 
  FI patients 
(n=10) 
FN patients 
(n=14) 
Controls    
(n=20) 
Sign Post  hoc 
  Mean (SD)  Mean (SD)  Mean (SD)    
CPT        
   d’  2.74 (1.04)  3.86 (.35)  4.25 (.51)  .000  FI<FN+CS 
   RT (ms)  546.6 (116.19)  495.14 (73.69)  441.85 (65.94)  .007  FI>CS 
Stroop         
   Word reading (s)  43.8 (7.72)  40.62 (5.57)  37.03 (4.39)  .011  FI>CS 
   Color naming (s)  45.71 (7.60)  37.50 (5.96)  34.41 (5.12)  .000  FI>FN=CS 
   Interference (s)  10.45 (5.82)  6.95 (3.35)  8.58 (5.97)  .284   
Trail Making          
   Trail A (s)  46.00 (22.36)  35.57 (10.50)  25.05 (6.66)  .000  FI>CS 
   Interference  70.58 (57.96)  37.10 (25.00)  45.71 (22.65)  .065   
Verbal Fluency           
   Category words  16.25 (2.63)  17.92 (3.36)  22.05 (6.38)  .008  FI<CS 
Finger tapping         
   Number of taps  52.1 (10.18)  56.16 (13.41)  64.54 (11.40)  .020  FI<CS 
CVLT         
   Encoding (trial 1-5)  38.80 (8.64)  48.64 (7.39)  55.20 (6.26)  .000  FI<FN<CS 
   Consolidation  1.80 (2.04)  1.64 (2.02)  2.40 (1.60)  .462   
   Retrieval  5.40 (2.95)  5.57 (1.87)  5.15 (1.84)  .849   
   Total intrusions  6.20 (5.94)  4.36 (5.26)  1.16 (1.20)  .007  FI>CS 
RCF         
   Copy  30.22 (4.63)  32.36 (4.14)  32.98 (2.2)  .155   
   Percentage recall  45.43 (23.91)  62.17 (24.0)  70.39 (16.92)  .018  FI<CS 
FI=frontally impaired; FN=frontally normal; CS=controls. 
 
 
3.3 Saccadic performance of the FI, FN and control group. 
 
The FI, FN and the control groups differed significantly for 3 of the 7 saccadic 
measures (Table 3): the number of inhibition errors on the antisaccade task 
(F=7.87, p=.001), the number of inhibition errors on the memory task (χ
2=6.85, 
p=.033), and the number of delay errors on the memory task (F=3.79, p=.032).  
Both the FI and FN group showed significantly more inhibition errors on the 
antisaccade task than controls (p values of .016 and .003 respectively). With 
respect to the memory task, the FI group showed significantly more inhibition 
errors (p=.022) and delay errors (p=.025) than the control group, whereas Frontal normality in schizophrenia 
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differences between the FI and FN group and the FN and control group were not 
significant.  
 
Table 3. Saccadic performance in the FI, FN, and control group.  
 
* FI=frontally impaired; FN=frontally normal 
 
 
3.4 Presence of deficits on frontal saccadic and frontal NP measures in 
patients. 
 
Table 4 shows that patients with impaired performance on frontal NP measures 
did not necessarily perform poorly on frontal saccadic measures, and vise versa. 
Three patients with normal saccadic performance showed impaired performance 
on NP measures, while nine patients with impaired saccadic performance 
showed normal NP performance. 
 
 Table 4. Presence of deficits on frontal saccadic and frontal NP measures in patients. 
 
   Frontal saccadic performance
** 
   normal impaired 
normal  5 9 
Frontal NP performance
*  Impaired  3 7 
* performance on CPT d’, Stroop interference, TMT interference, and Verbal Fluency. 
** performance on antisaccade inhibition errors, memory saccade inhibition errors, and memory saccade 
delay errors. 
  FI patients 
(n=10) 
FN patients 
(n=14) 
Controls 
(n=20) 
Sign Post  hoc 
  Mean (SD)  Mean (SD)  Mean (SD)     
Visually guided task          
   Latency  197.32 (30.11)  199.13 (35.05)  196.04 (25.10)  .958   
   Early anticipations  7.8 (8.69)  5.71 (5.37)  2.75 (2.31)  .376   
Antisaccade task           
   Latency  387.63 (78.17)  369.22 (62.37)  330.55 (58.79)  .064   
   Inhibition errors  28.89 (15.56)  31.04 (20.82)  12.59 (7.35)  .001  FI=FN>CS 
   Latency Inhibition errors  247.19 (58.15)  237.29 (41.20)  221.00 (40.56)  .331   
Memory task          
   Inhibition errors   8.67 (5.81)  9.28 (11.49)  3.40 (4.89)  .033  FI>CS 
   Delay errors   21.25 (19.63)  14.22 (9.24)  8.31 (5.40)  .032  FI>CS Frontal normality in schizophrenia 
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3.5 Frontal saccadic measures, frontal NP measures, psychomotor speed 
and memory. 
 
The signs of the raw data were adjusted so that a lower value on any measure 
represented poorer performance. Using a Bonferroni correction, only two-tailed 
p values smaller than .003 were considered significant for correlation 
coefficients. As shown in Table 5, antisaccade inhibition errors were 
significantly correlated with CPT d’ (r=.45, p=.002) and with the composite 
score for psychomotor speed (r=.49, p=.001), while inhibition errors on the 
memory saccade task were significantly correlated with the composite score for 
memory (r=.47, p=.001). 
 
Table 5. Correlations between frontal saccadic measures and NP measures.  
 
  Antisaccade 
Inhibition errors 
Memory saccade 
Inhibition errors 
Memory saccade 
Delay errors 
Frontal (composite score)  .32 .24 -.03 
   CPT d’  .45 *  .22  .28 
   Stroop interference  .14 .33 -.14 
   TMT interference  -.04 .10 -.21 
   VF items in category  .11 .17  .003 
Psychomotor speed (composite score)  .49** .33  .40 
Memory (composite score)  .35 .47  * .41 
* = p<.002 
**  = p<.00 
 
 
4.  Discussion 
 
In order to examine whether frontal impairment is a core deficit of 
schizophrenia, we examined frontal function with two different approaches. In 
addition, we examined whether combined use of traditional NP and saccadic 
tasks would increase the sensitivity to detect frontal impairment. Based on the 
NP tasks alone, 42% of our patients demonstrated frontal deficits, whereas 
combined use of NP and saccadic tasks revealed frontal impairment in 79% of 
our patients. This suggests that addition of saccadic tasks to the NP measures Frontal normality in schizophrenia 
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used in the present study significantly increased the sensitivity to detect frontal 
impairment.   
The question whether the saccadic measures were more sensitive to frontal 
impairment than NP tasks, was addressed by comparing the performance on 
saccadic measures in patients with and without frontal impairment on a NP 
battery. A high level of antisaccade inhibition errors was obtained in FN 
patients, who were presumed to have intact frontal function. Apparently, the 
antisaccade task was able to reveal frontal deficits which were not detected by 
the frontal NP tasks used in the present study. This might be due to a strong 
stimulus-response compatibility (Gale & Holzman 2000) and the absence of 
verbal and manual task components. These characteristics might imply a 
relatively short and restricted pathway in the brain, which probably reduces the 
impact of (inhibitory) control mechanisms. With respect to the memory saccade 
task, the performance of the three groups revealed a pattern similar to that of the 
NP tasks. This suggests that the memory task is less sensitive to frontal 
impairment than the antisaccade task, which might be due to the fact that, 
although both tasks address inhibitory functions, the memory task addresses 
them in a less stringent way. In the memory task, visual targets are presented 
while the fixation point remains on, which implies that the orienting system is 
not fully prepared for immediate action. In the antisaccade task, however, 
fixation point offset results in disengagement of attention, which renders 
subjects more vulnerable to an immediate response to novel targets. The 
memory task also requires a larger number of cognitive processes, which 
provides the opportunity to compensate for problems in one task process by 
investing more effort in others. In combination with its slower pace, this makes 
the memory task is a better comparison to the NP tasks.  
Although the high antisaccade error rate in the FN group suggests that this task 
is more sensitive to frontal impairment than the NP tasks, a closer look at the 
presence of frontal saccadic and frontal NP deficits in individual patients 
revealed that patients with impaired performance on frontal saccadic measures 
not necessarily performed poor on frontal NP measures, and vise versa. These 
findings suggest that the frontal saccadic and NP tasks address, at least to some 
extent, different frontal functions. This was interpreted as evidence for the 
notion that combined use of NP and saccadic tasks is the most favorable method 
to assess frontal function. Future studies using, for example, functional brain Frontal normality in schizophrenia 
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imaging techniques should provide evidence for the idea that our frontal 
saccadic and NP measures indeed target different frontal functions.  
The finding that 21% of our patients did not show frontal impairment on either 
the NP or the saccadic tasks, contradicts the notion of frontal deficits as a core 
deficit of schizophrenia. On the other hand, all our patients suffered from 
deficits in either the frontal, speed, or memory domain, which strongly suggests 
that cognitive deficits (instead of frontal  deficits) are a core deficit of the 
disease.  
A related issue, is the ongoing debate as to whether the cognitive deficits in 
schizophrenia should be characterized as a generalized cognitive deficit or as 
deficits in specific cognitive domains. The common view is that schizophrenic 
patients suffer from specific deficits against a background of generalized 
cognitive dysfunction, with specific impairment in verbal learning, vigilance, 
speeded visual-motor processing (Saykin et al. 1991, 1994; Censits et al. 1997) 
and executive functioning (Mohamed et al. 1999). The present study did not 
support the idea of cognitive deficits being a generalized deficit, since only nine 
patients showed deficits in all three domains. We also failed to find evidence for 
the existence of specific deficits in either the frontal, psychomotor speed, or 
memory domain, since deficits in these three domains were present in 
respectively 79%, 67% and 67% of the patients.  
With respect to the relationship between saccadic performance and NP 
performance within the frontal, psychomotor speed, and memory domain, our 
main finding was a remarkable lack of significant association between frontal 
saccadic measures and the composite score for frontal NP function. With 
respect to individual frontal NP measures, however, we found a strong 
correlation between antisaccade inhibition errors and CPT d’. Apparently, 
antisaccade performance and the sensitivity to detect targets in a memory-load 
CPT depend on a common function, and thus probably on common brain 
regions. This idea is supported by neuroimaging studies reporting that the CPT 
is associated with brain activation in the right DLPFC and the mesial frontal 
cortex (Hager et al. 1998), while these areas have also been found to be active 
during the antisaccade task (Sweeney et al. 1996; Doricchi et al. 1997). For the 
other frontal NP measures, we found, however, no significant association with 
saccadic measures, which suggests a lack of overlap in the frontal functions 
addressed by both type of measures. This is also suggested by our finding that Frontal normality in schizophrenia 
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deficits on frontal saccadic measures were not necessarily accompanied by 
deficits on frontal NP measures. It should be noted here, that our patients 
showed a remarkable accurate performance on two putative frontal NP 
measures, namely Stroop interference and TMT interference. Other studies have 
also failed to observe an association between frontal saccadic measures and 
frontal NP measures, except for the WCST and a working memory task. We 
hypothesize that, compared to NP tests, voluntary saccades depend on a 
relatively limited set of brain regions, with crucial involvement of the DLPFC. 
The probably limited DLPFC dependence of our NP tasks might have resulted 
in only marginal associations with the saccadic measures, as compared to NP 
tasks with large DLPFC involvement, like the WCST and tests of spatial 
working memory. 
Another intriguing finding was that psychomotor speed-abilities were 
significantly associated with antisaccade inhibition errors. This was unlikely to 
be caused by an underlying defect in basic oculomotor processes, since the 
performance on visually guided saccades was accurate. It appeared that all 
psychomotor speed measures were significant contributors to the association, 
except for Finger Tapping. This suggests that a general slowness in information 
processing was underlying the association rather than a deficit in motor abilities. 
Slow processing of incoming information, and probably also slow rehearsal of 
task instructions, might have resulted in greater problems to overcome response 
tendencies.  
With respect to the significant correlation between memory saccade delay errors 
and performance in the memory domain, it appeared that encoding deficits were 
mainly responsible for the significance of the association. This may be because 
of the relatively slow pace of the memory saccade task (trial duration of 4.5 s, 
as compared to 2.8 s in the antisaccade task), which required active rehearsal of 
the task instruction not to initiate the saccade before fixation point offset. 
However, the oculomotor program for the saccade was prepared immediately 
after stimulus presentation. Poor encoding of the task instruction might, 
therefore, have rendered patients vulnerable to early initiation of saccades.  
In sum, the present study does not support the view that frontal impairment is a 
core deficit of schizophrenia, but our results do support the notion that cognitive 
deficits are a core feature of the disease. We did not found evidence for the 
existence of either a generalized deficit or deficits in specific cognitive domains. Frontal normality in schizophrenia 
 
 
55 
The use of traditional NP measures in combination with saccadic tasks appeared 
to increase the sensitivity to detect frontal impairment. In particular the 
antisaccade task appeared able to reveal frontal deficits. Frontal saccadic 
measures were, however, only marginally associated with frontal NP measures.  Frontal normality in schizophrenia 
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Abstract 
 
Long-term memory impairment is often found in schizophrenia. The question 
remains whether this is caused by other cognitive deficits. One hundred 
eighteen first episode patients were compared with 45 controls on several 
memory tasks. The role of processing speed and central executive functions on 
memory performance was examined with regression analysis for all subjects 
and for patients separately. Deficits were found in general verbal learning 
performance and retrieval in episodic memory and semantic memory. 
Processing speed reduced disease related variance in all memory variables. 
Coordination, organization of information, and speed of processing were the 
best predictors for long-term memory deficits in patients. The amount of 
explained variance, however, is small, especially in general verbal learning 
performance.  
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1. Introduction 
 
Although no single neurocognitive test or construct completely separates 
schizophrenic patients and controls (Heinrichs & Zakzanis, 1998), long-term 
memory impairment is often found in schizophrenia. Some researchers even 
suggest that schizophrenia patients have a specific deficit in long-term memory 
against a background of more generalized cognitive dysfunctioning (Saykin, 
Gur, et al., 1991; Saykin, Shtasel, et al., 1994). Memory impairments, especially 
impairments in long term memory, are also associated with a variety of 
functional outcome measures, such as vocational outcome, community 
functioning and quality of life, in schizophrenia (Green, 1996; Green, Keen, 
Braff & Mintz, 2000).  
Memory, however, is not a unitary concept and can be divided into several 
systems and processes (Schacter & Tulving, 1994). Long-term memory can be 
divided into episodic and semantic memory systems. Episodic memory enables 
people to encode and retrieve personal information, which is encoded in relation 
to spatial and temporal context. Three processes can be distinguished in 
manipulating episodic information: encoding or learning of new information; 
storage of information; and explicit retrieval of information. The other long-
term memory system is semantic memory, an organized amount of context-free 
knowledge, together with rules to manipulate this knowledge. Explicit retrieval 
processes can also play a role in the retrieval of information from semantic 
memory. In contrast to these explicit memory systems, there is also implicit 
memory, which deals with the automatic cognitive and motor processes, which 
do not require conscious attention. 
Some diseases are characterized by specific memory deficits. Storage deficits in 
episodic memory, for example, are typical for patients with Alzheimer’s or 
Korsakov disease. Impaired initiation of retrieval strategies on the other hand is 
typically found in patients with Huntington’s and Parkinson’s disease (Paulsen 
et al., 1995). In schizophrenia, however, impairments in explicit memory are 
prominent, while lesser impairments in implicit memory are found (e.g. Clare, 
McKenna, Mortimer & Baddeley, 1993; Goldberg, Hyde, Kleinman & 
Weinberger, 1993; Kazes et al., 1999). Many studies report problems in 
episodic memory, but most of them only find learning and retrieval deficits, 
while storage is relatively spared (e.g. Aleman, Hijman, de Haan & Kahn, 1999; Long-term memory deficits 
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Brebion, Amador, Smith & Gorman, 1997; Hawkins Sullivan & Choi, 1997; 
Paulsen et al., 1995). Although the majority studied verbal memory only, visual 
memory impairments are found as well, and there is no evidence for a 
difference between both modalities (Aleman et al., 1999). There is also 
evidence for semantic memory deficits (McKay et al., 1996). This seems to be 
caused by inefficient access to the semantic store, which could be labeled as a 
retrieval deficit (Joyce, Collinson & Chrichton, 1996). In sum, the memory 
deficits found in schizophrenia are explicit, verbal as well as visual and mostly 
concern active memory processes, such as learning and retrieval processes in 
long term memory systems. These systems are at least partly dependent on other 
cognitive functions, such as speed of information processing, and central 
executive processes. Should the memory impairments in schizophrenia be 
understood as pure memory deficits or as the result of another underlying 
cognitive deficit? Because different brain regions mediate these cognitive 
functions, this is an important question in the search for basic mechanisms in 
schizophrenia.  
Several studies have described a slowing of processing speed on a number of 
cognitive tasks as a major cognitive deficit in schizophrenia (Nelson et al, 1990; 
Schatz, 1997; Van der Does Dingemans, Linszen, Nugter & Scholte, 1996). 
Most studies make a distinction between sensorimotor speed and cognitive 
speed. The latter requires controlled information processing and is more 
impaired in schizophrenia than simple sensorimotor speed (Nelson et al., 1990; 
van Hoof, Jogems-Kosterman, Sabbe, Zitman & Hulstijn, 1998). The influence 
of processing speed on other cognitive functions has been studied extensively in 
aging research by Salthouse (1996). He found evidence that age-related slowing 
of processing speed influences other cognitive measures, such as memory. A 
few studies have examined the relation between processing speed and memory 
measures in schizophrenia. Brébion, Amador, Smith and Gorman (1998) and 
Brébion et al. (2000) concluded that memory deficits may be partly accounted 
for by a slowing of processing speed.  
Executive functions are thought to play a role in effortful cognitive processes. 
Recent research suggests that the central executive has different component 
functions (Baddeley, 1996; 1998; Nathaniel-James, Brown & Ron, 1996; 
Salamé, Danion, Peretti & Cuervo, 1998), such as: coordination of performance; 
switching of strategies to handle a task; selective attention and inhibition, Long-term memory deficits 
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organization of information. Although the central executive is thought to play 
an important role in schizophrenia (Goldman-Rakic, 1994), the results are not 
always consistent, probably due to a large variance in the patient group. And it 
is not clear what component of the central executive is related to memory in 
schizophrenia (Salamé et al., 1998). Organization of information however, is a 
good candidate because strategic processes, such as organization of to-be-
learned information, play a role in the encoding of new information (Fletcher 
and Henson, 2001). Recall is better for word lists that can be organized in 
semantic categories for example, and a strategic approach in a visual copy and 
memory task, such as the Rey Complex Figure, leads to better results on the 
reproduction part of this task (e.g. Chiulli, Haaland, La Rue & Garry, 1995). 
Therefore organization of information might be an important determinant of 
memory performance within schizophrenia as well.  
In this study, we examined long-term memory in a large group of first episode 
schizophrenia patients. Because slowing of processing speed is often found in 
schizophrenia, we analyzed the relations between long-term memory and basic 
cognitive functions to test our first hypothesis that differences in processing 
speed explain the differences in memory measures between patients and 
controls. Next we examined whether variance in memory measures within the 
patient group is explained by differences in central executive functions, 
especially organization of information. 
 
 
2. Method 
 
2.1. Subjects 
 
The study included 118 patients who had recently experienced a first or a 
second psychotic episode according to DSM-IV (American Psychiatric 
Association, 1994) and received a diagnosis within the schizophrenia spectrum 
(schizophrenia, schizoaffective disorder, schizophreniform disorder). All 
patients participated in a Dutch multicenter study of the university hospitals of 
Groningen, Utrecht and Amsterdam. Diagnosis was based on a structured 
interview (SCAN; Wing et al., 1990 or CASH; Andreasen, Flaum & Arndt 
1992). Exclusion criteria were mental retardation according tot DSM-IV Long-term memory deficits 
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(American Psychiatric Association, 1994) and a known systemic or neurological 
illness. Subject characteristics of patient are given for the entire group and the 
three different diagnostic groups in table 1. No differences in memory or 
cognitive measures were found between the diagnostic categories. Accordingly 
they were treated as one group. Ninety-five subjects had their first episode, 23 
subjects experienced their second episode. Twenty-five patients used typical 
antipsychotics, seventy-five were on atypical antipsychotics and eighteen 
patients did not use antipsychotic medication. Ten patients also used 
anticholinergic medication. Twenty-eight patients had a diagnosis for alcohol 
abuse, 55 for cannabis abuse and 16 for other drug abuse. No significant 
differences on memory measures between patients with and without a substance 
abuse diagnosis were found, except for the patients with alcohol abuse, who 
performed significantly better on general verbal learning performance: F (1,117) 
= 7.76, p = .006. Forty-five healthy controls were included in order to establish 
standard scores on memory tests. Thirty-eight males and seven females were 
included. Mean age was 24 years (SD 6.4). There were no significant 
differences between patients and controls for sex:  χ² (1, 1 63) = 2.10, ns, or age: 
F (1, 161) = 0.29, ns. Patients and controls were not matched on education level. 
The Dutch educational system differentiates already after primary school into 
four levels, therefore we have chosen a coding system rather than years of 
education. This goes from 1: primary school up to 8: university or graduate 
school. Because thirty seven percent of the patients still received education, we 
took the level they were aiming at minus half a point. Mean education level for 
controls was 5.9 (SD 1.5). There was a significant difference between patients 
and controls: F(1.161) = 30.45, p < .000. The most likely explanation is that a 
number of patients quit school before finishing one of the four different high 
school levels, due to prodromal symptoms. Therefore they only received the 
code for primary school. All control subjects finished at least one of the 
additional high school options. Although subjects from both groups are 
represented at the highest level (university or graduate school), the mode of the 
control group is at a higher level than that the mode of the patients group. 
Therefore education is entered as a covariate in the analyses of the differences 
between patients and controls and it is treated as a possible confounder in the 
regression analyses. 
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Table 1. Subject characteristics of patients by diagnosis 
 
 
Subject 
characteristics 
All patients 
n = 118 
M (SD) 
Schizophrenia 
(a), n = 84 
M (SD) 
Schizophreniform 
(b), n= 19 
M (SD) 
Schizoaffective 
(c), n = 15 
M (SD) 
F   
 
Post-hoc 
c 
Age  23.30 (5.27)  22.45 (4.54)  26.63 (6.81)  23.80 (5.56)  5.30** a<b 
Education 
(range 1-8) 
4.0 (2.2)  3.8 (2.2)  4.7 (2.2)  4.1 (2.0)  1.37  
PANSS  
(range 30-210) 
61.85 (18.03)  65.24 (18.48)  51.53 (13.91)  56.20 (14.08)  5.75** a>b 
Positive
a  2.22 (1.06)  2.44 (1.07)  1.60 (0.85)  1.83 (0.85)  6.83** a>b 
Negative   2.33 (0.95)  2.46 (1.02)  1.89 (0.72)  2.18 (0.63)  2.99 
Disorganization  1.86 (0.68)  1.95 (0.72)  1.64 (0.56)  1.61 (0.46)  2.87 
Depression  2.34 (0.95)  2.32 (0.93)  2.21 (1.09)  2.63 (0.89)  0.90 
Excitement  1.61 (0.73)  1.69 (0.74)  1.44 (0.73)  1.40 (0.68)  1.53 
MADRS  
(range 10-60) 
14.13 (10.22)  14.39 (10.50)  12.06 (8.69)  15.20 (10.71)  0.48 
Age at onset  22.18 (5.11)  21.26 (4.18)  26.28 (6.93)  22.01 (4.95)  7.98*** a<b 
Sex m/f  87 / 31  66 / 18  12 / 7  9 / 6  3.57
b 
a Standardized PANSS ratings ranging from 1: absent to 7: extreme.  
b χ² test. 
c Tamhane. * p < .05. ** p < .01. 
 *** p < .001. 
 
 
2.2. Procedures and Instruments 
 
Memory measures.  
All patients were tested after being on stable medication for at least six weeks. 
Table 2 gives an overview of the memory measures. The Dutch translation of 
the California Verbal Learning Tests (CVLT; Delis, Kramer, Kaplan & Ober, 
1987) was used to asses long-term verbal episodic memory. The CVLT is a list-
learning task in which 16 words from 4 categories (list A) are presented over 5 
immediate recall trials. Following the five trials, a second list (B) is presented 
for one interference trial. Directly after this presentation, short delay free and 
cued recall of list A are assessed. After 20 minutes long delay free and cued 
recall are assessed, immediately followed by a yes-no recognition task with 28 
distracters. The total sum of words over the first five learning trials was taken as 
a measure of general verbal learning performance. The difference between long-
term free recall and immediate recall trial on 5 was taken as a measure of 
storage. Retrieval was computed by subtracting the standardized score of long 
term free recall from the standardized score on the recognition task. Because it 
is difficult to find a visual memory task with measures for encoding, storage and 
retrieval, and there is no evidence for a difference between verbal and visual 
memory in schizophrenia, we decided to use the recall measures from the Rey Long-term memory deficits 
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Complex Figure Test (RCFT; Rey, 1964) only. Subjects were administered a 
copy trial, an immediate recall and a delayed recall trial in which they had to 
draw the complex figure. The RCFT was scored using explicit scoring criteria 
from Duley, Wilkins, Hamby and Hopkins (1993) based on the method 
developed by Osterrieth (1944). The mean percentage correct from the 
immediate and the delayed recall (recall: copy x 100) was used as a visual 
memory measure. Retrieval from semantic memory was measured with a 
category fluency task in which subjects had to name as many words from one 
category (animals and professions) as possible in one minute. Although it 
cannot be denied that frontal functions play a role in category fluency, several 
studies also prove that the performance on category fluency is also influenced 
by the contents of the semantic store or semantic memory or the access to the 
semantic store. (Joyce et al., 1996; Chertkow & Bub, 1990). 
 
Basic cognitive variables that may influence memory. 
These additional measures were collected in the same test session (see table 2). 
The time in seconds on word reading and color naming of a computerized 
STROOP task were taken as measures of processing speed.  A modified version 
of the Trailmaking Test  (Vink & Jolles, 1985) was administered as a second 
task for processing speed. This version consists of three parts. In part A, the 
subject must connect consecutively numbered circles from 1 to 26. In part B, 
the subject must connect circles with the letters A through Z. In part C the 
subject must connect 26 consecutively numbered and lettered circles, by 
alternating between the two sequences. Time on part A and part B were taken as 
measures of processing speed. All speed measures correlated highly with each 
other in the total group of subjects (r ranging from .50 to .91, with p < .000). 
Therefore they were averaged after a z-transformation, to create one processing 
speed score. Five different measures were used in order to examine different 
component processes of the central executive.  The Continuous Performance 
Task used in this study (CPT; Van den Bosch, Rombouts & Asma, 1996) is a 
double stimulus version, with a memory load, in which a subject has to react 
when the number seven appears on a computer screen after the number 3.   
Patients have to remember the last stimulus, the task instruction, and stay alert 
to react to the new stimulus. The sensitivity index (d’) of this double-stimulus 
CPT was used to assess the ability to coordinate the allocation of processing Long-term memory deficits 
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capacity (Coordination). In another study of our group (Broerse, Holthausen, 
van den Bosch & den Boer, 2001), significant correlations were found between 
CPT d’ and the percentage of inhibition errors on an antisaccade task, which is 
an established frontal executive task. The interference score of the Trailmaking 
Test (interference = C- ½ (A + B)  / ½ (A + B)) was taken as a measure of the 
ability to switch between search strategies (Switching). The STROOP 
interference score (STROOP color word – STROOP color naming) was used to 
assess selective attention and inhibition (Selective attention). We had two 
measures for organization.  The semantic cluster score from the CVLT was 
taken as a measure of organization of verbal information. Regarding visual 
memory we decided to take the method of drawing as a measure of 
organization. We used a binary approach wherein a drawing strategy in which 
the main figure was drawn first was coded as normal and a drawing strategy 
with a fragmented approach was labeled as abnormal (Chiulli et al., 1995; 
Lezak, 1983). 
 
Psychopathology. 
Symptoms were rated on the Positive and Negative Syndrome Scale (PANSS; 
Kay, Fiszbein & Opler, 1987) within the same week as the neuropsychological 
assessment. These ratings were used to obtain dimensional scores by calculating 
the sum scores loading high on the positive, negative, disorganization, 
depression and excitement dimensions as described in Lindenmayer, Bernstein 
Hyman, Grochowski and Bark (1995). Depressive symptoms were also rated 
with the Montgomery Åsberg Depression Rating Scale(Montgomery and 
Åsberg, 1979). Symptom ratings are given in table 1.  
 
 
3. Results 
 
All variables were inspected to see if they resembled the normal distribution. If 
not, log transformations were performed. This was the case for STROOP 
interference and the positive and disorganization dimensions from the PANSS. 
Differences between patients and normal controls on all memory and cognitive 
variables were tested with ANCOVA with education as covariate. If the effect 
of the covariate was significant, estimated marginal means are given, which are Long-term memory deficits 
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corrected for education (with raw means in parentheses).  Effect sizes were 
computed for the differences between controls and patients on all memory and 
cognitive measures using Cohen’s d, with the standard deviation of the control 
group (table 2). Patients performed significantly worse on all long term memory 
measures, except storage of verbal information, which was left out of further 
analyses. The effect sizes showed that general verbal learning performance and 
semantic memory were especially disturbed, with large effect sizes (according 
to Cohen, 1969). Patients also performed significantly worse on most basic 
cognitive measures, with large effect sizes except for Trail Making interference 
(small) and CVLT semantic clustering (medium).   
 
Table 2. Long-term memory and other cognitive variables in patients and controls. 
 
      
     Cognitive measures 
Controls n = 45 
M ± SD 
Patients n = 118 
M ± SD 
F-value 
 
Effect sizes 
Cohen’s d 
Memory Measures       
     CVLT trial 1-5  56.38 ± 8.52  45.69 ± 9.21  45.59****  -1.25 
     CVLT storage  -0.68 ± 1.49  -1.15 ± 2.25  1.66  -0.32 
     CVLT retrieval   0.11 ± 1.65   1.18 ± 1.77  12.01**  -0.65 
     RCFT  immediate recall  70.50 ± 16.21  61.71 ± 20.19  5.86*  -0.54 
     RCFT delayed recall  68.39 ± 16.46  61.31 ±  18.37  5.11*  -0.43 
     Category fluency  22.68 ± 5.09  18.06 ± 4.27  33.96****  -0.91 
Estimated marginal means
a      
     STROOP names (time)   38.33 ± 4.59 
(36.76) 
47.29 ± 9.91 
(47.91) 
28.70**** -1.95 
     STROOP colors (time)  33.77 ± 5.68  
(34.42) 
44.72 ± 9.14 
(45.27) 
32.55**** -1.58 
     Trailmaking A (time)  26.71 ± 7.54 
(25.13) 
38.13 ± 15.08 
(38.88) 
19.81****   -1.51 
     Trailmaking B (time)  26.87 ± 9.68 
(24.62) 
37.19 ± 15.78 
(38.38) 
14.85**** -1.07 
     CPT d ‘   4.14 ± 0.55 
(4.29) 
 3.60 ± 0.77 
(3.53) 
17.23**** -0.98 
     CVLT semantic     
      clustering 
 2.05 ± 0.99 
(2.05) 
 1.61 ± 0.66 
(1.57) 
8.98** -0.44 
Raw means      
     Trailmaking interference  41.51 ± 30.05  48.31 ± 44.31  1.11  -0.23 
     STROOP interference   7.43 ± 5.17  11.59 ±  11.44  2.17*  -0.80 
     RCFT organization type 
     (% normal) 
84% 62% 7.50
b** - 
a Means adjusted for the covariate education, raw means without adjustment are shown within parenthesis. 
 
b χ² test. * p < .05. ** p < .01. ***p < .001. **** p < .0001. 
 
 
Correlations between all memory and cognitive variables and education for all 
subjects and for the patient group separately are given in table 3 and 4.   Long-term memory deficits 
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Table 3: Correlations between memory measures and cognitive measures for the whole group 
(patients and controls, N = 163) 
 
  2  3 4 5 6 7 8  9  10  11  12 
                
1.Verbal 
learning 
.223** .347*** .365*** .415*** .460*** .362*** .160*  .061 .419*** .300*** .277*** 
2. Verbal 
storage 
- .465***  .184* .245**  .176* .189* .074 .128  .178* .303*** .086 
3. Verbal 
retrieval 
 - .197*  .369*** .357*** .300*** .137  .185* .297*** .257**  .181* 
4. Visual 
memory 
   - .231**  .323***  .301***  .095  .076 .129  .346*** .148 
5. Semantic 
memory 
    -  .571***  .423***  .125  .064 .335*** .255**  .288*** 
6. Speed of  
processing 
     -  .577***  .236**  .040 .340*** .289*** .436*** 
7. Coordi-
nation 
      -  .159*  .136  .245**  .262**  .429*** 
8. Selective 
attention 
       -  .139  .089  .100  .159* 
 9. 
Switching 
         -  .055  .096  .109 
10. Verbal 
organization 
           -  .265**  .299*** 
11. Visual 
organization 
            -   . 2 1 3 * *  
12. 
Education 
             -  
* p < .05. ** p < .01. ***p < .001.  
 
There are significant correlations between all memory measures in the whole 
subject group, and between most memory measures in the patient group. As for 
the cognitive measures, speed, coordination and verbal and visual organization 
are significantly associated. Correlations between memory variables and 
psychopathology measures were computed. Only two significant correlations 
were found for semantic memory and the negative and disorganization 
dimensions respectively (r = .262, p = .005; r = .228, p = .014) 
In order to examine whether speed explains the difference in memory measures 
between patients and controls, we used the method suggested by Salthouse 
(1996). In the original method, which is based on regression analysis, group is 
first entered as a predictor, to calculate the amount of variance predicted by 
group membership for each memory measure, the so-called disease related 
variance. Secondly, in a new analysis, speed is entered as a first predictor before 
group, to see if the amount of variance explained by group is reduced 
considerably. We altered this method slightly to control for the possible 
confounding effect of education. First group is entered as a predictor, as in the 
original method. Secondly education was entered after group.  Long-term memory deficits 
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Table 4. correlations between memory measures and cognitive measures for patient group ( n = 
118) 
 
  2  3  4 5  6 7 8  9  10  11  12 
                    
1.Verbal 
learning 
.200* .231*  .337*** .294**  .222*  .242** .118 .018  .236* .189* .188* 
2. Verbal 
storage 
-  .297**  .191* .151 .127  .186* .036  .079  .193*  .303**  .083 
3. Verbal 
retrieval 
  -  .178  .301**  .248** .255** .098 .151  .255**  .189* .109 
4. Visual 
memory 
    -  .153  .318** .314** .054 .060  .046  .298**  .099 
5. Semantic 
memory 
     - .436***  .382*** .090 .008  .228* .173* .240** 
6. Speed of 
processing 
       -  .439***  .239* .129 .234*  .203*  .310** 
7. Coordi-
nation 
         -  .140  .136  .144  .204*  .319*** 
8. Selective 
attention 
         -  .113  .060  .086  .232* 
 9.  
Switching 
           -  .045  .078  .046 
10. Verbal 
organization 
             -  .150  .207* 
11. Visual 
organization 
               -  .175 
12. 
Education 
                 -  
* p < .05. ** p < .01. ***p < .001.  
 
If the coefficient of group changed more than 10 %, education was treated as a 
confounder. This was the case for visual and semantic memory. For these 
variables we conducted two separate analyses. In the first group was entered 
after speed, to see how much the disease related variance is reduced by speed. 
In the second group was entered after education to see how much the disease 
related variance is reduced by education (table 5). Entering processing speed in 
the model reduced disease-related variance in all memory variables.  
 
Table 5: Reduction of disease related variance after entering speed and education as a first 
predictor for the whole group (patients and controls, N = 163). 
 
     Memory 
     Measures 
Disease related 
variance 
R² group  
∆ R² for group, after 
speed as a first 
predictor 
∆ R² for group, after 
education as a first 
predictor 
      
Verbal learning   .22 ****  .07****  - 
Verbal retrieval  .07****  .01  - 
Visual memory  .04 *  .00  .02 
.18 ****  .01  .11****  Semantic memory 
    
* p < .05. ** p < .01. ***p < .001. **** p < .0001. Long-term memory deficits 
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And although education is a confounder for disease related variance in visual 
and semantic memory, speed still reduced more of the disease related variance 
than education. 
Finally, with hierarchical multiple regression analysis with forced entry, the best 
fitting regression model for the whole group is computed, using all cognitive 
variables: speed, coordination, selective attention, switching, verbal and visual 
organization. Education was also entered in the model to examine for possible 
confounding. There was no confounding, so education was left out of the 
analyses. Results are presented in table 6.  
 
Table 6: Hierarchical multiple regression analyses for long term memory variables in all subject (n = 
163), schizophrenic patients (n = 118) and controls ( n= 45) 
 
     Memory 
     measures 
Predictors B  β R²   
All subject (N = 163)        
   Verbal learning   Speed   2.58  .38 ****  .30 **** 
     Organization
a  3.93 .31  ****   
   Verbal retrieval  Speed  0.41  .30 ****  .20 **** 
 Organization
a  0.46 .20  *   
 Switching  0.01  .19  *   
   Visual memory  Organization
b  3.93  .29 ****  .17 **** 
  Speed   3.41  .24 **   
Speed  2.08  .54 ****  .35 ****     Semantic memory 
Organization
a  0.88 .14  *   
Patients (n = 118)        
   Verbal learning  Organization
a  3.26  .23 *  .10 ** 
 Coordination  2.31  .20  *   
   Verbal retrieval  Coordination  0.51  .22 *  .11 ** 
 Organization
a  0.60 .22  *  
   Visual memory  Speed  1.47  .26 **  .18 **** 
 Organization
b  3.47 .23  *  
  Semantic memory  Speed  1.41  .38 ****  .25 **** 
 Coordination  1.10  .20  *   
Controls (n = 45)        
   Verbal learning   Organization
a  0.46 .46** .39**** 
     Speed  0.49  .37**   
   Visual memory  Organization
b  1.05 .39  **  .16** 
   Semantic memory  Speed  2.63  .40**  .16** 
a Organization of verbal material (CVLT semantic clustering). 
b Organization of visual material (RCFT organization 
type). * p < .05. ** p < .01. ***p < .001. **** p < .0001. 
 
A combination of processing speed and organization made the best prediction 
for all memory variables.  
Secondly we analyzed the influence of basic cognitive variables on long term 
memory within the patient group with hierarchical multiple regression analyses Long-term memory deficits 
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with forced entry, using all cognitive variables (speed, coordination, selective 
attention, switching, verbal and visual organization). Because the role of disease 
severity on memory is not clear, psychopathology dimensions were also entered 
in the model. Results are presented in table 6. The coordinating component of 
the central executive (CPT d’) is the best predictor for both general verbal 
learning performance and verbal retrieval. Processing speed is the best predictor 
for visual memory and semantic memory, but CPT d’ still explains additional 
variance of these variables. Organization is a significant predictor for all three 
episodic memory measures but not for semantic memory. As for the role of 
disease severity, the psychopathology dimensions were not significant 
predictors. 
The influence of basic cognitive variables on long-term memory within the 
control group was also analyzed with hierarchical multiple regression analyses 
with forced entry. Results are presented in table 6. Organization is the best 
predictor for general verbal learning performance and visual memory. Speed is 
the best predictor for semantic memory and also explains some variance in 
general verbal learning.  
 
 
4. Discussion 
 
The long-term memory deficits in schizophrenia found in this study correspond 
to a large extent with those reported in other studies (e.g. Aleman et al., 1999; 
Paulsen et al., 1995), in which learning and retrieval deficits were reported but 
no storage deficits. In contrast with the results of two large meta-analyses 
(Aleman et al.; Heinrichs & Zakzanis, 1998) verbal memory deficits in our 
patients appeared more severe than visual memory deficits. Although some 
studies suggest a differential deficit in verbal learning and memory in 
schizophrenia (e.g. Saykin et al., 1991) most of these studies, including ours, 
used a non-verbal memory task that is not comparable to word list learning. A 
recent study of Tracy et al. (2001) showed similar results on verbal and non-
verbal memory tasks in schizophrenia with a non-verbal memory task, which 
produced the same memory component measures as the CVLT. Therefore we 
think that the difference in effect sizes on verbal and visual memory measures 
are caused by differences in task characteristics and not by modality specific Long-term memory deficits 
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deficits. There were also significant differences between patients and controls 
on basic cognitive variables, thought to influence memory. These differences 
were most apparent for processing speed and the coordinating component of the 
central executive. Although significant, the differences were less pronounced 
for the selective attention and the organization components of the central 
executive. There was no significant difference between patients and controls on 
the switching component of the central executive, suggesting that a distinction 
between different central executive components is valid indeed. Although there 
was a difference in education between patients and controls in this study, the 
differences in cognitive variables were still clearly significant after controlling 
for the effect of education. 
Because of the difference in education between patients and controls, the 
possible confounding effects of education were examined for all regression 
analyses. Education only was found to be a confounder for disease related 
variance in visual and semantic memory. However, education was not a 
confounder for the regression of cognitive variables on memory measures in the 
whole group. Our first hypothesis was partly confirmed. Processing speed did 
reduce the disease-related variance in all memory variables, suggesting that part 
of the differences in long-term memory performance between schizophrenic 
patients and controls could be due to a slowing of processing speed in 
schizophrenia. Although education reduced part of the disease related variance 
in visual and semantic memory, speed still reduced a larger part of the disease 
related variance than education. For general verbal learning performance, group 
membership, however, still explained some of the variance after entering 
processing speed as first predictor. This remained significant even after entering 
organization as a second predictor. This could point to a special role of verbal 
learning deficits in schizophrenia. Processing speed still was the best predictor 
for all verbal memory measures in the total subject group, and second to 
organization for visual memory.  Switching was the only central executive 
measure with additional predictive power, in this case for verbal retrieval. The 
total amount of variance explained is limited to a maximum of 35 % for 
semantic memory. 
Our second hypothesis was also partly confirmed. The combination of 
coordination and organization of information gave the best prediction for long-
term verbal episodic memory measures in patients. Processing speed together Long-term memory deficits 
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with coordination and organization respectively gave the best prediction for 
semantic memory and visual memory. The other central executive components, 
on which patients performed almost at a normal level, did not predict long-term 
memory in schizophrenia. This suggests that only central executive components 
that are affected by the disease, mediate memory performance in schizophrenia. 
An additional analysis of the control group, which performed well on all central 
executive measures, revealed that the coordination component did not influence 
memory performance; organization however did. An association between 
organization of information and encoding in normal subjects is found in other 
studies as well (Fletcher, Shallice & Dolan, 1998). We suggest a differential 
influence of central executive components on long-term memory, in which 
some components, such as organization, always influence long term memory 
performance, while others, such as coordination only have a negative influence 
when they break down. One should keep in mind, however, that the amount of 
explained variance in the patient group is modest, especially for episodic 
memory performance, suggesting that basic cognitive functions only have a 
limited influence on long-term memory functions. Data presented in other 
publications confirm our results. Brébion et al. (1998) presented correlations of 
processing speed and working memory with long-term memory measures 
ranging from .39 to .50, indicating a maximum of 25 % explained variance in 
long-term memory.  
Psychopathology did not influence memory performance in this study. This is in 
contrast with the general trend that shows a moderate influence of negative 
symptoms on memory performance (Aleman et al., 1999). Some correlational 
longitudinal studies found memory measures to be partly related to active 
episodes (Censits, Ragland, Gur & Gur, 1997; Hoff et al., 1999). This could 
explain our negative results, because symptom ratings were rather mild, and 
patients were in a relatively stable phase of the disease.  
Organization of information, coordination and especially speed were the best 
predictors for long-term memory in this study. This raises the question what is 
meant by “speed of processing”. The neurophysiology behind this construct is 
still unknown. Simple reaction times tend to be long relative to transduction and 
transmission times  (Hanes and Schall, 1996). Speed could refer to efficiency of 
information processing, and therefore is likely to reflect some kind of executive 
process. Speed and central executive components were correlated in this study Long-term memory deficits 
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but they explained different parts of the variance in long-term memory. These 
speed related “executive processes” probably operate in such a short time 
interval that they are almost impossible to assess with executive tasks. 
Electrophysiological and functional imaging studies could help to clear this 
issue. 
The main conclusion is that the influence of more basic cognitive deficits on 
long-term memory in schizophrenia is modest, especially for verbal learning.  It 
seems that the long-term memory deficits in schizophrenia are primary deficits. 
The question remains what sub processes of memory are to be held responsible. 
Because learning of information is most impaired, the early perceptual encoding 
of stimuli or the establishment of memory traces are the most likely candidates.  
Imaging studies of verbal encoding point to a special role for the prefrontal 
cortex and the medial temporal regions including the hippocampus (Cabeza & 
Nyberg, 2000). In an excellent review of neuropathological and functional 
studies, Harrison (1999) postulates that the pathofysiology of schizophrenia 
reflects aberrant activity in, and integration of, the components of a distributed 
circuitry involving the prefrontal cortex, hippocampus and certain subcortical 
structures. Although the concept of localized dysfunctions still dominates 
research in schizophrenia, a growing body of evidence indicates that deficits in 
connectivity between and within the different components of the suggested 
circuitry, which are supposed to be involved in coordination and organization of 
information, are more likely. Because the process of establishing memory traces 
depends on the coordinated forming of associations between several features it 
is conceivable that deficits in connectivity also cause memory deficits, 
especially in the phase of encoding of information. 
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Abstract 
 
The cognitive correlates of five symptom dimensions based on PANSS ratings 
were examined in a group of 50 recent onset psychotic patients, using both 
objective and subjective cognitive measures. We were particularly interested in 
the depression dimension, since it has not been studied extensively thus far. The 
depression dimension showed a fairly high number of correlations with both 
objective and subjective cognitive measures, such as problems with simple and 
divided attention, psychomotor slowing and subjectively experienced 
distractibility, overload and diminished attentional control. The other 
dimensions, including the negative symptoms, had less cognitive correlates. It is 
possible that previous studies based on a three-dimensional model confounded 
correlates of negative symptoms with correlates of depressive symptoms. The 
results of this study suggest the need for more research into the mechanisms 
underlying the relationship between depressive symptoms and cognitive 
functioning in schizophrenia, and that patients with depressive symptoms are 
less efficient in information processing, but can compensate by investing more 
mental effort. Because subjective cognitive measures were related to mental 
effort in previous research they can be a useful tool in future research. 
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1. Introduction 
 
Although schizophrenia is associated with a diversity of cognitive impairments, 
such as deficits in attention, memory, motor functioning and executive 
functioning (Gold and Harvey, 1993; Gourovitch and Goldberg, 1996; Rossel 
and David, 1997), it is not possible to specify a typical cognitive profile. This is 
partly due to the heterogeneity of the disease. Attempts to group patients into 
different subtypes of schizophrenia have not led to a solution. However, during 
the last decade a more promising dimensional approach has emerged, which 
categorizes symptoms instead of patients (Andreasen and Carpenter, 1993). 
Studies have consistently identified a positive, a negative and a disorganization 
dimension (Andreasen et al., 1994). Some, using a wider range of symptom 
ratings, also found excitement and  depression-anxiety dimensions ( Bell et al., 
1992, 1994; Kay and Sevy, 1990; Lindenmayer et al., 1994, 1995). It has been 
suggested that the dimensions represent different pathological processes (Liddle 
et al., 1987; 1992). If this is true, it is likely that the symptom dimensions have 
specific cognitive correlates.   
A number of studies have addressed the cognitive correlates of these 
dimensions of schizophrenia (Addington et al., 1991; Berman et al., 1997; 
Brown and White, 1992; Liddle, 1987; Liddle and Morris, 1991; Norman et al., 
1997; Van der Does et al., 1996). Most included only positive, negative and 
disorganization symptom dimensions. The negative dimension has been shown 
to correlate with poor generation or execution of cognitive strategies, slow 
responses on simple attention tasks, poor abstract reasoning and impaired set 
shifting. The positive dimension appears to correlate mainly with poor verbal 
memory, and the disorganization dimension has been shown to correlate with 
attentional dysfunction and inhibition problems. Only two studies examined 
cognitive correlates of depressive symptoms, focusing on attention and verbal 
memory respectively. Van der Does et al. (1996) found a significant  correlation 
with poor selective attention and Brebion et al. (1997) found that depressive 
symptoms correlated significantly with poor semantic encoding and reduced 
verbal recall and recognition. 
It is well established that a proportion of the patients, ranging from 11% to 55% 
(Palmer et al., 1997), do not show cognitive deficits on neuropsychological or 
objective cognitive measures, although they often complain about their Psychopathology and cognition 
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cognitive functioning. It is possible that these individuals perform below the 
level they could have achieved if not ill. Another explanation might be that they  
are able to compensate for their cognitive deficits on neuropsychological tasks 
by investing more mental effort. These tasks usually measure basic cognitive 
functions over a short period, in a structured way,  whereas in daily life patients 
probably reach their limits because the pressure on their information processing 
capacity is much larger. Ratings of subjective cognitive experiences could be 
helpful in obtaining an indirect measure of mental effort, because a recent study 
has shown that self-report ratings of increased mental effort are associated with 
subjective experiences of mental overload and distractibility (Van den Bosch & 
Rombouts, 1998).   
Subjective cognitive deficits are failures or difficulties experienced by a person 
in the perception and processing of internal and external information, which are 
usually measured with self-report questionnaires. A small number of studies 
have examined subjective cognitive functioning in schizophrenia. These studies 
report a high prevalence of subjective cognitive deficits (Liddle et al., 1988; 
Peralta and Cuesta, 1998; Van den Bosch et al., 1993). There is a striking lack 
of correlation between objective and subjective measures. Williams et al. (1984) 
did not find a relation between self-report of cognitive difficulties and a choice 
reaction time task. Van den Bosch and Rombouts (1998) found no correlation 
between subjective cognitive dysfunctions and vigilance performance. 
Our main objective in this study was to examine whether the five 
psychopathology dimensions have different cognitive correlates in recent onset 
psychotic patients. We were particularly interested in the depression dimension, 
because there is good evidence for its independent existence and it has not been 
studied extensively thus far. Although we do not know which specific cognitive 
functions are associated with this dimension, we hypothesized that it would 
have at least some cognitive correlates. Neuropsychological tasks addressed 
attentional, memory, executive and motor speed functions. To get an indirect 
measure of the amount of mental effort people invest to compensate for their 
cognitive deficits, we also included subjective ratings of cognitive functioning. 
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2. Method 
 
2.1. Subjects 
 
The study included fifty psychiatric patients who had recently experienced a 
first or second psychotic episode. Psychiatric diagnosis according to DSM-IV 
(American  Psychiatric Association, 1994) was based on all information 
available, including a structured interview (Schedules for Clinical Assessment 
in Neuropsychiatry, SCAN; Wing et al, 1990). This study was part of a larger 
epidemiological study for which they gave informed consent. Exclusion criteria 
were severe mental retardation and a known systemic or neurological illness. 
Subject characteristics are given in table 1. There were no significant   
differences between the schizophrenic patients and patients with another 
psychotic disorder for sex (Chi-square = 0.02, ns), age (F = 0.12, ns), or 
educational level (F = 1.62, ns). 
 
Table 1.  Demographic characteristics of patients by diagnosis. 
 
Diagnosis n  age 
    m               sd    
sex 
m / f 
educational level*  
    m               sd 
schizophrenia  32  24.8  6.3  22 / 10  3.8  1.3 
schizophreniform disorder  10  23.7  6.3  7 / 3  2.4  0.7 
delusional disorder  2  28.5  4.9  2 / -  4.0  1.4 
brief psychotic disorder  2  18.  2.1  - / 2  3.5  0.7 
psychotic disorder NOS  4  31.8  9.4  3 / 1  4.8  1.9 
Total  50  25.0  6.6  34 / 16  3.6  1.4 
* educational level goes from 1: primary school, up to 6: university degree  
 
The average daily dosage of antipsychotic drugs was 6.1 mg haloperidol 
equivalents (range 1.0 - 20.0 mg). Seven patients were drug-free. Fifteen 
patients also used antiparkinsonian drugs. 
 
 
2.2. Procedures and instruments 
 
During the first week after admission patients were interviewed with the SCAN. 
Psychiatric diagnosis was made at a consensus meeting, seven weeks after 
admission. Only subjects with a diagnosis within the schizophrenia spectrum 
(schizophrenia, schizophreniform disorder, delusional disorder, brief psychotic Psychopathology and cognition 
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disorder, psychotic disorder NOS) were included. Patients were tested after a 
period of six weeks on stable medication. Within the same week their symptoms 
were rated on the Positive and Negative Syndrome Scale (PANSS; Kay et al., 
1987). Dimensional scores were obtained by calculating sum scores of 
symptoms loading high on the five dimensions described in a large factor 
analytical study (Lindenmayer et al., 1995). 
Objective cognitive functioning was measured using a neuropsychological 
battery measuring attention, memory, executive functioning and motor speed. 
Vigilance was measured with the sensitivity index d’ of a double stimulus 
Continuous Performance Task (CPT; Van den Bosch et al, 1996). A 
computerized STROOP task measured reaction time in two simple (names, 
colors) and one complex selective attention task (interference). Forms A and B 
of a computerized version of the Trail Making Test were used to measure 
simple and divided attention respectively. The Digit Span subtest of the 
Wechsler Adult Intelligence Scale (WAIS; Stinissen et al., 1970) was used to 
measure immediate verbal memory, and the delayed recall score of the Dutch 
translation of the Rey Auditory Verbal Learning Task (RAVLT; Rey, 1964) was 
used to measure long-term verbal memory. Executive functioning was measured 
as the number of steps taken on a computerized Maze task and motor speed was 
measured by Fingertapping.   
Subjective cognitive functioning was measured with the Test of Attentional 
Style (TAS; Van den Bosch et al., 1993). The TAS is a self-report questionnaire 
of 31 items containing five subscales. Responses are on a five point scale 
ranging from 1: “never” to 5: “always”. The first two subscales refer to 
cognitive problems and are called (1) Distractibility and (2) Overload. The other 
three subscales measure perceived cognitive efficacy and are named (3) 
Processing capacity; (4) Attentional Control and (5) Conceptual Control. The 
last subscale was left out of analysis because it does not distinguish patients 
from normal controls (see Van den Bosch et al, 1993, for a more extensive 
description). 
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3. Results 
 
Table 2 presents the data on the symptom dimensions and the cognitive 
measures. The symptom ratings, especially on the excitement and the 
disorganization dimensions, were fairly low. This is no surprise because patients 
were rated after a period of six weeks on stable medication. 
 
Table 2.Symptom dimensions, neuropsycho-
logical  tests and subjective cognitive 
functioning six weeks after admission. 
 
The excitement dimension was left 
out of analysis because of the very 
low variability in scores. We do not 
give the norm-scores for the 
objective cognitive variables 
because the tasks were standardized 
on different groups. In general the 
STROOP, Trail Making and Maze 
tasks were performed poorly. 
Performance on the CPT, 
Fingertapping, Digit Span and 
verbal learning tasks where within 
the normal range. All variables resembled the standard normal distribution, 
except the positive and the disorganization dimensions, which were skewed to 
the left. Therefore we used parametric as well as nonparametric correlation 
analysis. Because we predicted higher levels of symptomatology to be 
associated with poorer cognitive performance, one-tailed tests of significance 
were used (table 3).  
The depression dimension in particular correlated significantly with a number of 
objective and subjective cognitive variables: slow performance on STROOP 
colors, Trailmaking A and B, Fingertapping and subjectively experienced 
distractibility, overload and diminished attentional control. The other symptom 
                                                 
1 This computerised version takes longer then the paper and pencil test. 
2 Minimum number of steps, which means an excellent performance, is 205. 
3 For mean scores and standard deviations of a normal control group see: Van den Bosch et al 
(1993). 
 Mean  SD 
Symptom dimensions     
    positive (5 PANSS items)  9.9  5.0 
    negative (6 PANSS items)  12.4  5.0 
   disorganization (5 PANSS items)  7.7  2.7 
    depression (4 PANSS items)  9.3  3.3 
    excitement (3 PANSS items)  3.7  1.1 
Neuropsychological tests     
    CPT d’  3.6  0.9 
    STROOP names (s)
1 53.6  9.1 
    STROOP colors (s)  50.4  9.3 
    STROOP interference (s)  68.0  15.3 
    Trail Making A (s)¹  84.6  39.2 
    Trail Making B (s)  103.3  40.6 
    Mazes number of steps
2 280.5  108.0 
    Fingertapping (10 s)  50.9  12.5 
    Digit Span WAIS  12.8  3.6 
    Delayed recall RAVLT  9.4  2.6 
Subjective Cognitive Functioning
3    
    Distractibility   23.1  4.7 
    Overload  16.8  4.6 
    Processing Capacity  17.8  3.4 
    Attentional Control  15.2  2.3 Psychopathology and cognition 
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dimensions showed less significant correlations with these variables. The 
positive dimension correlated with poor delayed verbal recall and slow 
Trailmaking B, as well as subjective overload experiences. The disorganization 
dimension correlated with subjective distractibility and overload experiences, 
but not with objective test measures. The negative dimension correlated with 
poor Fingertapping and the subjective experience of distractibility and 
diminished processing capacity. 
 
Table 3.  Correlations between symptom dimensions and cognitive variables. 
 
 cognitive variables  positive 
 dimension † 
disorganization 
 dimension †  
negative 
 dimension ‡ 
depression 
 dimension ‡ 
Objective       
CPT d’  0.10  -0.05  -0.04  0.06 
STROOP names  0.01  0.03  0.08  0.23 
STROOP colors  0.13  0.09  0.13  0.35** 
STROOP interference  0.07  0.02  0.09  0.23 
Trail Making  A  0.15  0.04  0.12  0.26* 
Trail Making  B   0.32*  0.17 0.24  0.29* 
Mazes number of steps  -0.08   0.05  0.12  0.15 
Fingertapping -0.19  -0.02   -0.25*  -0.28* 
Digit Span WAIS   -0.01  -0.05  -0.18  -0.17 
Delayed recall RAVLT   -0.33*  -0.05 0.07  0.19 
Subjective        
Distractibility 0.20   0.24*   0.30*  0.49*** 
Overload   0.31*   0.25*  0.22  0.44** 
Processing Capacity  0.05  0.03   -0.26*  -0.07 
Attentional Control  -0.11  -0.09  -0.12  -0.33** 
† Spearman rank-order correlation coefficients; ‡ Pearson product-moment correlation coefficients. 
One-tailed significance, *p <  .05, **p  < .01, ***p <  .001 
 
The associations between objective and subjective cognitive measures were 
examined with one-tailed tests for significance on the Pearson product-moment 
correlations. Distractibility correlated significantly  (p < .05) with the STROOP 
interference (0.27), Fingertapping  
(-0.25) and Digit Span (0.34). Processing capacity correlated significantly (p < 
.05) with Trail Making B (0.30), and Attentional control correlated significantly 
with Delayed verbal recall (0.35). The subjective experience of Overload had no 
objective cognitive correlates.     
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4. Discussion 
 
In this study on recent onset psychotic patients we found significant correlations 
between several symptom dimensions and subjective as well as objective 
cognitive variables.   Depressive symptoms were associated with a fairly high 
number of cognitive ratings such as problems with simple and divided attention, 
psychomotor slowing and subjective experiences of  distractibility, overload and 
diminished attentional control. The other symptom dimensions showed fewer 
cognitive correlates, with some overlap with the depression dimension. 
Negative symptoms correlated with psychomotor slowing and the experience of 
distractibility, as did the depressive symptoms. However, there was a unique 
correlation with the experience of diminished processing capacity. Somewhat 
surprisingly, disorganization symptoms correlated only with subjective 
experiences of distractibility and overload but not with objective cognitive 
measures. Positive symptoms correlated with problems in divided attention and 
subjective experiences of overload, like depressive symptoms, but there was a 
unique correlation with poor verbal recall. The last finding is in accordance with 
other studies (Berman et al., 1997; Norman et al., 1997), whereas the findings 
concerning negative and disorganization symptoms are not. In most studies 
these dimensions correlate with executive and attentional tasks (Addington et 
al., 1991; Berman et al., 1997; Brown and White, 1992; Liddle, 1987; Liddle 
and Morris, 1991; Norman et al., 1997; Van der Does et al., 1996). Our negative 
findings regarding objective cognitive correlates of the disorganization 
dimension might be due to the fact that our patients had relatively few of these 
symptoms because they were on stable medication. There are several possible 
explanations for the lack of objective cognitive correlates of the negative 
symptoms in this study. First, in other studies this dimension usually correlates 
with less structured executive tasks like Verbal Fluency and Wisconsin Card 
Sorting, while we used an executive task (Mazes) which forces the subject to 
find the only possible solution. Second, the patient group also differed from 
other studies, most of which were based on more chronic patients. Studies of 
recent onset patients are not confounded by long-term medication or 
hospitalization, but these patients have a higher prevalence of depression 
(Addington et al., 1998; Koreen et al., 1993). This makes it more likely that 
cognitive correlates of depressive symptoms are identified. Moreover, studies Psychopathology and cognition 
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based on a three-dimensional model of symptomatology are likely to confound 
correlates of negative symptoms with correlates of depressive symptoms. Most 
studies have only looked at negative, positive and disorganization dimensions.  
The evidence in favor of an independent dimension of depressive symptoms in 
schizophrenia is quite strong, as is shown by several factor analytical studies 
(Bell et al., 1992; 1994; Kay and Sevy, 1990; Lindenmayer et al., 1994; 1995), 
correlational studies (Kuck et al., 1991; Newcomer et al., 1989), and studies 
investigating the differences between schizophrenic patients with and without 
depression (Kohler et al., 1998; Lindenmayer et al., 1991). It is important to 
study these symptoms and their cognitive correlates in addition to the core 
symptoms of psychosis. If the causal mechanisms of the symptom dimensions 
and their cognitive correlates are the same regardless of the diagnostic category, 
then the causal mechanisms of some cognitive problems of psychotic patients 
with depressive symptoms could be the same as those in affective disorder 
patients. Depressive patients are less efficient in effortful information 
processing, and this would show in a slowness in reacting and responding   
(King and Caine, 1996). This agrees well with our findings on objective 
cognitive tasks.  
The correlations of depressive symptoms with subjective cognitive complaints 
are also interesting. There is a relationship between depressive symptoms and 
subjective experiences of distractibility and mental overload. Previous research 
showed that in schizophrenic patients these subjective complaints were strongly 
related to ratings of the amount of mental effort people felt they had to spent on 
cognitive tasks (Van den Bosch & Rombouts, 1998). It could be speculated that 
depressive symptoms are accompanied by less efficient information processing, 
as a result of which patients have to invest more effort, which, in turn, results in 
subjective cognitive complaints in spite of normal results on neuropsychological 
tasks. This points to the importance of subjective measures for cognitive 
research. There were some correlations between subjective and objective 
cognitive tasks, but subjective mental overload had no objective cognitive 
correlates. This could mean that this scale addresses problems, which cannot 
easily be assessed by neuropsychological tasks. 
The results of this study suggest that more research should be directed at the 
mechanisms behind the relationship between depressive symptoms and 
cognitive dysfunctioning in schizophrenia. In this study, the depression Psychopathology and cognition 
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dimension of the PANSS was used. In future research more sophisticated 
depression scales might be used. Subjective cognitive ratings and psycho 
physiological measures of mental effort could be helpful in unraveling the 
relationship between depressive symptoms and cognition. Psychopathology and cognition 
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Abstract 
 
Objective: This study examined the predictive value of cognitive functioning in 
a first episode group for course of illness and functional outcome in 
schizophrenia. Method: One hundred and eighteen first episode patients were 
tested on a cognitive battery. One hundred and three patients participated in the 
follow-up two years after inclusion. Data were gathered to predict course of 
illness, social role functioning, competitive employment, and need for care. 
Differences in outcome between cognitively normal and cognitively impaired 
patients were also analyzed. Results: Cognitive measures at inclusion did not 
predict relapse rate, social functioning or competitive employment. Time in 
psychosis or in full remission, as well as need for care were partly predicted by 
specific cognitive measures. Although statistically significant, the predictive 
value of cognition was very limited, explaining a maximum of six percent of the 
variance in these measures. There was a significant difference between patients 
with and without cognitive deficits in general on competitive employment status 
and the work role. Conclusions: Although cognitive deficits in a global sense 
may affect work performance, the predictive value of specific cognitive 
measures for outcome in schizophrenia is quite limited. This challenges the idea 
that cognitive impairment should be considered as the core of the disease and 
suggests that the relation between cognition and outcome is not that 
straightforward, and might be affected by other mechanisms, such as mental 
effort and compensation. 
 Cognition and outcome 
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1. Introduction 
 
There is no doubt that cognitive deficits are often found in schizophrenia. As for 
the nature of the cognitive deficits in schizophrenia, most authors agree that 
there are specific deficits against a background of generalized cognitive 
dysfunctioning (Saykin et al., 1994). In an extensive meta-analyses the largest 
differences between schizophrenia patients and healthy controls were found for 
verbal memory, performance IQ and vigilance (Heinrichs and Zakzanis, 1998).  
Schizophrenia often runs a chronic course, which is difficult to predict. One of 
the most important course specifiers is relapse rate. Relapse rate in the first year 
is relatively low but rises substantially in the following years. Five years after 
first contact it varies around 70 – 80% (Robinson et al., 1999; Wiersma et al., 
1998). Common sense suggests that cognitive competence is likely to be a 
predictor of course of illness. One reliable study so far has investigated the 
predictive value of cognitive measures on course of illness. No significant effect 
was found (Robinson et al., 1999). 
Functional outcome is multidimensional, consisting of several domains such as 
interpersonal functioning, functioning in community settings, performance of 
basic daily activities, occupational functioning. Although only a modest 
percentage of patients end up staying in a psychiatric hospital or living in 
sheltered accommodation (14% in a six-site European study; Wiersma et al., 
2000), a large percentage of the patients living in the community experience 
problems with independent functioning, performance of basic daily activities or 
leisure activities. The onset of schizophrenia is also associated with a 
pronounced decline in employment (Mueser et al., 2001).  
Although an increasing number of studies investigate the association between 
cognitive functioning and functional outcome in schizophrenia (see Green et al., 
2000 for a review), only a few have investigated the longitudinal predictive 
value of cognition on functional outcome (Goldman et al., 1993; Johnstone et 
al., 1990, Addington and Addington, 2000; Fujii and Wylie, 2002; Velligan et 
al., 2000). The results are rather inconsistent. Two of these studies find no 
association (Johnstone et al., 1990, Addington and Addington, 2000). The other 
three found some significant cognitive predictors for several outcome domains 
(Goldman et al., 1993; Fujii and Wylie, 2002; Velligan et al., 2000). However, 
only one of these studies used a first episode group, while prediction is most Cognition and outcome 
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relevant early in the disease. No association was found, but in this study only 
two cognitive measures were used as a predictor. 
Because of the lack of cognitive prediction studies in first episode groups, the 
aim of this study was to investigate the predictive value of cognitive functioning 
in recent onset group for course of illness, social role functioning, occupational 
functioning and need for care two years after inclusion. 
 
 
2. Method 
 
2.1. Subjects 
 
The study included 118 patients who had recently experienced a first or a 
second psychotic episode according to DSM-IV and were diagnosed within the 
schizophrenia spectrum (schizophrenia, schizoaffective disorder, 
schizophreniform disorder). All patients participated in a Dutch multicenter 
study of the university hospitals of Amsterdam, Groningen and Utrecht. This 
study focused on the predictive value of neuropsychological and 
neurobiological factors for functional outcome at two year follow-up in all first 
or second episode patients who were referred to the departments of psychiatry 
for in- or outpatient treatment over a period of 1.5 years (1997-1998). After 
complete description of the study to the subjects, written informed consent was 
obtained. Diagnosis was based on a structured interview (SCAN; Wing et al., 
1990 or CASH; Andreasen et al., 1992). Exclusion criteria were severe mental 
retardation and a known systemic or neurological illness. Hundred and three 
patients participated in the follow-up after two years (87%). There were no 
significant differences in age, sex, cognitive measures, and psychopathology at 
illness onset between these 103 patients and the 15 lost to follow-up. There was 
a significant difference in level of education (F = 6.82, df = 1, 116, p = .010) 
and mean abbreviated WAIS score (F = 6.05, df = 1, 116, p = .015) in favor of 
the patients who completed the follow-up assessment. At follow-up seventy-
seven males and twenty-six females were included. Mean age at inclusion was 
23.6 years (sd 5.5).  
Forty-five healthy controls, thirty-eight males and seven females, were included 
in order to establish standard scores on cognitive tests. Exclusion criteria for Cognition and outcome 
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controls were a history of mental illness, mental retardation and a known 
systemic or neurological illness. Mean age was 23.8 years (sd 6.4). There were 
no significant differences between patients and controls for sex (χ²  = 1.67, df = 
1, 146,  n.s.) or age (F = 0.63, df = 1, 146, n.s.). At inclusion twenty-four 
patients used typical antipsychotics, sixty-seven patients used atypical 
antipsychotics, eight patients did not use antipsychotic medication, and the 
medication data from four patients were missing. Ten patients also used 
anticholinergic medication.  
 
 
2.2. Procedures and instruments 
 
Cognitive measures 
All patients completed an extensive neuropsychological battery after being 
stabilized for at least six weeks on medication. The cognitive measures in our 
study were chosen because of their widespread use in clinical practice, evidence 
for their discriminatory power in studies of schizophrenia patients and normal 
controls (Keefe et al., 1995; Saykin et al., 1994; van den Bosch et al., 1996) and 
some evidence for prediction of outcome according to former studies (Goldman 
et al., 1993; Fujii and Wylie, 2002; Velligan et al., 2000). Vigilance was 
assessed with the sensitivity index (d’) of a double stimulus Continuous 
Performance Task. Processing speed was assessed with a compound scores of 
times in seconds on word reading and color naming on a computerized Stroop 
task and time on part A and part B of a modified version of the Trailmaking 
Test (Vink and Jolles, 1985). This version consists of three parts: part A with 
numbers 1 to 26, part B with letters A through Z and part C with 26 numbers 
and letters alternately. All speed measures showed high intercorrelations in the 
total group of subjects. Therefore they were averaged after a z-transformation 
based on the scores of the healthy controls, to create one score. Selective 
attention and inhibition was assessed with the Stroop interference score (Stroop 
color word minus Stroop color naming). General verbal learning performance 
(verbal encoding) was assessed with the total sum of words over the first five 
learning trials of the Dutch translation of the California Verbal Learning Test 
(Delis et al., 1987). Verbal Fluency was operationalized as the mean number of 
words over two categories in one minute (animals and professions). Intelligence Cognition and outcome 
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was assessed with four subtests of the Dutch translation of the Wechsler Adult 
Intelligence Scale (Stinissen et al., 1970): comprehension, vocabulary, block 
design and picture arrangement. The mean C-score of these four subtests was 
taken as a measure of intelligence. These C-scores go from 0 to 10 with a mean 
of 5 and an S.D. of 2. Because the Dutch translation of the WAIS is from 1970, 
we also give corrected mean C-scores in which we take into account an 
estimated IQ gain of 0.25 points a year from 1971 to 1997 (Flynn, 1998). The 
corrected mean C-score is 5.6 with an S.D. of 1.5, which is on an average level 
compared to the general population. Table 1 gives the scores on these cognitive 
predictors for patients and controls. Patients performed significantly below the 
level of controls on all cognitive measures, except for the WAIS score. To 
investigate whether having a cognitive impairment in a global sense at inclusion 
influenced outcome, we also analyzed the differences in outcome measures 
between “cognitively normal” (CN) and “cognitively impaired” (CI) patients. In 
order to assign patients to these groups, scores on a large neuropsychological 
battery were transformed into z-scores using means and SD’s from the controls. 
A patient was considered cognitively impaired if he had at least one z-score of 
two or more below the control group (for more details: Holthausen et al., 2002).  
 
Table 1. Means and standard deviations for cognitive predictors; patients compared with normal 
controls 
 
 Patients 
N = 103 
Controls 
N = 45 
Sign. 
      
Vigilance (CPT d’)  3.53 (0.77)  4.29 (0.55)  .000 
Speed of processing *  -1.9  (1.4)  0.0 (1.0)  .000 
Selective attention (STROOP interference)  11.6 (11.4)  7.4 (5.2)  .037 
Verbal encoding (CVLT trial 1-5)  45.7 (9.2)  56.4 (8.5)  .000 
Verbal fluency (number of words)  18.0 (4.3)  22.7 (5.1)  .000 
Intelligence (mean WAIS C-score 1-10)**  6.2 (1.5)     
Mean corrected WAIS C-score  5.6 (1.5)     
      
* Mean z-score on CPT reaction time, Trailmaking A, STROOP 1 and 2. 
** Mean WAIS subtest score on Comprehension, Vocabulary, Block design, Picture arrangement. 
 
 
Course of illness 
Data were gathered with a case record form, using all possible sources of 
information. Data were analyzed over a mean period of 25 months (range 20-
32). A relapse was defined as a period in which the patient experienced Cognition and outcome 
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delusions, hallucinations or conceptual disorganization, which interfered with 
daily life. These symptoms had to be severe enough to obtain a score of 4 
(moderate) or higher on the Positive and Negative Syndrome Scale (PANSS; 
Kay et al., 1987). In order to score a new relapse, there had to be a previous 
period of 30 days without these psychotic symptoms. Only relapses after 
inclusion were counted. Thirty-eight patients (37%) experienced a psychotic 
episode at inclusion. Therefore we also looked at the percentage of time in 
psychosis. Remission was defined as a period without psychotic symptoms that 
would justify  
a score of four or higher on the PANSS. We made a distinction between full and 
partial remission. Full remission was defined as a period without any psychiatric 
symptoms (PANSS scores < 2). Partial remission was defined as a period 
without severe psychotic symptoms, but with other psychiatric symptoms or 
less severe psychotic symptoms (PANSS scores < 4). The percentage of time in 
full remission was used for analyses.  
 
Social functioning, competitive employment and need for care 
  Social functioning was assessed with the Groningen Social Disabilities 
Schedule (GSDS; Wiersma et al., 1988), a semi-structured interview that 
measures social role functioning on seven roles for the month preceding the 
interview. Social functioning was assessed at inclusion and at the follow-up. 
Mean social role score and the percentage of subjects showing disability on 
individual social roles were taken as outcome measures. Data concerning 
competitive employment were also gathered using the case record form. 
Competitive employment was defined as having a job, which enabled the person 
to make a living, or studying with a scholarship, because these students are 
required to fulfill certain standards concerning their study performance.  
Need for care during the month preceding the follow-up was rated with the 
Camberwell Assessment of Needs (CAN; Slade et al., 1996). This is a 
structured interview in which the interviewer rates the need for care according 
to the patient on 22 topics on a 3-point scale (no problem, no problem /moderate 
problem due to help given, serious problem). We grouped the needs into four 
domains: ADL, mental health care, rehabilitation, services (Wiersma and 
Buschbach, 2001). The total number of needs (score ≥ 1), and the mean score 
on each of the four domains were taken as outcome measures. Cognition and outcome 
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2.3. Statistical analyses 
 
All cognitive predictor variables were inspected to see if they resembled the 
normal distribution. A log transformation was performed for Stroop 
interference. The outcome data that were measured on an interval scale were 
also checked for normality of distribution. Relapse rate, time in psychosis, time 
in full remission, ADL-, rehabilitation- and service needs all had a positive 
skew and could not be normalized with the appropriate transformations. The 
other outcome measures resembled the normal distribution. Because 
hierarchical multiple regression analysis is rather robust for violation of the 
assumption that the criterion variable has to resemble the normal distribution we 
still used this method for analysis. For relapse rate, we also used logistic 
regression because the distinction between having no relapses at all and having 
one or more relapses appears to be most important. The predictive value of 
cognition for separate social roles, improvement or deterioration of social 
functioning over two years and competitive employment was analyzed with 
logistic regression. In order to investigate whether a cognitive impairment in a 
general sense at inclusion influenced outcome, differences in outcome between 
CN and CI patients were analyzed with one-way ANOVA’s and χ2 tests. All 
tests were two-tailed. 
 
 
 3. Results 
 
3.1. Outcome two years after inclusion 
 
Course of illness 
Seven of the 103 patients were psychotic during the entire follow-up period. 
Forty-nine patients had one or more relapses after inclusion. The mean 
percentage of time in psychosis for the whole group was 32%; the mean 
percentage of time in full remission was 25%. Fifty-three patients never were in 
full remission. The mean percentage of time in psychosis for these patients was 
40%. 
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Social functioning, competitive employment and need for care  
Table 2 gives the differences in social functioning between inclusion and 
follow-up. There was a significant improvement of the mean role score. Overall 
69 % of the patients showed an improvement in social functioning, 29 % 
showed a deterioration, 2% remained stable. There were no differences in sex, 
age or course of illness between both groups. There was also a significant 
increase in the number of patients without social disabilities, from 2 patients at 
inclusion to 12 patients at follow-up (p = .013). Both at inclusion and follow-up, 
most patients showed disabilities in the work role.  
Only 21 patients (21 %) fulfilled the criteria for competitive employment at 
follow-up. Of the remaining 81 patients (79%), 19 had regular activities, but 
depended on social welfare or their family to make a living. Five patients 
reported no problems for which they experienced a need for care. Most patients 
(67%) did have a need for care on 1 to 4 areas. The mean number of needs was 
3.5, mostly concerning mental health care.  
 
Table 2. Differences in social role functioning between inclusion and Follow-up 
 
 Inclusion  Follow-up  Sign. 
 
Mean role score* 
 
1.2 (0.6) 
 
0.9 (0.7) 
 
.000 
Self care**  44.7  22.5  .000 
Family role  75.7  52.4  .000 
Kinship role  60.2  50.0   ns. 
Partner role  65.0  61.0   ns. 
Citizen role  78.6  62.1  .012 
Social role  62.1  58.3   ns. 
Work role  86.4  68.0  .003 
      
* Standardized GSDS ratings ranging from 0: no disability to 3: extreme disability. 
** Percentage of subjects showing disability, differences between inclusion and follow-up were tested with the 
McNemar test, using the χ
2 distribution. 
 
 
3.2. Prediction of course of illness, social functioning, competitive 
employment and need for care with cognitive variables 
 
Cognition did not predict relapse rate. Even if the seven chronic psychotic 
patients were left out of the analysis, cognition still did not predict relapse rate.  
Selective attention and verbal fluency were significant predictors for time in 
psychosis. Verbal fluency was also a significant predictor for time in full Cognition and outcome 
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remission. Cognitive measures did not predict the mean social role score, 
disabilities on separate social roles, the distinction between improvement or 
deterioration in social functioning over two years or competitive employment. 
Vigilance did predict the number of needs and speed of processing predicted the 
need for care in the domain of rehabilitation (table 3). 
 
Table 3. Hierarchical multiple regression on course of illness and need for care 
 
 R  R²  %  explained 
variance 
Beta Sign. 
Time in psychosis         
   Selective attention   .23  .05  5  -.25  .010 
   Verbal Fluency        -.23  .020 
Time in full remission        
   Verbal Fluency  .20  .04  4  .20  .049 
Number of needs        
   Vigilance  .24  .06  6  .24  .018 
Rehabilitation needs        
   Speed of processing  .24  .06  6  -.24  .012 
        
 
 
 
3.3. Differences between CN and CI patients 
 
Table 4 gives an overview of the differences between CN and CI patients on all 
outcome measures. There were significant differences on the work role, 
competitive employment, the number of needs for care and the need for mental 
health care. We computed the odds ratios (OR) for the influence of cognitive 
impairment on the dichotomic outcome measures. The OR for CI patients 
showing impairment on the work role was 1.8. The OR for CI patients having 
no competitive employment was 1.4.  
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Table 4. Differences between CN and CI patients on all outcome measures 
 
  CN patients 
(n = 20) 
CI patients 
(n = 83) 
Test Significance 
(two-tailed) 
Relapse  rate (% patients)       
    No relapse   65 %  52 %     
    Relapse after inclusion  30 %  41 %  χ
2 = 1.133  n.s. 
    Chronic psychotic  5 %  7 %     
Course of illness         
   % of time psychotic  27 (36)  33 (33)  F = 0.575  n.s. 
   %  of time full remission  27 (35)  24 (31)  F = 0.241  n.s. 
Social functioning          
   Total score
a  0.79 (0.91)  0.83 (0.59)  F = 0.062  n.s. 
   Self-care
b 26.3  20.0  χ
2 = 0.366  n.s. 
   Family role  36.8  56.8  χ
2 = 2.458  n.s. 
   Kinship role  52.6  48.8  χ
2 = 0.933  n.s. 
   Partner role  47.4  64.6  χ
2 = 1.906  n.s. 
   Citizen role  47.4  65.4  χ
2 = 2.131  n.s. 
   Social role  52.6  58.0  χ
2 = 0.183  n.s. 
   Work role  42.1  74.1  χ
2 = 7.228  .007 
Need for care         
   Number of needs  2.5 (2.1)  3.8 (2.6)  F = 3.967  .049 
   Mental health care  0.17 (0.15)  0.28 (0.19)  F = 6.453  .013 
   ADL  0.05 (0.10)  0.11 (0.21)  F = 1.689  n.s. 
   Rehabilitation  0.20 (0.30)  0.26 (0.36)  F = 0.481  n.s. 
   Services  0.07 (0.12)  0.15 (0.23)  F = 1.991  n.s. 
Competitive employment
c  40 16 χ
2 = 5.734  .017 
a: Standardized GSDS ratings ranging from (0) no disability to (3) extreme disability 
b: Percentage of subjects showing disability 
c: Percentage of subjects with competitive employment   
 
 
4. Discussion 
 
In this longitudinal study the predictive value of cognitive functioning for 
course of illness and functional outcome in first onset schizophrenia was 
investigated.  
As was expected, the patients as a group performed below healthy controls on 
all cognitive measures at inclusion. Both course of illness and functional 
outcome after two years in our sample illustrate the generally poor outcome of 
schizophrenia. Half of the patients had one or more relapses and a large part of 
the patients had psychiatric symptoms during most of the follow-up period. 
Only 21 percent of the patients were able to obtain competitive employment or 
to follow some kind of study. This is in accordance with the competitive 
employment rate mentioned in literature (Mueser et al., 2001). Although the 
majority of patients showed an improvement in social functioning at follow up Cognition and outcome 
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as compared to inclusion, most patients (82 %) still had social disabilities. Most 
patients experienced some need for care, especially in the area of mental health 
care.  
Our main finding was that the predictive value of cognition at illness onset on 
course of illness and functional outcome is very limited. One of the most 
important course specifiers, relapse rate, was not predicted by cognitive 
performance at inclusion. Selective attention and verbal fluency at inclusion 
predicted time in psychosis during the follow-up period and verbal fluency 
predicted time in full remission. Although significant, the predictive value of 
these cognitive measures was very limited, explaining five and four percent of 
the variance in these outcome measures respectively. These results are roughly 
in accordance with the only other study, which investigated the predictive value 
of cognition on course of outcome and found no significant effects (Robinson et 
al., 1999).  
Cognitive measures at inclusion did not predict social functioning. This is not 
surprising, in view of the rather inconsistent results of other longitudinal 
prediction studies. However, there seems to be a sharp contrast with the 
conclusions of the meta-analysis of Green et al. (2000), which suggests that 
several cognitive functions have significant cross-sectional relationships with 
functional outcome. This could partly be due to inclusion of studies with 
laboratory assessment of social skills, in which similarities between 
neuropsychological test conditions and social skill assessment might have 
caused an overestimation of the real correlations between these constructs. A 
closer look at the results of the cross-sectional studies focusing on the 
association of cognition with social functioning in daily life, also shows that the 
results in this area are positive but not impressive (Goldman et al., 1993; 
Addington and Addington, 1999; Addington et al., 1998; Buchanan et al., 1994, 
Heslegrave et al., 1997; Jaeger and Douglas., 1992).  Most studies find some 
significant correlations, but the p-values are all in the .01 - .05 range, which in 
view of the number of analyses in these studies, are not likely to survive a 
Bonferroni correction. The same holds for the association between cognition 
and work related variables (Addington and Addington, 1999; Addington et al., 
1998; Bellack et al., 1999; Breier et al., 1991; Dickerson et al., 1996; Brekke et 
al., 1997; Lysaker et al., 1995).  Cognition and outcome 
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Cognition seems to have some predictive value for need for care. Vigilance at 
inclusion did predict the number of needs for care a patient had at follow up. 
Speed of processing did predict the needs in the rehabilitation domain. The 
predictive value of these cognitive measures was also very limited, explaining 6 
percent of the variance for both outcome measures. We cannot exclude the 
possibility that the subjective nature of the instrument used to assess need for 
care in this study has influenced this association. Most patients have told us 
during interviews that cognitive deficits, which were assessed at inclusion and 
subsequently explained to them, still played a role in their lives. It is 
conceivable that this affects their self-confidence in a negative way and 
therefore increases their subjective experience of need for care.  
In a general sense, cognitive deficits appear to be associated with problems with 
the work role and with competitive employment at follow up. The risk of work-
related impairments was almost twice as large for patients with cognitive 
impairments compared to patients without cognitive impairments at inclusion, 
and their chances on having competitive employment were reduced to a similar 
degree. It seems that having a cognitive deficit in general, regardless of the 
nature of the deficit, may affect work performance, and acts as a limiting factor 
for occupational functioning. 
There are limitations to this study. First cognition was only measured at the 
beginning of the disease. It is possible that cognitive performance in our sample 
has deteriorated and that cognition at follow-up is associated with outcome. 
There is, however, evidence that cognitive deficits are relatively stable early in 
the disease (Rund, 1998). Secondly, the functional outcome measures are valid 
for the month preceding the follow-up, and might therefore be considered more 
or less a random indication. However, a closer look at the socio-demographic 
data gathered with case record forms shows that the social situation is rather 
stable for most patients after the initial months of the disease. Another 
limitation is that the effects of different kinds of anti-psychotic medication 
taken during follow-up are not known. 
Our results suggest that the predictive value of cognition on course of illness 
and functional outcome is not that large and challenge the idea that cognitive 
impairment is the core of the disease. Nevertheless, most patients show obvious 
cognitive deficits and many of them indicate that they are bothered by these 
deficits in daily life. It is possible that the relation between cognitive test Cognition and outcome 
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performance and functional outcome is obscured by compensation-mechanisms, 
which enable some patients to partly conceal their cognitive problems by 
investing more effort during test performance. In daily life however, when there 
is a constant appeal to many different cognitive functions, this compensation is 
likely to fail. This is in accordance with results from functional imaging studies, 
suggesting that schizophrenia patients show neural inefficiency, which shows as 
elevated activity on performance-corrected tasks (Ramsey et al., 2002). We 
think that future studies on the relation between  cognition and outcome in 
schizophrenia should include measures to assess this compensation during 
cognitive testing, such as subjective ratings of mental effort, psycho 
physiological parameters or brain imaging patterns of compensatory cortical 
activation. 
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Summary and general discussion 
 
At present it has no doubt that cognitive deficits play a role in schizophrenia. 
There is however less consensus about their cause, nature and outcome. The 
studies presented in this thesis focused on the nature and outcome of cognitive 
deficits in schizophrenia. In chapter two the heterogeneity in cognitive 
performance in schizophrenia is examined. Chapter three investigated the claim 
that frontal, or rather executive, impairment is a core deficit in schizophrenia. 
Chapter four is concerned with the mutual relations between cognitive functions 
in schizophrenia, with the focus on memory problems. In chapter five the 
relation between cognition and psychopathology was investigated. Finally, 
chapter six reported on the influence of cognition on outcome. In this final 
chapter the results of these studies are compared with the most important 
findings in the literature to see whether this could unravel a part   of the puzzle. 
 
 
1.  Cognition and schizophrenia 
 
The results presented in chapters two, four and six showed that schizophrenia 
patients as a group performed below the level of healthy controls on almost all 
cognitive tasks, except for the storage of verbal information and selective 
attention. The largest impairments were found for general verbal learning and 
speed of information processing. This is to a large extent in accordance with the 
results of a large meta-analysis on cognition in schizophrenia, which reported 
the largest impairments on global verbal memory and performance IQ 
(Heinrichs and Zakzanis, 1998). It is well known that performance IQ has a 
strong speed component. The relatively spared storage of verbal material is also 
often reported (e.g. Aleman et al., 1999).  
A discussion about cognitive deficits cannot ignore the special role which 
executive or “frontal” deficits are supposed to play in schizophrenia. These 
terms are often mixed up, because the frontal lobes are presumed to mediate 
executive functioning. Because of the resemblance between patients with frontal 
lobe lesions and patients with schizophrenia (e.g. Benson and Stuss, 1990) 
research into frontal or executive functions in schizophrenia received a lot of 
attention. In this thesis several cognitive tasks, which appeal to executive Summary and general discussion 
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functions were used: the double stimulus version of the Continuous 
Performance Task (CPT), Stroop interference, Trailmaking Test interference 
and Verbal Fluency. In chapter three two experimental methods were used as 
well, the antisaccade task and the memory saccade task. On three of these tasks, 
CPT signal detection, Verbal Fluency and the antisaccade inhibition task, 
patients differed significantly from healthy controls. These differences were less 
pronounced for Stroop interference and memory saccade errors and no 
significant differences were found on the Trailmaking Test inference score. 
These results do not support the idea of a dysexecutive syndrome as the core 
cognitive deficit in schizophrenia.  
There is a distinction between the performance on a task and the underlying 
cognitive function. Most tasks depend on several cognitive functions or 
constructs. Mutual correlations between several different cognitive tasks can 
shed some light on this matter. Correlations between cognitive tasks, presented 
in chapter four, demonstrate that both signal detection on the CPT and Verbal 
Fluency correlated strongly with speed of processing measures, while this was 
less pronounced for Stroop interference and absent for Trailmaking interference. 
The antisaccade task in chapter three only correlated with speed of processing 
measures and signal detection on the CPT. This could suggest that speed of 
processing rather than executive functions play an important role in the 
differences between patients and healthy controls on these tasks. Of course it is 
still not known what “processing speed” is in neurophysiological terms. It is not 
unlikely that speed of processing reflects executive processes on a very short 
time interval, responsible for the efficiency of our information processing.  
 
 
2. Cognitive heterogeneity in schizophrenia 
 
Although schizophrenia patients, as a group, show specific cognitive deficits 
against a background of general cognitive dysfunctioning, there are large inter-
individual differences. In chapter two a group of patients with normal cognitive 
performance according to clinical norms was identified. In chapter three 
patients were classified according to the cognitive deficits on both cognitive and 
saccadic tasks. The idea that this diversity is caused by the existence of different 
subgroups cannot be corroborated on the basis of the results presented in Summary and general discussion 
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chapter two. No differences were found between patients with and without 
cognitive deficits on obstetric complications, premorbid adjustment, age at 
onset, psychopathology and substance abuse. The only difference was in social 
functioning, in particular on the occupational role, which is a consequence 
rather than a cause of differences in cognitive performance. Although the 
“cognitively normal” patients performed within clinical limits, as a group their 
performance was below the level of healthy controls and their profile was more 
or less the same as that in “cognitively impaired” patients. Twenty-four percent 
of the healthy controls also showed cognitive deficits according to clinical 
criteria. This is in accordance with other studies showing that a part of the 
normal controls also exhibit cognitive deficits (e.g. Palmer et al., 1997). An 
interesting question would be whether these cognitively impaired controls show 
the same subclinical profile as the patient group. This could mean that cognition 
in general should be viewed as a dimensional phenomenon lying on a 
continuum with normal performance. It could also point to a bias in testing by 
which certain specific deficits show up because some tests are more difficult 
than others (Chapman and Chapman, 1978). A closer look at the mean z-scores 
of the cognitively impaired controls showed that this was not exactly the case. 
They were most disturbed on verbal encoding and selectivity of attention, while 
the patients as a group had most difficulty with speed of information processing 
and verbal encoding. A model in which separate cognitive dimensions are seen 
as discrete but interrelated dimensions seems more plausible. It could be 
hypothesized that the dimensions of verbal encoding and speed of processing 
play a special role in schizophrenia.  
In chapter four the association between several explicit long-term memory 
processes and speed of processing was examined to see whether the memory 
deficits in schizophrenia are primary deficits or secondary to a slowing in 
processing speed. Although speed reduced part of the disease related variance in 
memory, it did not explain all the differences between patients and controls on 
long-term memory tasks. A dimensional approach also leaves room for research 
into other risk or protective factors, which modulate the expression of these 
cognitive dimensions. Compensation capacity, for example, could be a 
protective factor. The term compensation is often used in dementia research in 
which context Satz (1993) developed the Brain Reserve Capacity (BRC) theory. 
In short, this theory states that due to environmental enrichment, genetic Summary and general discussion 
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predisposition or both, some individuals develop a cognitive reserve that may 
increase the threshold for cognitive deficits after brain pathology. The study 
presented in chapter two suggested that this compensation capacity, indirectly 
measured by intelligence and educational level, could explain why some 
schizophrenic patients did not show cognitive deficits during 
neuropsychological assessment. It could be speculated that these risk and 
protective factors can obscure the relationship between cognition and other 
domains of functioning in schizophrenia. A dimensional approach on cognitive 
research in schizophrenia, which also incorporates certain protective and risk 
factors, seems to be the best approach to unravel the role of cognition in 
schizophrenia. 
 
 
3. Different approaches to the assessment of cognition in 
schizophrenia 
 
Throughout this thesis three separate methods to assess cognitive functioning 
were used: clinical cognitive tests, experimental saccadic paradigms and a 
questionnaire of subjective cognitive problems. The correlations between the 
first two methods were not very impressive. Only a few significant correlations 
were found. These correlations, however, were rather robust and still significant 
after a Bonferroni correction. It is also remarkable that the saccadic tasks 
correlate with the most impaired cognitive measures in schizophrenia, namely 
speed of processing, vigilance and verbal encoding. This could suggest that 
these measures represent the most impaired neurocognitive systems in 
schizophrenia.  
The correlations between subjective and objective, or neuropsychological 
cognitive measures are another story. Only a few correlations were significant, 
and none of them holds significance after a Bonferonni correction for multiple 
testing. This is in accordance with the literature in which only marginal 
correlations between objective and subjective cognitive measures were found 
(Van den Bosch and Rombouts, 1998; Williams et al., 1984; Zanello and 
Huguelet, 2001). In chapter five it is suggested that some schizophrenia patients 
are able to improve their cognitive performance by investing more mental 
effort, but at the cost of more subjective complaints. This mechanism could Summary and general discussion 
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certainly obscure correlations between objective and subjective cognitive 
measures. It also suggests that subjective measures of cognition or mental effort 
are useful supplement to cognitive research in schizophrenia. 
 
 
4. Cognition and antipsychotics  
 
Given the rather extensive literature on the allegedly positive effects of the 
novel atypical antipsychotics on cognition, no discussion on cognition in 
schizophrenia is complete without paying attention to this topic. Most articles 
report a cognitive improvement with atypical antipsychotics (e.g. Harvey and 
Keefe, 2001; Meltzer and McGurk, 1999). However, this is obscured by a few 
factors. Firstly, there is a publication bias of industry-sponsored studies 
reporting positive effects. Secondly, most studies compare the effect of atypical 
antipsychotics with the effect of high doses of classical antipsychotics. 
Although some researchers suggest that the effect of classical antipsychotics on 
cognition is neutral (Green et al., 2002) there is some evidence for subtle 
adverse effects of classical antipsychotics on cognition (Carpenter and Gold, 
2002). While normal persons, for example, show practice effects on repeated 
cognitive tests, this improvement is not manifested in clinical trials of classical 
antipsychotics with schizophrenia subjects. There is also some evidence for 
motor slowing due to the extrapyramidal effects of (high dosed) classical 
antipsychotic drugs (Mortimer, 1997). Moreover, when cognitive performance 
of patients receiving atypical antipsychotics is compared with patients receiving 
low doses of classical drugs, no differences are found (Green et al., 2002).  
Thirdly, the results are also biased by the addition of anticholinergic drugs, to 
suppress extrapyramidal side effects of classical antipsychotics, which can 
negatively influence memory performance. In conclusion, there is hardly any 
evidence for a positive effect of atypical antipsychotics on cognition. Or to 
quote Carpenter and Gold (2002)”few researchers will consider taking atypical 
antipsychotics themselves, or describe them to patients with dementia in order 
to improve cognitive functioning.” 
Does this have any consequences for the studies reported in this thesis? In order 
to answer this question extra analyses have been performed on the data of the 
Dutch multicenter study on first episode schizophrenia (see chapter 2, 4 and 6). Summary and general discussion 
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In this total group, twenty-five patients used classical antipsychotics, seventy-
five used atypical antipsychotics and eighteen patients did not use 
antipsychotics, during cognitive assessment at inclusion. Most of the medication 
free group refused to take medication. No significant differences between these 
three groups were found on PANSS psychopathology dimensions or general 
social functioning. The medication free subjects in general performed better on 
all cognitive measures. This was significant for vigilance, speed of processing, 
Stroop interference and verbal learning. 
It seems highly unlikely that they represent a cognitively better subgroup. They 
only differ from the other group in their noncompliance, probably due to a 
stronger negative evaluation of subjectively experienced side effects. 
There was only one significant difference between subjects with atypical and 
classical medication. Subjects with atypical medication performed significantly 
slower on measures of processing speed. Although only ten patients used 
anticholinergic medication, data concerning the influence of this type of 
medication on cognitive performance were analyzed as well. Patients with 
anticholinergic medication performed significantly worse on verbal 
consolidation and verbal fluency. Although these patients did not participate in 
a randomized controlled double blind medication trial, the data in this study 
suggest that the effects of medication on cognitive functions could be negative 
rather than positive. Neither do they suggest any beneficial effect on cognition 
of atypical medication above classical antipsychotics. This latter finding 
probably results from the generally low dose of classical antipsychotics used in 
this study. Thus it is possible that the cognitive deficits found in schizophrenia 
are at least partly caused by medication, although this could never be a strong 
effect. It is not likely that the differences between cognitively “normal” and 
cognitively impaired patients are caused by medication because no significant 
differences in medication use were found between these two groups. Neither is 
an influence of medication expected on the relation between cognition and 
psychopathology or functional outcome. The same holds for negative effects on 
saccadic task performance, because animal studies showed that only clozapine, 
which was not prescribed to the subjects in our study, had a marginal effect on 
saccadic brain mechanisms. In conclusion, no strong effects of the use of 
antipsychotic medication on the results presented in this thesis are expected. 
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5. Cognition and psychopathology 
 
The ways in which the relationship between psychopathology and cognition is 
investigated has led to different results. In chapter two the question whether 
patients with more cognitive deficits showed more psychopathology was 
investigated in a cross-sectional design by comparing the levels of 
psychopathology between patients with and without cognitive deficits. No 
significant differences were found. Instead of using multivariate group 
comparisons, another approach is to study the correlations between dimensional 
scores of psychopathology and cognitive measures in a cross-sectional design. 
This was investigated in chapter five and although some correlations between 
cognitive measures and psychopathology dimensions were found, none of these 
could stand a Bonferroni correction for multiple testing, meaning that their 
significance is only marginal. This is in accordance with the inconsistent 
findings of other cross-sectional studies in the literature both for recent onset 
and chronic patients. Longitudinal studies with multivariate statistics on 
changes in cognition mostly yield negative results, even if changes in 
psychopathology take place (e.g. Rund, 1998). These negative results are not 
surprising. In view of the large variance of psychopathology and cognition 
within schizophrenia it could be suggested that it is better to investigate the 
relationship between psychopathology and cognition by looking at intra-
individual changes in both psychopathology and cognition. In recent onset 
groups positive correlations have been found between clinical improvement and 
improvement of cognitive performance (Censits et al., 1997; Gold et al., 1999; 
Hoff et al., 1999). In more chronic patients groups these correlations have not 
been found (Heaton et al., 2001; Hughes et al., 2002). It is possible that in 
recent onset schizophrenia some cognitive functions are negatively influenced 
by the severity of psychopathological symptoms. But this is only a small effect 
because even if there is an obvious improvement of symptomatology, cognitive 
impairment still persists.  
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6. Cognition and outcome in schizophrenia 
 
In schizophrenia research in general two domains of outcome can be 
distinguished: course of illness and functional outcome. Although the latter is 
often bracketed together with cognition, few studies looked at the association 
between cognition and course of illness. In chapter six a significant relation was 
found between selective attention, verbal fluency and time in psychosis. 
However, both cognitive measures together only explained five percent of the 
variance, which is not very impressive. This is in concordance with a study by 
Verdoux et al. (2002) of the relation between cognitive measures and the 
recurrence of psychosis in a mixed diagnose group with a first psychosis. This 
result was also just significant. Cognition did not have any predictive value for 
course of illness in another study of Robinson et al. (1999). In sum, the 
predictive value of cognition for course of illness is at most marginal.  
Cognition had some limited predictive value for need for care in chapter six. 
This could reflect the subjective nature of the need for care assessment, by 
which subjectively experienced cognitive deficits might increase the subjective 
evaluation of need for care. 
In theoretical models cognition is often seen as one of the main causes of social 
and occupational dysfunctioning in schizophrenia (e.g. Goldman-Rakic, 1994; 
Cornblatt, 1999). This view is often copied in theoretical reviews (e.g. Holden, 
2003; Kuperberg and Heckers, 2000). Usually these statements are based on 
two quantitative reviews by Green (1996; 2000). A closer look at these reviews 
shows that the results are mostly based on cross-sectional studies with mixed or 
chronic patient groups. Moreover most significant correlations between 
cognition and functional outcome do not stand a Bonferonni correction for 
multiple testing. In order to study the predictive value of cognition in 
schizophrenia the most logical choice would be a recent onset group, because 
such a study would not have a bias towards the inclusion of more chronic 
subjects with poorer outcome. In the literature to date only one longitudinal 
prediction study of recent onset patients was found, without any significant 
results. In our study (chapter 6) neither specific, nor global cognitive measures 
had any predictive value for social functioning two years after illness onset. 
Specific cognitive measures did not predict work performance, but having a 
cognitive deficit in a general sense did. The difference between work Summary and general discussion 
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performance and social functioning lies mainly in the importance of 
interpersonal interactions. It is possible to perform well on certain jobs without 
having a lot of interpersonal contacts. Obviously the role of cognition in 
interpersonal contacts is very limited and emotional disturbances or positive or 
negative symptoms may play a much larger role in social dysfunctioning in 
schizophrenia. The general influence of cognitive deficits on work performance 
suggests that cognitive deficits work as rate limiting factors on occupational 
functioning, possibly in the same sense as physical handicaps can hamper work 
performance. 
 
 
7. Cognition and brain dysfunctioning in schizophrenia 
 
One of the most important conclusions which can be drawn from the results in 
this thesis is that cognitive dysfunctioning is not directly related to other 
domains of functioning, such as psychopathology or functional outcome, and 
probably represents a separate dimension in schizophrenia. This makes it hard 
to maintain the claim that cognitive deficits are the core deficit and probably the 
cause of schizophrenia. Therefore it would be illogical to presume that the brain 
mechanisms, which mediate cognitive performance in schizophrenia are the 
same that cause the disease. 
The question remains how to fit the cognitive deficits into the most recent 
theories and insights concerning brain dysfunctioning in schizophrenia.  
Because cognitive tasks are rather indirect measures of brain functioning, we 
can only speculate on the basis of the results presented in this thesis.  
In the past brain research in schizophrenia has been dominated by the concept 
of localized dysfunctions. Several regions of the brain were put forward as the 
“site” of schizophrenia: the basal ganglia, the temporal lobes and most of all the 
frontal lobes. In chapter three the performance of schizophrenia patients on anti- 
and memory saccadic tasks were compared with healthy controls. Although a 
number of patients performed significantly worse than normal controls, some 
patients did not show any deviant performance on these tasks. The brain 
mechanisms behind saccadic task performance have been examined relatively 
well. One of the most important regions involved in performance on these tasks 
is the dorsolateral prefrontal cortex. The existence of a patient group with Summary and general discussion 
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normal performance on these tasks could suggest that the involvement of this 
region is not of crucial importance in schizophrenia. Of course this is 
speculative, but the results of a large meta-analysis on structural and functional 
imaging results gives stronger evidence for this claim (Zakzanis and Heinrichs, 
1999). This meta-analysis suggests that the average magnitude of difference 
between patients and controls is generally too modest to support the idea that 
frontal brain dysfunction is a necessary component of schizophrenia.  
Nowadays more and more researchers leave this localistic approach and catch 
on to the idea that certain circuits in the brain connecting multiple cognitive 
sites and systems play an important role in the pathopsychology of 
schizophrenia (Andreasen et al., 1998; Harrison et al., 1998). This is not so far 
from the localized view because most often circuits connecting the prefrontal 
cortex, temporal lobe or more specific the hippocampus and certain subcortical 
areas are proposed to play a crucial role in schizophrenia. It is very well 
possible that disconnection problems somewhere in these circuits can cause a 
range of different symptoms and deficits. The memory deficits in schizophrenia 
for example could be due to a problem in connectivity necessary in the forming 
of memory traces. Although the neurophysiology of speed of information 
processing is still unknown, it is likely that “speed” reflects the efficiency by 
which certain brain areas are employed to complete a simple task. It is possible 
that problems in connectivity make certain processes less efficient, thereby 
effecting speed of processing negatively. 
This efficiency by which certain circuits work, could also play a role in 
compensation processes. There is indeed some evidence from functional 
imaging research, showing that schizophrenia patients show neural inefficiency, 
which shows as elevated activity on performance-corrected tasks (e.g. Ramsey 
et al., 2002).  
These are all speculations however and schizophrenia is still a disease whose 
mechanisms are relatively unknown. 
 
 
8. Conclusion  
 
In sum, cognitive deficits, especially in verbal encoding and speed of 
information processing are often found in schizophrenia. Contrary to popular Summary and general discussion 
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opinion, no apparent evidence is found for specific deficits in executive 
functions. The most important finding however is that there are large inter-
individual differences in cognitive performance in schizophrenia. These 
differences could not be explained by the existence of different subgroups or by 
disease severity. Cognition is also not, or marginally related to other domains of 
functioning, such as psychopathology and social functioning.  
The question presents itself whether cognition plays such an important role in 
schizophrenia that it justifies the large effort in research. The answer is still 
affirmative, especially since conversation with patients teaches us that most of 
them have the subjective experience that cognitive deficits play a role in their 
life. But in order to unravel the role of cognition in schizophrenia conceptual 
changes have to be made. 
Firstly, it seems better to treat cognitive functions as discrete but interrelated 
dimensions in schizophrenia, without a direct or causal relationship to 
psychopathology or social functioning. Because of the inter-individual 
differences it might be better to focus on intra-individual changes and relations 
with other levels of functioning. Examples of this kind of research are studies 
on the predictive value of individual changes in cognition in recent onset 
schizophrenia.   
Secondly, protective or risk factors, which can alter the expression of cognitive 
dimensions, have to be studied as well. A possible protective factor is the 
compensation capacity, which enables persons to perform at a higher level by 
investing more mental effort. A possible risk factor could be the initial level of 
mental fatigue before task performance. Both factors can be studied by using 
subjective questionnaires on mental effort, mental fatigue and subjectively 
experienced task load together with the cognitive measures. Or by physiological 
measures thought to reflect mental effort or fatigue, such as changes in systolic 
blood pressure or in certain frequencies in heart rate variability. A potential 
problem of these types of studies is that specific physiological measures are 
sensitive to the use of specific antipsychotics (Agelink et al., 2001). Also very 
interesting are functional imaging studies of patterns of compensatory cortical 
activation on performance corrected tasks. 
Thirdly, a lot of patients learn to live with their deficits after a few years and 
rearrange their lives in order to avoid situations that they cannot cope with. 
Searching for solitary work, resting a lot in the weekends or having a very Summary and general discussion 
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protective partner who takes care of a lot of daily life hassles are examples. 
Outcome measures do not always take these changes into account, thereby 
missing confounding factors on the relationship between cognition and 
outcome.  
In sum, both experimental studies on the relations between compensation 
capacity or mental fatigue and cognition, and large longitudinal studies on the 
effects of changes in cognition early in the disease on outcome in a more stable 
phase of the disease, taking confounding factors into account, are interesting 
directions for future research. 
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Inleiding 
 
Schizofrenie is een ernstige psychiatrische ziekte, met afwijkingen in denken, 
taal, waarneming, gedrag, emotie, motivatie en cognitie (verwerking van 
informatie). Het ziektebeeld verschilt per patiënt en geen enkel symptoom is op 
zichzelf typerend voor de ziekte. Psychotische episodes met wanen, 
hallucinaties en vaak bizar gedrag worden afgewisseld met periodes waarbij 
negatieve symptomen, zoals initiatiefverlies, psychomotorische armoede en 
emotionele vervlakking op de voorgrond staan. Er is meestal ook sprake van 
een duidelijke achteruitgang in het sociaal functioneren. De gemiddelde leeftijd 
waarop men ziek wordt is rond de vijfentwintig jaar voor mannen, en rond de 
dertig jaar voor vrouwen. Ongeveer een kwart van de patiënten herstelt volledig 
na een of twee psychotische episodes, de helft herstelt slechts gedeeltelijk met 
terugkomende psychotische episodes, terwijl het overgebleven kwart een 
chronisch beloop heeft. Het is tegenwoordig algemeen geaccepteerd dat 
schizofrenie wordt veroorzaakt door een stoornis in de hersenen. Cognitie wordt 
vaak gezien als een niveau dat tussen de neurobiologische afwijkingen  en de 
hogere niveaus van functioneren, zoals zelfbewustzijn en sociaal functioneren, 
inzit. Volgens sommige onderzoekers zijn cognitieve stoornissen zelfs de 
oorzaak van de ziekte. 
Cognitieve stoornissen komen vaak voor bij schizofrenie. Als groep laten 
schizofrene patiënten afwijkingen zien op alle cognitieve functies, waarbij de 
verbale geheugenfunctie en de snelheid van informatieverwerking het meest 
verstoord lijken te zijn. Tussen patiënten zijn er echter grote verschillen. 
Sommige patiënten bijvoorbeeld  laten in een standaard neuropsychologisch 
onderzoek helemaal geen afwijkingen zien. Binnen de groep met cognitieve 
afwijkingen zijn de verschillen ook erg groot. Sommigen hebben alleen maar 
een probleem met een enkele cognitieve functie, zoals bijvoorbeeld met het 
aanleren van verbaal materiaal of het langdurig alert blijven reageren, anderen 
hebben stoornissen in verschillende cognitieve domeinen. Een van de 
belangrijkste onderzoeksvragen is dan ook hoe men om moet gaan met deze 
cognitieve heterogeniteit. In groepsvergelijkingen tussen patiënten met 
schizofrenie en gezonde controles gaat veel informatie verloren door de grote 
onderlinge verschillen in cognitief functioneren binnen de patiëntgroep. Dit zou Nederlandse samenvatting 
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kunnen worden veroorzaakt door het bestaan van subgroepen van patiënten. 
Hier is tot op heden echter weinig bewijs voor gevonden.  
Misschien is een dimensionele aanpak van cognitief functioneren bij 
schizofrenie nog de beste manier. Hierbij gaat men ervan uit dat verschillende 
continu verdeelde cognitieve functies min of meer aangetast kunnen zijn bij 
individuen met schizofrenie. 
Deze dimensionele aanpak ziet men ook terug in het onderzoek naar de 
verschillende symptomen bij schizofrenie. Over het algemeen worden drie tot 
vijf symptoomdimensies onderscheiden: positieve symptomen, negatieve 
symptomen, desorganisatie symptomen en vaak depressieve en agitatie 
symptomen. Er zijn verschillende onderzoeken gedaan naar de relatie tussen 
deze psychopathologie dimensies en het voorkomen van bepaalde cognitieve 
stoornissen. Er zijn wel enige relaties gevonden, maar de onderzoeksresultaten 
zijn niet erg consistent en de gevonden verbanden zijn niet erg sterk. 
Ditzelfde geldt voor de relatie tussen cognitie en alledaags functioneren, waarbij 
met name de relatie tussen cognitie en sociaal en beroepsmatig functioneren is 
onderzocht. 
In de studies die in hoofdstuk twee tot en met zes worden gepresenteerd is het 
cognitief functioneren bij patiënten met schizofrenie op verschillende manieren 
met verschillende instrumenten onderzocht. Tevens is er gekeken naar de 
relaties tussen cognitie en andere niveaus van functioneren bij schizofrenie, 
zowel op hetzelfde meetmoment als over een langere periode. 
De studies die in hoofdstuk twee, vier en zes worden beschreven zijn gebaseerd 
op de gegevens van de “multicenter" studie naar neurobiologische en 
neuropsychologische predictoren van functionele status bij eerste episode 
schizofrenie”. Deze studie was een samenwerking tussen academische 
ziekenhuizen van Groningen, Amsterdam en Utrecht. In eerste instantie deden 
honderd achtendertig patiënten mee. Honderd achttien van deze patiënten deden 
mee aan het cognitieve testonderzoek en van deze groep deden honderd en drie 
patiënten mee aan het vervolg onderzoek twee jaar later. 
In hoofdstuk zeven worden deze onderzoeksresultaten samengevat en 
vergeleken met de meest belangrijke bevindingen uit de literatuur, met de 
bedoeling meer te kunnen zeggen over de aard en de gevolgen van cognitieve 
stoornissen bij schizofrenie. 
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Hoofdstuk 2 
 
Dit hoofdstuk beschrijft een studie naar de kenmerken van patiënten die volgens 
de klinische normen geen cognitieve stoornissen zouden hebben. De vraag was 
of het bestaan van deze groep verklaard wordt door algemene verschillen in de 
ernst van de ziekte, het bestaan van een etiologisch afwijkende subgroep of dat 
er in principe wel cognitieve stoornissen zijn maar dat deze klinisch niet 
significant zijn omdat men ervoor kan compenseren. 
Drieëntwintig van de honderd en achttien patiënten die recent een eerste of 
tweede psychotische episode hadden gehad werden als cognitief normaal 
bestempeld (CN).  Deze groep werd vergeleken met patiënten met cognitieve 
stoornissen (CI: “cognitively impaired”) wat betreft geboorte of zwangerschap 
complicaties, premorbide functioneren, leeftijd waarop men ziek is geworden, 
psychopathologie, sociaal functioneren en middelenmisbruik. Bovendien 
werden intelligentie en opleidingsniveau van beide groepen vergeleken als 
indirecte maten voor cognitieve compensatie capaciteit. Het cognitief 
functioneren van de CI en de CN groep werd vergeleken met een groep van 
vijfenveertig gezonde controles. CN patiënten presteerden gemiddeld als groep 
onder het niveau van gezonde controles en hadden ook min of meer hetzelfde 
cognitieve profiel als CI patiënten, maar dan op een hoger niveau. Er werden 
geen verschillen tussen beide patiëntgroepen gevonden, behalve op sociaal 
functioneren, wat eerder als een consequentie dan als een oorzaak van 
cognitieve stoornissen moet worden gezien. Dit verwerpt de hypothese dat een 
verschil in ernst of het bestaan van aparte subgroepen het bestaan van een CN 
groep zou verklaren. De CN patiënten scoorden echter beduidend hoger dan de 
CI patiënten op intelligentie en opleidingsniveau. Mogelijk kan een  verschil in 
cognitieve compensatie capaciteit het bestaan van de CN groep verklaren. 
 
 
Hoofdstuk 3 
 
In dit hoofdstuk wordt de hypothese dat schizofrenie wordt veroorzaakt door 
afwijkingen in de frontale gebieden van de hersenen getoetst door de Nederlandse samenvatting 
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aanwezigheid van zogenaamde “frontale dysfuncties” met behulp van 
neuropsychologisch onderzoek en oogbewegingstaken te onderzoeken.  
Tevens werd de relatie tussen deze taken bestudeerd. Vierentwintig eerste 
episode patiënten namen deel aan dit onderzoek. Op de “frontale” 
neuropsychologische taken liet slechts de helft van de patiënten een gestoorde 
prestatie zien. Indien dit gecombineerd werd met de “frontale” 
oogbewegingstaken liet bijna tachtig procent een gestoorde prestatie zien. Dit 
betekent echter ook dat er bij twintig procent van de patiënten geen 
aanwijzingen zijn voor “frontaal dysfunctioneren”  op beide meetmethodes, dit 
verwerpt de hypothese dat schizofrenie wordt veroorzaakt door afwijkingen in 
frontaal functioneren.  
De associatie tussen de beide meetmethodes die in dit onderzoek werden 
gebruikt was ook niet erg groot. Dit zou kunnen betekenen dat beide methodes 
een beroep doen op verschillende frontale functies. 
 
 
Hoofdstuk 4 
 
Hoofdstuk vier onderzoekt de vraag of de vaak voorkomende stoornissen in het 
lange termijngeheugen bij schizofrenie primaire stoornissen zijn, of dat ze 
worden veroorzaakt door andere cognitieve beperkingen. Honderd en achttien 
patiënten die recent een eerste of tweede psychotische episode hadden gehad 
werden vergeleken met vijfenveertig gezonde controles op verschillende 
geheugenmaten om na te gaan op welke maten patiënten de meeste beperkingen 
laten zien. Vervolgens werd gekeken in hoeverre beperkingen in de snelheid 
van informatieverwerking en executieve of sturende functies van invloed waren 
op deze geheugenstoornissen. Omdat een vertraging van de 
informatieverwerking vaak voorkomt bij schizofrenie werd de hypothese 
getoetst dat deze vertraging van de informatieverwerking de 
geheugenstoornissen zou veroorzaken. Dit werd getoetst met regressie analyses 
op alle subjecten, waarbij werd gekeken of snelheid van informatieverwerking 
de ziekte-gerelateerde variantie in de geheugenmaten vermindert. Tevens werd 
nagegaan of verschillen in geheugenmaten binnen de patiëntgroep kunnen 
worden verklaard door verschillen in executieve functies. De grootste 
beperkingen werden gevonden in het aanleren van verbaal materiaal en het Nederlandse samenvatting 
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ophalen van informatie uit het geheugen voor aan tijd en plaats gebonden 
informatie en het geheugen voor algemene informatie. Snelheid van 
informatieverwerking verklaarde inderdaad een deel van de verschillen tussen 
patiënten en controles bij alle geheugenmaten.  
Coördinatie van cognitie, organisatie van informatie en snelheid van 
informatieverwerking waren de beste voorspellers van stoornissen in het lange 
termijn geheugen binnen de patiëntgroep. De hoeveelheid verklaarde variantie 
was echter vrij klein, vooral voor beperkingen in het aanleren van verbale 
informatie, een van de meest gestoorde geheugenfuncties bij schizofrenie. Het 
lijkt erop dat de stoornissen in het lange termijngeheugen bij schizofrenie toch 
vooral primair zijn en slechts voor een heel klein deel beïnvloed worden door 
andere cognitieve beperkingen. 
 
 
Hoofdstuk 5 
 
In dit hoofdstuk wordt de relatie tussen verschillende psychopathologie 
dimensies en cognitieve maten onderzocht. Hierbij waren we met name 
geïnteresseerd in het verband tussen depressieve symptomen en cognitie bij 
schizofrenie omdat dit nog nauwelijks was onderzocht. Bij een groep van vijftig 
patiënten die recent een eerste of tweede psychose hadden doorgemaakt werd 
met behulp van de PANSS, een gestructureerd interview naar psychopathologie, 
de score op vijf psychopathologie dimensies bepaald. Tevens werd bij alle 
patiënten een neuropsychologisch onderzoek en een vragenlijst voor subjectieve 
cognitieve klachten afgenomen. Er werd ook gekeken naar de relatie tussen 
deze objectieve en subjectieve maten voor cognitief functioneren. De score op 
de depressie dimensie was meer dan de andere psychopathologie dimensies 
gerelateerd aan zowel objectieve als subjectieve cognitieve maten. Het verband 
tussen depressieve symptomen en cognitie was echter niet heel erg sterk. Tussen 
objectieve en subjectieve maten voor cognitie werd nauwelijks enig verband 
gevonden. 
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Hoofdstuk 6 
 
Hoofdstuk zes kijkt naar de predictieve waarde van cognitieve maten op het 
ziektebeloop en functioneren op de lange termijn bij eerste episode patiënten. 
Honderd en achttien patiënten die recent een eerste of tweede psychose hadden 
doorgemaakt, werden getest met een uitgebreide cognitieve testbatterij.  
Van deze groep deden uiteindelijk honderd en drie patiënten mee aan het 
follow-up onderzoek twee jaar later. Hierbij werden gegevens verzameld over 
het ziektebeloop gedurende deze twee jaren, sociaal functioneren, beroepsmatig 
functioneren en zorgbehoefte. De voorspellende waarde van cognitie voor deze 
uitkomst maten werd geanalyseerd met behulp van logistische en multivariate 
regressie. Tevens werd er gekeken naar de verschillen tussen patiënten met en 
zonder cognitieve stoornissen (CI en CN, zie hoofdstuk 2). De cognitieve maten 
hadden geen voorspellende waarde voor het aantal nieuwe psychotische 
episodes, sociaal functioneren of beroepsmatig functioneren. Ze waren wel 
voorspellend voor de tijd dat men psychotisch was tijdens de follow-up periode 
en de behoefte aan zorg. De voorspellende waarde was echter minimaal, slechts 
zes procent van de variantie in deze maten binnen de patiëntgroep werd 
voorspeld door cognitieve variabelen. Er was een significant verschil tussen CN 
en CI patiënten in het beroepsmatig functioneren. Patiënten zonder cognitieve 
beperkingen hadden twee keer zoveel kans op het vinden van regulier werk dan 
patiënten met cognitieve beperkingen. Hoewel het hebben van een cognitieve 
beperking in het algemeen van invloed is op beroepsmatig functioneren, is de 
predictieve waarde van de afzonderlijke cognitieve maten voor het functioneren 
op de lange termijn beperkt. Dit is niet in overeenstemming met de theorie dat 
cognitieve stoornissen de oorzaak van schizofrenie zouden zijn. Er wordt 
gesuggereerd dat de relatie tussen cognitie en andere niveaus van functioneren 
niet zo eenvoudig is als vaak wordt gedacht en dat deze relatie mogelijk wordt 
beïnvloed door andere mechanismen zoals mentale inspanning en compensatie 
capaciteit. 
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Hoofdstuk 7 
 
In dit hoofdstuk worden de resultaten uit de verschillende hoofdstukken 
samengevat en vergeleken met de bevindingen uit de literatuur om te zien of dit 
nieuwe inzichten oplevert over de aard en de gevolgen van cognitieve 
stoornissen bij schizofrenie. Het hoofdstuk wordt afgesloten met suggesties 
voor toekomstig onderzoek.  
Samenvattend kan worden gezegd dat cognitieve stoornissen, met name 
stoornissen in het opslaan van verbaal materiaal en in de snelheid van 
informatieverwerking, vaak voorkomen bij schizofrenie. In tegenstelling tot wat 
vaak wordt beweerd is er geen bewijs voor een specifiek defect in executieve 
functies.  
Belangrijker is echter dat er grote verschillen zijn in cognitief functioneren 
tussen patiënten. Deze verschillen worden niet veroorzaakt door het bestaan van 
verschillende subgroepen of verschillen in ernst van de ziekte. Cognitie is ook 
niet of nauwelijks gerelateerd aan andere domeinen van functioneren, zoals 
psychopathologie of sociaal functioneren.  
Men kan zich afvragen of cognitie wel zo’n belangrijke rol speelt bij 
schizofrenie. Het antwoord is nog steeds bevestigend, cognitieve stoornissen 
hebben een negatieve invloed op werkprestatie en uit de gesprekken met 
patiënten bleek dat velen het gevoel hebben dat hun cognitieve beperkingen een 
duidelijke rol spelen in het dagelijks leven. Om de rol die cognitie 
daadwerkelijk speelt in deze ziekte te kunnen onderzoeken moeten er wel enige 
conceptuele veranderingen worden gemaakt in het denken over schizofrenie.  
Ten eerste lijkt het beter om cognitieve functies als aparte dimensies te 
behandelen die geen direct causaal verband hebben met psychopathologie of 
sociaal functioneren. Doordat er zulke grote verschillen zijn binnen de 
patiëntgroep lijkt het beter om onderzoek met name te richten op intra-
individuele veranderingen in cognitief functioneren en de relaties met andere 
domeinen van functioneren, bijvoorbeeld door de predictieve waarde van 
individuele veranderingen in cognitie bij eerste episode patiënten te 
onderzoeken.  
Ten tweede moeten beschermende en risicofactoren, die de expressie van in 
aanleg aanwezig cognitieve beperkingen kunnen beïnvloeden, ook goed worden 
onderzocht. Een mogelijke beschermende factor is de cognitieve compensatie Nederlandse samenvatting 
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capaciteit, waardoor men beter kan presteren door zich mentaal meer in te 
spannen. Een mogelijke risicofactor is het niveau van algehele mentale 
vermoeidheid. Beide factoren kunnen op verschillende manieren worden 
bestudeerd. Bijvoorbeeld door het gebruik van subjectieve vragenlijsten of 
schalen voor mentale inspanning en mentale vermoeidheid tijdens cognitief 
testonderzoek. Of door het gebruik van fysiologische maten voor mentale 
inspanning of vermoeidheid, zoals veranderingen in de systolische bloeddruk of 
veranderingen in hartslag variabiliteit. Zeer interessant is het functional imaging 
onderzoek naar patronen van corticale compensatie capaciteit op cognitieve 
taken, waarbij voor taakprestatie wordt gecorrigeerd. In dit soort onderzoek 
werd gevonden dat als patiënten hetzelfde presteerden als controles er bij deze 
patiënten meer corticale activiteit werd waargenomen.  
Ten derde blijkt dat veel patiënten na een paar jaar leren leven met hun 
beperkingen en hun leven dan ook op een dusdanige manier inrichten dat 
situaties waar zij moeite mee hebben zoveel mogelijk worden vermeden, 
bijvoorbeeld door werk te zoeken waarbij men weinig te maken heeft met 
andere mensen, door in de weekenden veel te rusten of door een partner te 
kiezen die hen veel taken uit handen neemt. Veel uitkomst maten houden geen 
rekening met dit soort mechanismen, waardoor factoren die de relatie tussen 
cognitie en uitkomst vertroebelen niet worden opgemerkt. 
Samenvattend, zowel experimentele studies naar de relatie van cognitieve 
compensatie en mentale vermoeidheid met cognitie als grote longitudinale 
studies naar de effecten van cognitieve veranderingen vroeg in het ziekteproces 
op het uiteindelijk functioneren in een meer stabiele fase van de ziekte lijken 
interessant voor toekomstig onderzoek 
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